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1 Introduction 
 
 
 
During various industrial processes several xenobiotics, e.g. chlorinated aromatic and 
aliphatic hydrocarbons, occurring as products or by products, are often released into the 
environment where they accumulate as recalcitrant pollutants, highly toxic for the 
biosphere. Polychlorinated dibenzofurans (PCDBFs) and polychlorinated dibenzo-p-
dioxins (PCDDs) (Fig 1) are among the most toxic xenobiotics (Krowfke, 1986). They 
are generated during combustion of chlorine-containing organic materials or chemical 
processes, and cause significant public concern because they are ubiquitously present, 
even in food (Kalantzi et al., 2001). 
 
Fig.1.1 Chlorinated dibenzofurans (A) and dibenzo-p-dioxins (B) 
 
One possible approach to detoxify the environment from xenobiotics is the utilization of 
microorganisms which are abundantly present in soils and which are known to be major 
agents in the mineralization of organic substrates. In the recent years, various 
microorganisms have been isolated for their capability of transforming or even 
mineralizing xenobiotic organic compounds (Chaudry and Chapalamadugu, 1991). 
Microbial consortia capable of mineralizing compounds previously assumed to be 
recalcitrant have been established in laboratories giving encouraging results for future 
bioremediation technologies (Arfmann et al., 1997). The effective application of 
microorganisms for the detoxification of the environment requires a detailed knowledge 
about the relevant catabolic processes and crucial reactions, as well as on factors 
influencing their efficiency and the development of optimization strategies to overcome 
critical metabolic steps. The microbial degradation of monocyclic aromatics has been 
intensively studied (Zylstra and Gibson, 1991) (Sariaslani, 1989). Microbial 
degradation of bicyclic compounds such as polychlorinated biphenyls (PCB), and 
naphthalenes and of polycyclic aromatic hydrocarbons (PAHs), has received increasing 
O
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attention during the last years. However, studies on the microbial degradation of 
dibenzo-p-dioxins (DDs) and dibenzofurans (DBFs) have been scarce, probably due to 
the difficulty of isolating microorganisms able to attack those. Furthermore, highly 
chlorinated DBFs and DDs, especially those that have at least three out of four chlorine 
atoms in the 2,3,7,8-positions, are extremely toxic (Tyskind et al., 1993) and therefore 
dangerous to be handled in a laboratory. The best documented example of a highly toxic 
chlorinated DD is the cancerogenic and teratogenic 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) (Zober et al., 1998). Large quantities of this compound were discharged into 
the environment following the tragic accident in Seveso in 1976 during the 
manufacturing of the herbicide 2,4,5-trichlorophenoxyacetate (Hay, 1979). Until now, 
no microorganisms able to mineralize highly chlorinated DBFs and DDs have been 
isolated. However, bacteria able to aerobically mineralize unchlorinated and transform 
monochlorinated congeners have been isolated in the recent years. As it is known that 
anaerobic microbial consortia can reductively dehalogenate a wide range of 
polychlorinated organic compounds including the respective dibenzofurans and 
dibenzo-p-dioxins (Barkovskii and Adriaens, 1996), a promising biodegradation 
approach could consist of a combination of anaerobic and aerobic microbial activities, 
i.e. an initial reductive dehalogenation step leading to lower chlorinated congeners 
followed by aerobic degradation of the carbon skeleton as later discussed. The first 
organisms being capable to mineralize dibenzofuran have been described by (Strubel et 
al., 1989) and Fortnagel et al. (Fortnagel et al., 1989). Both Terrabacter sp. DPO1361 
(Schmid et al., 1997) formerly named Brevibacterium sp. DPO1361 (Strubel et al., 
1989) and Sphingomonas sp. HH69 (Harms et al., 1995) formerly named Pseudomonas 
sp. HH69 (Fortnagel et al., 1990) converted dibenzofuran to 2,2’.3-trihydroxybiphenyl 
and salicylic acid indicating a novel angular dioxygenation mechanism at the 4,4a 
position of dibenzofuran. Similarly, Staphylococcus auriculans DBF 63 (Monna et al., 
1993), recently also reclassified as Terrabacter, (Kasuga et al., 2001), and Terrabacter 
sp. DPO360 (Schmid et al., 1997), can mineralize dibenzofuran (Schmid et al., 1997). 
In contrast to the strains mentioned above, strain Sphingomonas sp. RW1, isolated from 
the river Elbe (Wittich et al., 1992), is capable not only of degrading dibenzofuran, but 
additionally to mineralize dibenzo-p-dioxin, a compound which by other strains is only 
subject to cometabolism (Monna et al., 1993) (Harms et al., 1990). Due to its 
exceptional catabolic characteristics, which include the capability to transform some 
mono- and dichlorinated congeners such as 1- and 2-chlorodibenzo-p-dioxin, 2,3-
dichlorodibenzofuran and 2,3-dichlorodibenzo-p-dioxin (Wilkes et al., 1996) strain 
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RW1 in the recent years was subject to various physiological, biochemical and genetic 
studies. The catabolic pathways for dibenzofuran and dibenzo-p-dioxin in RW1 have 
been proposed by Wittich et al. (Wittich et al., 1992) and are presented in fig. 1.2. The 
metabolism of both DBF and DD is initiated by a stereospecific angular dioxygenation 
of one of the aromatic rings leading to the formation of phenolic hemiacetals which 
spontaneously rearomatize to give 2,2’,3-trihydroxybiphenyl and 2,2’,3-
trihydroxydiphenyl ether, respectively. The trihydroxylated intermediates are subjected 
to an extradiol ring cleavage, similar to that described for ring-cleavage of 2,3-
dihydroxybiphenyl during the bacterial metabolism of biphenyl (Eltis et al., 1993). 2- 
hydroxy-6-(2-hydroxyphenyl)-6-oxo-hexa-2,4-dienoic acid (2-OH-HOPDA), the ring-
cleavage product of 2,2’,3-trihydroxybiphenyl (Strubel et al., 1991) is subjected to 
hydrolysis by 2-hydroxy-6-oxo-6-phenylexa-2,4-dienate-type hydrolases resulting in 
the formation of salicylate and 2-hydroxypenta-2,4-dienoate (Bunz et al., 1993) a 
reaction equivalent to that for hydrolysis of 2-hydroxy-6-oxo-6-phenyl-hexa-2,4-
dienoate during biphenyl metabolism. In contrast, the 6-(2-hydroxyphenyl)ester of 2-
hydroxymuconic acid, reported as ring-cleavage product of 2,2’,3-trihydroxydiphenyl 
ether was supposed to be subjected to spontaneous hydrolysis, giving rise to catechol 
and 2-hydroxymuconate (Wittich et al., 1992) (Wittich personal communication).Thus, 
by enzymes of the “upper pathway”, dibenzofuran and dioxin are transformed into 
salicylate and 2-hydroxypenta-2,4-dienoate on one hand and into catechol and 2-
hydroxymuconate on the other hand. 2-Hydroxymuconate (Whitman et al., 1992) and 2-
hydroxypenta-2,4-dienoate (Lian and Chapman, 1993; Lian and Chapman, 1994) are 
well documented intermediates of the catechol meta-cleavage pathway. As a catechol 
meta-cleavage pathway is induced during degradation of both DD and DBF by RW1 
(Wittich et al., 1992), mineralization of those compounds can be assumed. Beside a 
catechol meta-cleavage pathway, a catechol ortho-cleavage pathway is induced during 
DD degradation. Thus, the intermediate catechol can be degraded via both of those 
pathways, however, the relative importance of each of those routes cannot be assessed. 
In case of DBF degradation, both catechol meta-cleavage pathway as well as gentisate 
pathway are obviously induced. However, there are no data available, showing whether 
salicylate in RW1 is degraded by a salicylate 1-hydrolase and thus via catechol or by a 
salicylate 5-hydrolase and thus via gentisate. 
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Fig.1.2: Proposed catabolic pathway for dibenzofuran and dibenzo-p-dioxin in Sphingomonas 
sp. strain RW1. (I) dibenzo-p-dioxin (II) dibenzo-p-dioxin-cis-dihydrodiol (III) 2,2’,3-
trihydroxybiphenyl ether (IV) 2-hydroxy-6-oxo-6-(2-hydroxyphenoxy)-hexa-2,4-dienoate, (V) 
catechol,  (C6) 2-hydroxy-cis,cis-muconate, (VI) dibenzofuran, (VII) dibenzofuran-cis-
dihydrodiol, (VIII) 2,2’,3-trihydroxybiphenyl, (IX) 2-hydroxy-6-oxo-6-(2-hydroxyphenyl-hexa-
2,4-dienoate, (X) salycilate, (C5) 2-hydroxypentadienoate semialdehyde, (XII) 2-hydroxypenta-
2,4-dienoate, (XIII) 4-hydroxy-2-oxovalerate and (XIV) gentisate. Unstable compounds which 
spontaneously transform to other products are indicated in brackets. (Armengaud and Timmis, 
1997a) 
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1.1 Biochemical Characterization of the dioxin dioxygenase multicomponent 
complex 
 
The degradation of aromatic compounds is usually initiated by ring-activating reactions. 
In case of dioxygenolytic activation, the aromatic ring is attacked by the incorporation 
of two hydroxyl groups in ortho position to one another (Dagley, 1978). The cis-
dihydrodiols formed thereby are then rearomatized by cis-dihhydrodiol dehydrogenases. 
If the aromatic ring is substituted, the dioxygenation reaction can occur either on two 
adjacent unsubstituted carbon atoms or directly at a substituted and its neighbouring 
carbon atom. In the latter case, the reaction can be concomitant with the spontaneous 
elimination of the substituent, when the substituent can be eliminated as an anion. The 
formation of unstable dihydrodiol analogues has been reported during the degradation 
of haloaromatics such as 2-chlorobenzoate (Engesser and Schulte, 1989), 1,2,4,5-
tetrachlorobenzene (Beil et al., 1998b) or 2,2’-dichlorobiphenyl or sulfoaromatics 
(Haddock et al., 1995.). Due to spontaneous rearomatization, a dehydrogenase is nor 
required for degradation. Similar unstable dihydrodiol analogues, hemiacetals, will be 
formed during angular dioxygenation of biarylethers. Spontaneous rearomatization by 
loss of a phenolate group, which is simultaneously the cleavage of the former ether 
bond, results in the formation of two monocyclic aromatics from simple biarylethers 
(Engesser et al., 1990; Schmidt et al., 1992) or of dihydroxybiphenyl derivatives from 
dibenzofuran and dibenzo-p-dioxin, respectively. Ring-hydroxylating dioxygenases 
require oxygen, ferrous iron (Fe2+) and reduced pyridine nucleotides for catalysis. They 
are soluble, multicomponent enzyme systems comprising two or three separate proteins. 
In principle, these enzymes consist of a electron transport chain that channels the 
electrons from NAD(P)H to the catalytic terminal oxygenase component where 
substrate transformation takes place. The terminal oxygenase component usually 
contains a Rieske (2Fe-2S)-cluster and mononuclear iron. Together with the respective 
monooxygenases those enzymes are termed Rieske non-heme iron oxygenase (Gibson 
and Parales, 2000). The electron transport chain is composed of, either an iron-sulphur 
flavoprotein reductase, or two separate proteins, a flavoprotein reductase and an iron-
sulphur ferredoxin. 
The structure of ring-hydroxylating oxygenases differs considerably. The variation in 
the number and size of constituent compounds and in the nature of redox centers has 
been used to classify these enzymes into three groups as Class I, II, III (Batie and 
Kamin, 1986) (Batie et al., 1992). In the reductases of class I and Class III 
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dioxygenases both a flavin chromophor (FAD in Class IA and III or FMN in Class IB) 
and a plant-type [2F-2S] iron-sulphur cluster are present. Class III enzymes additionally 
contain a separate ferredoxin component carrier with a Rieske type [2F-2S] iron-sulphur 
cluster that serves as an intermediate electron-transfer. Reductases of Class II enzymes 
only contain FAD as prosthetic group and transfer the electrons via a separate 
ferredoxin with either a plant-type (ClassIIA) or Rieske-type (ClassIIB) [2F-2S] iron-
sulphur cluster to the terminal oxygenase. However, this system of classification is 
based mainly on the electron transport components and did not take into account 
information on the oxygenase itself. For example, 2-oxo-1,2-dihydroquinoline 
monooxygenase (Rosche et al., 1995) catalyzing a monooxygenase reaction and 
benzoate dioxygenase (Neidle et al., 1991) catalyzing a dioxygenase reaction are 
assigned to Class IB, as both systems have only an iron-flavoprotein reductase. In 
addition, the quinoline oxygenase component has a (α)6 composition, whereas benzoate 
dioxygenase have a (αβ)3 subunit composition. As the catalytic α-subunit components 
of all Rieske non-heme iron oxygenases on one hand define the substrate specificity of 
the enzyme complex (Beil et al., 1998a) (Mondello et al., 1997) and on the other hand 
are related to each other, Gibson and Parales (Gibson and Parales, 2000) proposed the 
oxygenase components to be considered as superfamily, which consists of clearly 
identifiable families.  
The stereospecific angular dioxygenation of dibenzofuran and dibenzo-p-dioxin in 
Sphingomonas sp. RW1 is carried out by the dibenzofuran 4,4a-dioxygenase (Bunz and 
Cook, 1993). The subunits constituting the electron supply system and the oxygenase 
itself were purified and biochemically characterized by Bünz and Cook (1993). The 
oxygenase was supposed to be a α2β2 heterodimer with subunit molecular weights of 
45 kDa (large α-subunit) and 23 kDa (small β subunit), respectively. UV-visible 
absorption spectroscopy indicated the presence in the large subunit of a Rieske-type 
2Fe-2S cluster usually contained in oxygenase subunits of ring-activating oxygenases. 
However the N-terminal sequence of the a subunit of the dioxin dioxygenase did not 
exhibit any significant similarity with other previously described dioxygenases. In vitro 
the dibenzofuran 4,4a-dioxygenase consisting of the oxygenase and the respective 
electron transport chain was able to transform both dibenzofuran (into 2,2’,3-
trihydroxybiphenyl) and dibenzo-p-dioxin (into 2,2’,3-trihydroxybiphenyl ether) by 
introduction of two atoms of oxygen from one single molecule of O2. The two oxygen 
atoms (fig. 1.2) are added to a pair of vicinal carbons one of which is involved in one of 
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the bridges between the two aromatic rings (Bunz and Cook, 1993). The enzyme could 
additionally transform biphenyl, xanthene, fluoren-9-one and dibenzothiophene.  
Two isofunctional, monomeric flavoproteins RedA1 and RedA2 capable of transferring 
electrons form NADH to a ferredoxin, which finally transported electrons to the 
oxygenase component, could be purified (Bunz and Cook, 1993). It was speculated that 
RedA2 constitutes the main reductase component of the electron transfer chain. Both 
proteins contained a labile flavine adenine dinucleotide cofactor but no iron-sulphur 
cluster, characteristica which clearly distinguishes them from reductases associated with 
Class III ring hydroxylating dioxygenases, such as naphthalene dioxygenase (Ensley et 
al., 1982), and from those associated with Class IA and Class 1B enzymes (Batie et al., 
1992). Again, no significant similarity was found between their N-terminal sequence 
and those of other known flavoproteins. The electron transfer system associated with 
the dioxin dioxygenase therefore appears unusual.  
The second component of the redox chain is a small ferredoxin, of 12 kDa in size. 
Protein sequence data showed that the ferredoxin resembles putidaredoxin (Armengaud 
and Timmis, 1997b) containing a plant type iron-sulphur cluster coordinated by four 
cysteine residues and indicated the ferredoxin to be unrelated to the Fe-S proteins which 
usually function as electron donor to ClassIIB ring hydroxylating dioxygenases and 
which contain a Rieske-type 2Fe-2S cluster coordinated by two cysteins and two 
histidines. It has therefore been proposed that the new multiple component dibenzofuran 
4,4a-dioxygenase of Sphingomonas RW1, according to the classification scheme of 
Batie et al. (Batie et al., 1992) belongs to ClassIIA of ring hydroxylating dioxygenases. 
The dioxin dioxygenase would then have been, beside the pyrazon dioxygenase 
described by Sauber et al. (Sauber et al., 1977), the second representative of this class. 
Another dioxygenase, the carbazole 1,9a-dioxygenase from Pseudomonas sp. strain 
CA10, has been recently characterized (Nojiri et al., 1999), which is able to catalyze an 
angular dioxygenation of several substrates in the same way as the dibenzofuran 4,4a-
dioxygenase of RW1, and also a mono-oxygenation as well as a cis dihydroxylation. 
The multiple capabilities of this enzyme and the broad substrate specificity made it 
interesting to attempt the purification and crystallization of the protein, which will 
surely reveal an interesting structural feature and a biochemistry maybe similar to that 
of RW1 dibenzofuran dioxygenase. 
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1.2 Genetic characterization of the enzymes constituting the dioxin dioxygenase 
complex 
 
The gene encoding the 2Fe-2S ferredoxin, fdx1, was amplified by PCR from a genomic 
library (Armengaud and Timmis, 1997b). The purified ferredoxin contained a 
putidaredoxin-type 2Fe-2S cluster. Fdx1 shares significant homology to several plant-
type 2Fe-2S ferredoxins involved in electron transfer to bacterial cytochrome P450 
containing monooxygenases. Those ferredoxins are phylogenetically unrelated to 
Rieske-type ferredoxins such as BedC1 and TodB which were up to now usually 
described to function in electron transfer to ring-hydroxylating dioxygenases (Erickson 
and Mondello, 1992; Morrice et al., 1988; Zylstra and Gibson, 1991). Fdx1 constitutes 
therefore an atypical electron transfer system for a multicomponent dioxygenase 
(Sauber et al., 1977). It has been clearly shown that this ferredoxin is able to transfer 
electrons to the dioxin dioxygenase in a reconstituted system (Armengaud et al., 1998; 
Bunz and Cook, 1993). The dioxin dioxygenase was active with both substrates 
dibenzofuran and dioxin, giving as a reaction product 2,2’,3-trihydroxybiphenyl and 
2,2’,3-trihydroxybiphenyl ether. On the other side no activity was observed when the 
dioxin dioxygenase was coexpressed with a class IIB electron-transfer system recruited 
from the biphenyl gene cluster of LB400 (Armengaud et al., 1998). These biochemical 
data confirmed that the dibenzofuran dioxygenase of RW1 belongs to the multi-
component dioxygenase class IIA. The sequence analysis of the DNA regions upstream 
and downstream of fdx1, revealed this gene surprisingly not to be clustered with either 
known oxido-reductases nor the genes encoding the α- and β-subunits of the 
dioxygenase itself. The gene fdx1 is, in contrast, located between two ORFs, whose 
sequences are related to that of a bifunctional protein which acts as a decarboxylase and 
an isomerase in the 4-hydroxyphenylacetic acid catabolic pathway of E. coli strain 
(Prieto et al., 1996). In the dibenzofuran/dioxin degradative pathway proposed for 
Sphingomonas sp. strain RW1 (Wittich et al., 1992) a role of such activities is not 
evident and it is still not clear whether these proteins could play a function for dioxin 
degradation. 
Additionally a gene encoding a protein with sequence similarities to glutathion-S-
transferases (GST) was identified downstream of the fdx1 gene. Genes encoding several 
classes of GST enzymes have been found to be broadly distributed among PAH- 
degrading microorganisms (Bartels et al., 1999) (Lloyd-Jones and Lau, 1997) (Shin et 
al., 1997) (Wang et al., 1994). The role played by GSTs in PAH degradation is still 
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unclear. In the case of BphK GST of Burkholderia sp. strain LB400, experimental 
evidences showed the GST enzyme not to be necessary for growth on biphenyl as a 
substrate (Bartels et al., 1999). However, because of the broad distribution of such 
enzymes and their high degree of sequence identity, it has been suggested they might 
have a function improving and supporting PAH degradation under specific reaction 
conditions. Also the gene encoding the flavoprotein, reductase RedA2, has been 
amplified by PCR from the genomic library of RW1 (Armengaud and Timmis, 1998). 
From the nucleotide sequence as well as from the biochemical data obtained with the 
recombinant form of this reductase, it is evident that this flavoprotein is similar to class-
I cytochrome P450-type reductases (Munro and Lindsay, 1996; Unger et al., 1986). 
Like fdx1, redA2 is not directly linked to any other gene encoding for dibenzofuran 
dioxygenase subunits, a ferredoxin or to oxygenase related genes. 
The dxnA1 and dxnA2 cistrons, encoding the large and small subunits of the dioxin 
dioxygenase, respectively, were also amplified from a genomic library by PCR 
(Armengaud et al., 1998). Since the genes of multicomponent dioxygenase systems 
were previously nearly exclusively found to be clustered, initially a PCR product was 
expected, which comprises both the genes encoding for the dioxin dioxygenase and that 
ones for the ferredoxin and/or reductase. However, like fdx1 and RedA2, dxnA1 and 
dxnA2 were not linked to any other gene necessary for encoding a functional 
dioxygenase. They were, nevertheless, coamplified with the gene encoding a HOPDA 
hydrolase, supposed to catalyze the third enzyme step in the dibenzofuran degradative 
pathway. The overall identity of the DnxA1 sequence with its counterparts in classIIB 
and class III dioxygenases is relatively low (40%) but clearly shows a phylogenetic 
relationship with three-component dioxygenases. Even though the homology research 
revealed DxnA1 not to be a member of previously described major clusters of Rieske 
type non-heme iron α-subunits of oxygenases, the major motifs common to this family, 
such as the environment of the Rieske-type 2Fe-2S cluster and the FeII binding site, are 
conserved compared to other three-component dioxygenases (Jiang et al., 1996). 
Interestingly in the FeII binding site of the large subunit a histidine residue is found at 
position 202 in place of a usual phenylalanine and a leucine residue at position 207 was 
found instead of a usual tyrosine. The two residues might play a critical role in the 
peculiar regiospecificity of the dioxin dioxygenase. The dxnA2 ORF codes for a 
polypeptide exhibiting 39% identity to the β subunits of the three-component 
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dioxygenases. Therefore DxnA1 and DxnA2 have the same phylogenetic distance from 
their class IIB counterparts.  
 
 
1.3 Biochemical and Genetic characterization of the meta-cleavage enzyme DbfB 
 
The ring-cleavage of 2,2’,3-trihydroxybiphenyl and the 2,2’,3-trihydroxybiphenyl ether 
formed from dibenzofuran and dioxin, respectively, is catalyzed by an extradiol or 
meta-cleavage dioxygenase termed DbfB or trihydroxybiphenyl  dioxygenase (Fig.1.2). 
Its structural gene designed dbfB has been cloned from a cosmid expression library of 
RW1 using a functional colorimetric assay, and sequenced (Happe et al., 1993). The 
gene dbfB has been localized, 4.5 Kb upstream of dxnA1A2 in the RW1 genome and 
opposite oriented (Armengaud et al., 1998). The deduced amino acid sequence reveals 
the enzyme to be a typical extradiol dioxygenase, as recently shown by a structure-
validated alignment (Eltis and Bolin, 1996; Han et al., 1995). Extradiol dioxygenases 
are a family of ferrous iron-containing enzymes that mediate aromatic ring cleavage in a 
wide variety of aromatic catabolic pathways, including those of naphthalene, benzene, 
biphenyl, and toluene (Harayama et al., 1992). The pivotal role of these enzymes has 
been revealed by genetic studies on the TOL pathway, which indicated that its extradiol 
dioxygenase is a major determinant of substrate specificity of this pathway (Ramos et 
al., 1987). Some specific reaction intermediates like 3-chlorocatechol, formed during 
the catabolism of a number of chlorinated aromatics, can severely inhibit the activity of 
these enzymes. This phenomenon represents a critical aspect in attempting the 
biodegradation of recalcitrant compounds. As an example, 1-chlorodibenzo-p-dioxin is 
transformed by RW1 into 3-chlorocatechol. Attack of trihydroxybiphenyl dioxygenase 
on this compound obviously leads to the formation of a reactive acylchloride, as 
described by Bartels et al. (Bartels et al., 1984), irreversibly activating this enzyme. As 
a consequence, activity against trihydroxybiphenyl is destroyed (Wilkes et al., 1996). 
After hyperexpression of dbfB in E. coli, the resulting protein has been aerobically 
purified and characterized (Happe et al., 1993). Interestingly DbfB resulted to be 
monomeric. Although other monomeric dioxygenases have been reported (Block and 
Lingens, 1992), extradiol dioxygenases are generally either tetrameric, such as the 
catechol 2,3-dioxygenase (Nakai et al., 1983; Wallis and Chapman, 1990) or octameric, 
such as the 2,3-DHB 1,2-dioxygenase (Eltis et al., 1993; Furukawa and Arimura, 1987; 
Taira et al., 1988). The significance of the difference in quaternary structure is not clear. 
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The best substrates of DbfB were 2,2’,3-trihydroxybiphenyl and 2,3-dihydroxybiphenyl, 
whereas monocyclic catechols such as 4-methylcatechol and catechol were only poorly 
transformed. This substrate spectrum places DbfB, in accordance with sequence 
similarities, into the subfamily of extradiol dioxygeneses with high activity against 
bicyclic compounds (Eltis and Bolin, 1996). Like various other extradiol dioxygenase 
(Eltis et al., 1993), DbfB was shown to be subject to substrate inhibition at high 
concentration of substrate (Happe et al., 1993). In contrast to di- and 
trihydroxybiphenyl, only small activity was observed with trihydroxybiphenyl ether, the 
intermediate of DD degradation, as a substrate. Moreover, incubation with this substrate 
resulted in a rapid decline of the observed activity. Since RW1 is able to grow on DD as 
sole carbon and no major problems during ring-cleavage of intermediates were observed 
in those growth studies (Wittich et al., 1992), the question arises how in vivo 
trihydroxybiphenyl ether transformation is performed and whether another meta-
cleavage dioxygenase besides DbfB, plays a major role in the DD degradation pathway 
by RW1. In this work we addressed this question with experiments oriented to better 
understand this critical reaction step in the DD catabolic pathway.  
 Sphingomonas sp. RW1 has been shown to contain, besides DbfB, additional meta-
cleavage enzymes (Happe et al., 1993) (Bunz and Cook, 1993) one of which, designed 
Edo2, was analyzed in detail in the present study. The presence of multiple meta-
cleavage enzymes is not an exception to RW1 but has recently been shown in various 
aromatic compounds degrading bacteria. The dibenzofuran degrader, Terrabacter sp. 
Strain DPO 360, contains three distinct extradiol dioxygenases (Schmid et al., 1997) in 
the same way as Rhodococcus globerulos P6, one PCB-degrader, (Asturias and Timmis, 
1993). The reason for the multiplicity of such isoenzymes has not yet been definitely 
explained.  
 
 
1.4 Biochemical and genetic characterization of RW1 hydrolases 
 
During the purification form dibenzofuran grown cells of RW1 of the peptides 
constituting the multicomponent dioxin dioxygenase, two hydrolases namely H1, later 
on dxnB, and H2 were identified and characterized (Bunz et al., 1993) (Armengaud et 
al., 1998). The gene dxnB encoding the hydrolase H1 could be coamplified with 
dxnA1A2 and found to be localized precisely 270 bp downstream of dxnA2. The N-
terminal sequences of the monomeric hydrolases H1 and H2 revealed 50% homology. 
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Both enzymes could be shown to catalyze the third step in the dibenzofuran degradative 
pathway, i.e. the hydrolysis of 2-hydroxy-6-oxo-6-(2-hydroxyphenyl)hexa-2,4-dienoate 
(HOHPDA) into salicylate and 2-hydroxypenta-2,4-dienoate. They were also active 
against 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate (HOPDA), the ring-cleavage 
product of dihydroxybiphenyl, forming benzoate and 2-hydroxypenta-2,4-dienoate. 
However neither benzoate nor salicylate were produced in stoichiometric amounts. In 
case of 2-hydroxy-6-oxo-6-(2-hydroxyphenyl)hexa-2,4-dienoate (HOHPDA) turnover, 
this can easily be explained by the instability of the substrate which is subject to a 
spontaneous intramolecular Michael addition (Fortnagel et al., 1990) (Strubel et al., 
1991) (Wittich et al., 1992) (Kohler et al., 1993) resulting in the formation of 3-
(chroman-4-on-2-yl)pyruvate. This observation is not limited to enzymatic reactions in 
vitro. Formation of chromanone derivatives from HOHPDA has also been reported to 
occur in growing cells, showing the hydrolysis to be a critical step in dibenzofuran 
degradation, with the need of a highly active hydrolase with high affinity for the 
substrate to overcome spontaneous reactions giving rise to dead-end metabolites. 
 
 
1.5 Overview of the genetic organization for dibenzofuran and dibenzo-p-dioxin 
catabolic pathways in RW1 
 
From the sequencing analysis, the genes coding for the enzymes involved in DD and DF 
degradation appeared to be dispersed on the chromosome. In fig. 1.3 an overview of the 
genetic organization is presented. Several loci have been identified (Armengaud and 
Timmis, 1997a), some of which have been already previously described. Locus A is 
associated to genes dxnA1A2, dbfB and dxnB encoding respectively the α and β subunits 
of the dibenzofuran 4,4a-dioxygenase, the meta-cleavage dioxygenase DbfB and the H1 
hydrolase. Genes fdx1 and redA2 encoding for ferredoxin and reductase associated with 
RW1 dibenzofuran dioxygenase, are carried by respectively locus B and C. Locus D has 
been identified by hybridizing the cosmidic library of RW1 with a probe obtained by 
mean of two primers, designed on the basis of DxnA1 N-terminal and of conserved 
motives in class IIB dioxygenases. Those primers, originally meant to amplify 
dxnA1A2, led to the amplification of a short fragment, carrying an ORF encoding a 
polypeptide showing identity to another α-subunit ring-hydroxylating dioxygenase. By 
analyzing the surrounding sequence of edo2 gene, carried by Locus E, additional ORFs 
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were identified, sharing homology with α and β subunits of ring-hydroxylating 
dioxygenases and indicated in fig.1.3 as ORFs G1, G5, G6. Locus E, furthermore, was 
found to present several degradative genes including that of a monooxygenase specified 
by ORF G4. The deduced polypeptide sequence of ORF G4 exhibited significant 
identity with several flavin-containing monooxygenases from different sources. 
Between edo2 (ORF G2) and ORF G4, a short ORF (106 aa) has similarities to Rieske-
type 2F-2S ferredoxins associated with class IIB and III ring-hydroxylating 
dioxygenases. ORF G7, downstream of G4, specifies for a polypeptide homologous to 
HOPDA hydrolases. This cistron resembles that one of locus A where the genes 
dxnA1A2 and dbfB, dxnB, and dxnC are located. dxnC is the first of ten ORFs identified 
downstream dxnB and apparently organised in a compact operon as recently described 
(Armengaud et al., 1999). The first three ORFs of the locus, dxnC, ORF2, and fdx3, 
specify a protein with a low homology to bacterial siderophore receptors, a polypeptide 
representing no significant homology to known proteins, and a putative ferredoxin, 
respectively. In in vitro assays Fdx3 could be reduced by RedA2. In vivo coexpression 
of fdx3 and redA2 with dxnA1A2 confirmed that Fdx3 can serve as an electron donor for 
the dioxin dioxygenase also. The midpoint redox potential of this ferredoxin is similar 
to that exhibited by Fdx1. The gene fdx3 if followed by gene dxnD which encodes a 69-
kDa phenol monooxygenase-like protein with activity for the turnover of 4-
hydroxysalicylate, and by dxnE encoding for a 37-kDa protein whose sequence and 
activity are similar to those of known maleylacetate reductases. The following dxnF, 
encodes a 33-kDa intradiol dioxygenase which efficiently cleaves hydroxyquinol, 
yielding maleylacetate, the ketoform of 3-hydroxy-cis,cis-muconate. The heteromeric 
protein encoded by the following dxnGH is a 3-oxoadipate succinyl coenzyme A 
(succinyl-CoA) transferase, whereas dxnI (Armengaud et al., 1999) specifies a protein 
exhibiting marked homology to acetyl-CoA acetyltransferases (thiolases). The last ORF 
of the operon codes for a putative transposase. dxnD, dxnF, dxnE, dxnGH, and dxnI thus 
form a complete 4-hydroxysalicylate/hydroxyquinol degradative pathway. Summarizing 
the genetic diversity of Sphingomonas sp. RW1, 4 different α-subunits of ring-
hydroxylating dioxygenase, two β-subunits, two reductases, three ferredoxins, three 
meta-cleavage enzymes have been found until now. Furthermore, as previously 
described, two different hydrolases, H1 and H2, could be isolated. A third hydrolase H3 
was identified in the present study. The H3 structural gene was found to be clustered 
with that one of RW1 meta-cleavage dioxygenase Edo 3, also identified and described 
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for the first time in this study. H3 and edo2 genes should be associated to a new locus. 
A similar genetic organization to that one on RW1, where genes encoding for enzymes 
involved in a same degradation pathway are found to be dispersed among several gene 
cluster, has been described by M. Romine et al. in case of Sphingomonas 
aromaticivorans F199 (Romine et al., 1999). Also F119 contains several oxygenase 
subunits which appears to be characteristic of Sphingomonas sp. It has been suggested 
that the respective gene products could randomly combine to give hybrid aromatic 
oxygenases. It is unclear why Sphingomonas sp. strain RW1 presents several groups of 
isoenzymes and whether, for instance, they play a role in different metabolic pathways. 
With this work we have started to address this question, especially concerning the three 
meta-cleavage enzymes.  
 15 
HindIII
EcoRI
dxnC ORF2 fdx3 dxnD dxnE dxnF dxnG
ClaI BamHI XhoI
PstI PvuII SphI NsiI NdeI
XmaI
SmaI
XhoI
KpnI
PstI XhoI SacI
ORF G1
ORF G3 ORF G8ORF G6
ORF G7ORF G4 ORF G5EDO 2
Locus E
dxnA1 dxnA2 dxnBdbfB
PstI
XhoI NotI EcoRI
EcoRI
NsiI ClaI
PstI NsiI
NdeI HindIII
PstI
Locus A
BamHI BamHIHindIII PstI ScaI PstI
ORF E1 ORF E2 ORF E4
ORF E3fdx1
Locus B
BamHI EcoRI
redA2
Locus C
ORF H1
Locus D
0 .0 1 .0 2 .0 3 .0 4 .0 5 .0 10 .08 .06 .0 7 .0 9 .0
reductase
α-subunit of ring-
hydroxylating dioxygenase
ferredoxin
hydrolase
β-subunit of ring-
hydroxylating dioxygenase
Symbol       gene product or
   putative gene product
other enzyme
ring-cleaving dioxygenase
 
 
Fig. 1.3: Genetic organization of RW1 loci as described in (Armengaud et al., 1998) 
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1.6 Goal 
 
The detailed investigation on a genetic and biochemical level of dioxin and 
dibenzofuran catabolism in Sphingomonas  sp. strain RW1 is necessary to clarify the 
limitations and possible bottlenecks of the pathways, especially when confronted with 
chlorinated congeners, to identify the enzymes and respective genes necessary for 
degradation and finally to develop strategies for the optimization of bacteria to detoxify 
in the environment highly recalcitrant chlorinated dibenzofurans and dioxins. 
The usefulness of this strategy can be seen in efforts to obtain biocatalysts for the clean-
up of sites contaminated with PCBs. Various biphenyl degraders have been analyzed in 
detail for the degradative route, and the genes and the gene products involved in the 
transformation of different PCB congeners have been identified. The range of PCBs 
transformable was show to depend mainly on the specificity of the initial dioxygenase 
(Erickson and Mondello, 1993; Mondello et al., 1997). The amino acids defining the 
substrate specificity could be defined and enzyme variants capable to transform a range 
of PCB congeners, previously not metabolizable by a single organism, could be 
engineered (Hrywna et al., 1999; Kumamaru et al., 1998). Natural isolates, when 
confronted with PCBs, in the best case, transform them into chlorobenzoates, as 
degradative pathway for chlorobenzoates in those strains is usually missing. Misrouting 
of excreted chlorobenzoates by the natural microflora can result in the formation of 
highly toxic intermediates, thus having a severe negative effect on the performance of 
PCB transforming organisms in environments contaminated with PCBs (Blasco et al., 
1995). In order to achieve complete mineralization and thus avoiding substrate 
misrouting, either cocultures of strains transforming PCBs and those capable of 
mineralizing chlorobenzoates (Park et al., 1999) were applied, or alternatively, 
organisms were engineered to contain a complete metabolic route (Hrywna et al., 1999; 
Reineke, 1998). 
In contrast to the knowledge of biphenyl degradation and PCB transformation, there is 
only limited information on dioxin/dibenzofuran degradation and transformation of 
chlorinated congeners. The best described organism, Sphingomonas sp. RW1 can grow 
on dioxin and dibenzofuran as sole carbon source, but not on chlorinated dioxins and 
dibenzofurans which is apparently due to at least three reasons: the limited substrate 
range of the intial dioxin dioxygenase, the formation of dead-end products and the 
formation of toxic intermediates. Inhibition of extradiol dioxygenases by intermediarly 
formed 3-chlorocatechol was observed during 1-chloro-dibenzo-p-dioxin conversion by 
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resting cells of RW1. 3-chlorocatechol has often been reported to inhibit extradiol ring-
cleavage dioxygenases (Bartels et al., 1984; Klecka and Gibson, 1981; Wasserfallen et 
al., 1991). The best studied example is the catechol 2,3-dioxygenase of Pseudomonas 
putida mt-2 where the mechanism of inhibition was investigated (Bartels et al., 1984). 
The deactivation agent was supposed to be the ring-cleavage product 5-chloroformyl-2-
hydroxypenta-2,4-dienoic acid,  an acylchloride, formed by 2,3-clevage of 3-
chlorocatechol which irreversibly inactivates the ring-cleavage dioxygenase.  
Recently a novel extradiol dioxygenase has been purified from the bacterial strain 
Pseudomonas putida GJ31 (Kaschabek et al., 1998). This strain is able to degrade the 
chlorobenzene via 3- chlorocatechol and a meta-cleavage pathway (Mars et al., 1997), 
thus indicating that the enzyme is not subject to suicide inactivation as reported for the 
enzyme of strain mt-2. Actually, the enzyme was capable of a high rate turnover of 3-
chlorocatecol and 2-hydroxymuconate was found to be the meta-cleavage product. It 
can be reasoned that the initial acylchloride ring-cleavage product is subject to a rapid 
hydrolysis by the GJ31 enzyme whereas nucleophilic groups of the mt-2 enzyme react 
rapidly with the acylchloride to give inactive acylated enzyme derivatives. An 
alternative mode to overcome suicide inactivation has been reported by Heiss et al. 
(Heiss et al., 1995). A 2,3-dihydroxybiphenyl dioxygenase from the 
naphtalenesulfonate degrading Sphingomonas sp. strain BN6 cleaves 3-chlorocatechol 
between the C1 and C6 carbon thus resulting in the formation of 3-chloro-2-
hydroxymuconic semialdehyde, thereby avoiding the formation of an acylchloride. 
However despite the evidence that chlorocatechols can be degraded after meta-cleavage 
(Arensdorf and Focht, 1994), the dominant metabolic route for chlorocatechols 
degradation is via a chlorocatechol ortho-cleavage pathway. There are no indications 
that RW1 exhibits respective genes or activities. 
Whereas chlorinated dibenzo-p-dioxins, in case one aromatic ring is degraded, are 
transformed into catechols, the respective salicylates are the products when 
chlorodibenzofurans are transformable by enzymes of the dibenzofuran upper pathway 
of RW1. 3-,4-, and 5-chlorosalycilate, respectively, have been observed to accumulate 
as dead end products when RW1 is exposed to 4-chloro-, 3-chloro, or 2-
chlorodibenzofuran (Wilkes et al., 1996; Wittich, 1997). One strategy to achieve 
mineralization of chlorodibenzofurans can be the application of mixed cultures, 
consisting of a chlorodibenzofuran transforming organism, which should be capable to 
grow at the expense of one aromatic ring during this process, and a chlorosalicylate 
degrader. Some chlorosalicylate degrading organisms have been reported to date, 
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usually recruiting a salicylate 1-hydroxylase capable of transforming chlorosalicylates 
into chlorocatechols, followed by a chlorocatechol ortho-cleavage pathway resulting in 
transformation of chlorocatechols into Krebs cycle intermediates. However, some 
deviations of this route have been reported, such as Pseudomonas sp. RW1, which do 
not contain a chlorocatechol ortho-cleavage pathway and probably mineralize 4-
chlorosalicylate via 4-chlorocatechol and classical catechol ortho-cleavage pathway 
with protoanemonin as intermediate, or Sphingomonas RW5, which seems to degrade 
3,6-dichlorosalicylate via dichlorogentisate (Werwath et al., 1998). 
Actually 4-chloro-dibenzofuran could be mineralized by a coculture consisting of RW1, 
producing 3-chlorosalicylate, and the 3-chlorosalicylate degrader Burkholderia sp. 
strain JWS (Arfmann et al., 1997). Another example of a coculture for mineralization of 
chlorodibenzofurans is given by Sphingomonas sp. strain RW16 and Pseudomonas 
putida RW10 capable together of mineralization of 2- and 3-chlorodibenzofuran. 
Sphingomonas RW16 converts the two substrates into 5-chloro- and 4-chlorosalicylate 
respectively, which then are degraded by Pseudomonas putida RW10 to 4-
chlorocatechol and then further mineralized by a protoanemonin pathway (Wittich, 
1999). The bioavailability of chlorinated DBFs and DDs decreases with increasing 
chlorine substitution. Efficient degradation by co-oxidation therefore seems to be 
restricted to several dichlorinated congeners of DD and DBF. At least the 2,8-DCDF is 
dioxygenated at low rate by resting cells of Sphingomonas RW1 under concomitant 
release of HCl to a dead end product. Mixed cultures seem to be therefore a feasible 
approach for biodegradation of low halogenated compounds. An alternative to the use 
of mixed cultures is the application of genetic engineering techniques to enhance the 
degradative capabilities of a single organism. By this strategy, the intermediate 
excretion of intermediates, which can result in misrouting to unwanted products by 
other microorganisms, can be avoided. Furthermore, various different changes can be 
performed in a single strain by genetic techniques to optimize the performance. 
Mineralization of chlorinated dioxins necessitates a functional dioxin upper pathway 
and a pathway for chlorocatechol degradation. Coculture degradation needs the 
accumulation of chlorocatechols by a dioxin degrading organism which should be taken 
up by the second member of the consortium. However catechols and especially 
chlorocatechols exert their deleterious effects even at low concentration, and are 
supposed to be itself toxic. Thus coculture would necessitate a very effective 
consortium. In contrast, combination of the necessary catabolic modules in one strain 
could, at least theoretically, prevent any significant intracellular accumulation of toxic 
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intermediates.In order to create organisms capable to mineralize chlorodioxins and 
chorodibenzofurans, a major goal of the present study was the development of a gene 
cassette carrying all genes for the DD degradation upper pathway from Sphingomonas 
RW1. Such cassette could be used to enlarge the catabolic capabilities of 
chlorosalycilate and chlorocatechol degrading microorganisms able to include 
chlorinated DDs and DBFs. The new degraders could be useful for detoxification of 
these highly recalcitrant and toxic xenobiotics.  
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2 Materials and methods 
 
 
 
2.1 Instrumentation 
 
Agitator    SM25Edmund Bühler 
Anaerobic chamber   Coy 
Autoclave    Tecnomara 
Balance    PM460 and AE260, Mettler 
Bench centrifuges Biofuge Haereus Sepathec, Eppendorf centrifuge 
5415 
Cell incubators   Heraeus B5060, EK002 
Centrifuges    Sorvall Instruments RC5, RC3 
Computer    Macintosh and IBM 
Computer programs   Microsoft Word, Deneba Canvas, CSC ChemDraw 
     Pro, KaleidaGraph, GeneWork, Phylip pakage  
Drying machine   Heraeus 5042 
Electrophoresis chambers  BRL Horizon 58 and 5320 
FPLC     Controller LCC-500, pump P500, fraction collector 
     100, everything by Pharmacia 
French press    SLM Amico 
Heating bloc    Eppendorf Thermostat 5320 
HPLC     Diode array-detector SPD-10M10A, LC-10AD 
      pump, DGU-3A degaser, FCV10 AC valve 
system,      all by Pharmacia 
MilliQ water purifier   Millipore Milli-Q System 
Oxygen electrode   Bachofer 
PCR thermocycler   Perkin Elmer (GeneAmp PCR system 2400) 
pH-meter    Schott CG804 
Powersupply    Bachofer 
Protein gels chamber   Bio-Rad Mini Protein II Cell 
Spectrophotometer   Beckmann DU-70, Shimadzu UV-2100, Hitachi U 
      2000 
Ultracentrifuge   Sorvall Instruments Combi 
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Vacuum centrifuge   Savant DNA Speed Vac DNA A110 
Vortex     Janke&LKunkel IKA VF2 
 
 
2.2 Chemicals and reagents 
 
Most chemicals used in this study were obtained from Sigma and Aldrich, and were of 
the highest grade available. 2,3-Dihydroxybiphenyl (2,3-DHB) for enzymatic tests was 
obtained from Wako Chemicals GmbH. 2,2',3-trihydroxybiphenyl ether and 2,2',3-
trihydroxybiphenyl were gently synthesized by Rolf Wittich, Jean Armengaud and D. 
Pieper. 2-Pyrone-6-carboxylate was kindly provided by W. Reineke and used to 
synthesize 2-hydroxymuconic acid as previously described (Kaschabek et al., 1998). 
Oligonucleotide primers were obtained desalted from Gibco BRL and used without 
further purification. Restriction enzymes and reagents for genetic procedures were 
purchased from New England Biolabs, Boehringer Mannheim, Promega, United States 
Biochemicals and Sigma. 
 
 
2.2.1 Anaerobic preparation of a 50 mM 2,2',3-trihydroxybiphenyl-ether solution 
 
An amount of 11.6 mg purified 2,2',3-trihydroxybiphenyl-ether crystals was weighted 
and transferred into a Duran 2 ml glass sealed with a caucciu cap and filled up with N2. 
Crystals were dissolved inside of the anaerobic chamber with 1 ml methanol previously 
equilibrated for several hours under a N2 stream. 
 
 
2.3 Bacterial strains and plasmids 
 
All genes analyzed in this study originate from the genomic library of Sphingomonas  
sp. strain RW1  (H. Poth). Strain RW1 was isolated by R. Wittich (Wittich et al., 1992) 
for its capability to grow with dibenzo-p-dioxin and dibenzofuran as sole carbon 
sources. E. coli strains used in this study are listed in tab. 2.1. 
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Table 2.1: E. coli strains used in the present study 
 
Strain Reference 
DH5α (Hanahan, 1983) 
DH10B (Calvin and Hanawalt, 1988) 
BL21(DE3)[LysS] (Studier and Moffatt, 1986) 
 
Plasmids used in this study are summarised in table 2.2. 
 
Table 2.2: Plasmids used in the present study 
 
Plasmids Properties Reference or producer 
pBluescript II KS  cloning vector, Ap
r
 Stratagene 
pT7-7 expression vector, Ap
r
 (Tabor and Richardson, 1987) 
pCR-Script Amp SK(+)  cloning vector, Ap
r
 Stratagene 
pCR 2.1 cloning vector, Km
r
 Invitrogen 
pVLT35 expression vector, Sm
r
 (de Lorenzo et al., 1993) 
pAJ115 dxnA1A2-dxnB  genes, Tc
r
 (Armengaud et al., 1998) 
pAJ114 dbfB gene, Tc
r
 (Armengaud et al., 1998) 
pAJ130 redA2 -fdx1 genes, Ap
r
 (Armengaud and Timmis, 1998)
pRW1 Sphingomonas RW1 
plasmidic gene library, Ap
r
, 
edo2 gene 
(Happe, data not published) 
pRW4 Sphingomonas RW1 
plasmidic gene library, Ap
r
, 
edo3-H3 genes 
this work 
pBl4A/B 3.1 Kb SacI subcloned from 
pRW4, Ap
r
, edo3-H3 genes
this work 
pBl5A/B 1,270 bp EcoRI subcloned 
from pRW4, Ap
r
 
this work 
pBl6 0.8 Kb EcoRI-PstI, 
subcloned from pRW4, Ap
r
 
this work 
pBl7 1,945 bp EcoRI-SacI 
subcloned from pRW4, Ap
r
this work 
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pCRW4 edo3, Ap
r
  this work 
pT7W4 Construct used for Edo3 
overexpression,  Ap
r
  
this work 
pSK-22  edo2-2, Ap
r
 this work 
pSK-23  edo2-3, Ap
r
  this work 
pT7-22 Construct used for Edo2-2 
overexpression, Ap
r
  
this work 
pT7-23 Construct used for Edo2-3 
overexpression, Ap
r
  
this work 
 
 
2.4 Culture media and buffer solutions 
 
2.4.1 Complex media 
 
LB-Medium (Luria Bertani medium)  Bacto-Trypton  10g 
       Yeast extract   5g 
       NaCl    5g 
       to 1 l   pH 7.0 
Minimal medium  
 
Components for the minimal medium: 
 
2 x Buffer      K2HPO4 x12 H2O 
(50 mM phosphate buffer pH 7.6)   KH2PO4  
       to 1 l with MilliQ-H2O 
 
20 x Buffer      10 x concentrated 2 x buffer 
Trace elements(sterile filtrated)   HCl (25 %)   1.3 ml 
       ZnCl2    70 mg 
       MnCl2 x 4H2O           100 mg 
       H3BO4    62 mg 
       CoCl2 x 6H2O            190 mg 
       CuCl2 x 2H2O              17 mg 
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       NiCl2 x 6H2O              24 mg 
       NaMoO4 x 2H2O  36 mg 
       to 1 l with MilliQ-H2O 
 
100 x Salt-solution     Ca(NO3)2 x 4H2O  5 g 
       (NH4)2SO4   100 g 
       MgSO4 x 7H2O  20g 
       Fe-ammonium-citrate             1g 
       (28 % Fe) 
       to 900 ml with MilliQ-H2O 
       Trace elements solution 100 ml 
 
Assembling of the minimal medium  
 
Liquid medium    99 % (v/v) 2 x Buffer 
      1 % (v/v) 100 x Salts 
      C-source in the appropriate concentration 
 
Solid medium     10 % (v/v) 20 x buffer 
      1 % (v/v) 100 x Salts 
      1.5 % (w/v) purified agar 
      (OXOID Limited, Basingstoke,  
       Hampshire, England) 
      C-source in the appropriate concentration 
      in MilliQ-H2O 
 
E. coli cells were cultured at 30-37 °C in liquid medium containing the appropriate 
selection markers on a rotary shaker operated at 160 rpm, in Erlenmeyer flasks filled up 
with no more than 20 % of their total volume.  
Sphingomonas RW1 was cultured in liquid minimal medium with dioxin or 
dibenzofuran as carbon sources (0.1 % w/v) provided as crystals inside of glass tubes 
fixed to the cap of the erlenmeyer flasks. The two substrates diffused through the air 
phase to the cell suspensions. 
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2.4.2 Selection markers 
 
Antibiotics: 
 
Ampicillin (Ap)   1000 x solution 100 mg/ml in MilliQ-H2O 
     final concentration 100 µg/ml 
Chloramphenicol (Cm)  1000 x solution 30 mg/ml in ethanol 
     final concentration 30 µg/ml 
Spectinomycin (Sp)   1000 x solution 30 mg/ml in MilliQ-H2O 
     final concentration 30 µg/ml 
 
Xgal stock solution   20 mg/ml in dimethylformamide 
     stored at -20°C 
     50 µl added to each agar plate 
 
IPTG     stock solution  10 mM 
     concentration used 1 mM 
 
 
2.4.3 Other solutions 
 
50 x TAE  2M Tris + 50 mM EDTA + 57.1 ml acetic acid 
K/PO4   50 mM K2HPO4/KH2PO4, pH 7.0-9.0 
Na-acetate¯  20 mM acetic acid + NaOH, pH 5.0 
TE    10 mM Tris/HCl, 1 mM EDTA, pH 8.0 
Tris/HCl  100 mM Tris + HCl, pH 7.0-9.0 
 
 
2.5 Genetic methods 
 
Standard DNA manipulations were carried out essentially according to Sambrook et al. 
(Sambrook et al., 1989). 
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2.5.1 Plasmid preparation  
 
2.5.1.1 Preparation of big plasmids  
 
A total of 100 ml cell suspension was centrifuged (8,000 rpm, 10 min), resuspended in 
GTE-buffer (50 mM glucose, 10 mM EDTA, 25 mM Tris/HCl pH 8) containing 4 
µg/ml lysozyme and incubated on ice for 10 minutes. A volume of 10 ml lysis solution 
(NaOH/SDS) was added to the cell suspension and the mixture incubated for further 10 
minutes on ice. Cell membranes and proteins were precipitated by adding 7.5 ml 3 M 
sodium acetate (pH 4.8) followed by centrifugation for 15 minutes at 14,000 rpm. The 
nucleic acid was precipitated by adding to the clear supernatant 100 ml isopropanol 
(100%) followed by centrifugation (14,000, 15 min). The DNA pellet was dried, 
resuspended in 2 ml Tris/HCl buffer (pH 8.50 mM) LiCl (5 M), incubated for 15-30 min 
on ice and centrifuged at 6,000 rpm for 5 minutes. A volume of 10 ml ethanol was 
added to the supernatant. The mixture was incubated at -20°C for 1 hour and 
centrifuged (14,000, 10 min.). The DNA pellet was dried and resuspended in H2O. 
 
 
2.5.1.2 Preparation of plasmids by mean of column chromatography 
 
In this method the plasmidic nucleic acid was prepared by mean of a column 
chromatography. All necessary material and buffers were provided by Qiagen GmbH 
(Hilden, Germany). Column sizes were chosen with respect to the DNA quantity to be 
isolated. Qiagen tip 20, 100 and 500 columns were used to prepare plasmid DNA of up 
to 20, 100, 500 µg respectively. Purification was performed as suggested from the 
Qiagen company. 
 
 
2.5.2 Removal of traces of salts by dialysis 
 
A volume of 20 µl DNA solution was dropped on a filter membrane (Millipore, 0.025-
0.05 µm) floating on MilliQ-H2O and dialysed for 20 minutes. Salts present in the DNA 
suspension diffused through the membrane to the water following a concentration 
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gradient. DNA to be transferred into competent recipient cells through electroporation 
was always dialysed previous to transformation  (2.5.9). 
 
 
2.5.3 Polymerase chain reaction (PCR) 
 
The PCR reactions were performed in a total volume of 50 µl solution (10 mM Tris/HCl 
pH 8.50 mM KCl, 0.1 % Triton X-100, 1.25 mM MgCl2, 2 % DMSO) containing 50 
pmol of each primer (LTI), 50 ng of template, 200 µM of dNTPs, 2 units of 
thermostable polymerase Pfu (Stratagene Europe, Amsterdam) or Taq polymerase 
(Boehringer-Roche). After an initial denaturation step at 96 °C for 3 min, the conditions 
for annealing, polymerization and denaturation were 42 °C for 45 sec, 72 °C for 2 min 
per each 1,000 bp to be amplified and 96 °C for 1 min during 25 cycles, followed by a 
10 min polymerization step at 72 °C. Reactions were performed in a Perkin Elmer 
(GeneAmp PCR system 2400) PCR machine not requiring addition of mineral oil at the 
top of each raction sample. Amplified fragments were analysed and separated on a 1.5 
% agarose gel. The bands of interest were excised with a lancet from the agarose gel 
and the DNA purified as described in 2.5.1. 
 
 
2.5.4 DNA sequencing and homology research 
 
Nucleotide sequencing of both DNA strands was carried out using a PRISM Ready 
Reaction DyeDeoxy Terminator Cycle Sequencing kit (Perkin-Elmer) with double 
stranded templates in the presence of 5 % DMSO. Samples containing fluorescence-
labeled dideoxynucleotide terminators were processed on a 373 Stretch Applied 
Biosystem Automated Sequencer. Sequences were compiled by using GeneWorks 
software from IntelliGenetics. Homology analysis between sequences was performed 
using the CLUSTAL_X multiple sequence alignment program. The phylogenetic 
unrooted tree shown in this study was drawn by using TreeView belonging to the Phylip 
package program. 
 
 
2.5.5 Enzymatic restriction of DNA 
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Standard DNA manipulations were carried out essentially according to Sambrook. 
(Sambrook et al., 1989). Restriction enzymes and reagents for genetic procedures were 
purchased from New England Biolabs, Boehringer Mannheim, Promega, United States 
Biochemicals and Sigma. In each restriction reaction an amount of 0.5-3 µg DNA 
dissolved in 10 to 30 µl H2O-reaction buffer solution was digested with 0.5-2 Units 
restriction enzyme over 1-2 hours at the optimal reaction temperature for the enzyme. 
The reaction buffers (10x concentrated) were provided, together with the restriction 
enzymes, by the producing company. When required, BSA was added to the restriction 
reaction at a concentration of 100 µl/ml. The resulting DNA fragments were analysed 
on an agarose gel (2.5.6) 
 
 
2.5.6 Gel electrophoresis 
 
The size of DNA fragments or entire plasmids was determined by analysis on 0.8-1.5 % 
agarose gels. The necessary amount of agarose was dissolved in 1x TAE buffer, melted 
and poured into an electrophoresis chamber. A volume of 10 % v/v loading buffer (60 
% glycerin, 0.3 % xylolcyalnol 0,3 % (v/v) bromophenolblue) was added to the DNA 
samples. Samples were loaded onto the gel using as running buffer 1x TAE. The 
electrophoresis was performed at 20-100 Volt/cm. The agarose gel was stained in an 
ethidium bromide solution (1 g/ml)  for 10 minutes and analysed under UV light. 
 
 
2.5.7 DNA extraction from agarose gels 
 
After separation on agarose gels, DNA fragments of interest were cut out from the gel 
by mean of a lancet, weighted and treated by mean of the Qiagen II Agarose Gel 
Extraction Kit. All buffers were provided by Qiagen GmbH (Hilden, Germany). The 
extraction was performed following the protocol suggested by the provider. 
 
 
2.5.8 Ligation 
 
The reaction was carried out in a total volume of 20 µl containing 50 mM Tris/HCl pH 
7.5, 10 mM MgCl2, 10 mM DTT, 1 mM Spermidine, 1 mM ATP, 0,1 mg/ml BSA, 1 
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unit of T4-DNA ligase and at least 100 ng each DNA fragment to be ligated. The 
ligation reaction was performed at room temperature for 1 hour. Alternatively, in case 
of ligation of large DNA fragments, the mixture was kept over night in a PCR 
termocycler at a constant temperature of 16 °C. An aliquot of 1 to 5 µl of the reaction 
mixture was then transformed into E. coli cells as described in 2.5.9. 
 
 
2.5.9 Transfer of DNA into recipient microorganisms and screening methods 
 
2.5.9.1 Heat shock  
 
A volume of 200 ml LB medium was inoculated with 200 µl of an over-night culture of 
E. coli. As soon as the culture reached an OD600 of 0.4-0.6, it was cooled on ice for 20 
minutes. Cells were harvested (GSA rotor, 7000 rpm, 19 min, 4 °C) and all following 
preparation steps were performed at 4 °C and with previously cooled up material. The 
cell pellet was resuspended in 40 ml solution 1 (10 mM Na-acetate pH 5.6, 50 mM 
MnCl2, 5 mM NaCl) and incubated on ice for 20 minutes. This cell suspension was 
pelleted and resuspended in 4 ml solution 2 (10 mM Na-acetate, 5 mM MnCl2, 5 % 
glycerin, 70 mM CaCl2). Cells were stored at –70 °C in 200 µl aliquots and slowly 
melted on ice before usage. For each transformation 100 µl competent cells were mixed 
with approximately 500 ng DNA, kept on ice for at least 30 min before being heat 
shocked for 45 seconds at 42 °C in a water bath. After the heat shock, 1 ml LB medium 
was added to the cell-DNA mixture. After incubation at 37 °C for 1 hour, cells were 
plated on selective solid medium. 
 
 
2.5.9.2 Electroporation  
 
Electrocompetent cells were prepared as follows. A volume of 200 ml LB medium was 
inoculated with 200 µl of an over-night bacterial culture. The culture was harvested 
(GSA  rotor, 7000 rpm, 19 min, 4 °C) as soon as it reached an OD600 of 0.6-0.8 and 
washed once in 200 ml and once in 100 ml cold sterile MilliQ water. Cells were then 
resuspended in 200 µl cold sterile MilliQ water and stored at -70 °C until usage. For the 
electroporation, 200 µl cells were mixed with 20-500 ng dialysed DNA and transferred 
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into a precooled electroporation cuvette (0.1 cm). The electroporation was performed at 
1.7 kV (17 kV/cm), 25 F and 200 Ohm by mean of a "Gene Pulser"  (Bio-Rad, 
Hercules, USA). Cells were then resuspended in 800 µl LB, left shaking at 30 °C for 1 
hour and then plated on selective solid medium. 
 
 
2.6 Biochemical methods 
 
2.6.1 Screening of meta-cleavage activity by compound 2,3-dihydroxybiphenyl 
 
2,3-dihydroxybiphenyl has been shown to be a substrate for many extradiol 
dioxygenases, including DbfB of Sphingomonas sp. strain RW1. The meta-cleavage 
reaction product is yellow colored providing an easy colorimetric test for a rapid 
screening of bacterial colonies carrying 2,3-dihydroxybiphenyl meta-cleavage activity. 
In particular a sterile solution containing 0.1 % 2,3-dihydroxybiphenyl in 10 % acetone-
water was sprayed on the bacterial colonies. Positive clones could be identified because 
turning to yellow.  
 
 
2.6.2 Protein overexpression 
 
Overexpression of Edo2-2, Edo2-3 and Edo3, was carried out in E. coli  
BL21(DE3)[LysS] cells respectively transformed with constructs pT7-22, pT7-23 and 
pT7W4, carrying genes edo2-2, edo2-3 and edo3 cloned into vector pT7-7 under the 
control of a T7 RNA polymerase promoter Ø 10, inducible by isopropyl-thio-ß-D-
galactopyranoside (IPTG). E. coli cells were precultured at 30 °C in Luria-Bertani 
medium containing 50 mg/ml of ampicillin and 30 mg/ml of chloramphenicol, on a 
rotary shaker operated at 160 rpm. The same medium supplemented with 1.0 mM 
isopropyl-thio-ß-D-galactopyranoside (IPTG) was inoculated by 0.5-2.0 % of preculture 
and incubated as above until an OD600 of 2.0 was reached. Whole cells overproducing 
the extradiol dioxygenases were used for expression studies (2.7) or to prepare protein 
crude extracts (2.6.2). E. coli DH101 (pRW1) (B. Happe, not published) was also used 
in this study for expressing and purification of Edo2 extradiol dioxygenase. Cells were 
treated in the same way as the overexpressing strains. Protein crude extracts were 
prepared as described in 2.6.2. For overexpression of DbfB extradiol dioxygenase, E. 
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coli  BL21(DE3)[LysS] pT7-5-RW (Happe et al., 1993) was used. Overerexpression 
was carried out as for the other extradiol dioxygenase proteins. 
 
 
2.6.3 Preparation of cell crude extracts 
 
Cell extracts were prepared at 4 °C. For each extract 50 ml to 3 l cells were harvested 
by centrifugation (8000 rpm, 10 minutes), washed once in 50 mM phosphate buffer pH 
7.6, resuspended in 1 ml to 10 ml of the same buffer and disrupted in a French pressure 
cell (Aminco Corp.) operated at 20,000 Ib/in
2
. Cell debris was removed by 
centrifugation at 45,000 rpm for 45 min. For O2 free preparations, all manipulations 
were carried out in an anaerobic chamber (Coy, Ann Arbor, Mich.), filled with 95 % N2 
and 5 % H2. Traces of oxygen were removed by palladium catalyst. Cells were 
disrupted by sonication inside of the anaerobic chamber. All buffers were boiled under a 
stream of N2 and supplemented with 2 mM dithiothreitol.  
 
 
2.6.4 Determination of the protein content 
 
Protein concentrations were determined by the method of Bradford (Brandford, 1976), 
using bovine serum albumin (BSA) as a standard. The protein preparation was diluted 
with H2O to the final volume of 800 µl and mixed with 200 µl Bradford reagent 
(BioRad, Richmond, USA). After 8 minutes incubation at room temperature the 
absorbance at λ = 595 nm was measured by mean of a spectrophotometer and using 
zeroing against 800 µl H2O+ 200 µl Bradford reagent. The obtained absorbance was 
compared with that one of a series of standard BSA dilution solutions of known 
concentration and the protein content deduced. 
 
2.6.5 Determination of oxygen uptake rates 
 
Oxygen uptake rates were determined polarographically using an oxygen electrode  
Hansatech CB1D (Kings Lynn, England) in a temperated (25 °C) 1 ml reaction vessel. 
Calibration of the electrode was performed with oxygen saturated water (100 % or 253 
µM) and after addition of sodium dithionite (oxygen depleted). Oxygen uptake rates 
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were determined in a total volume of 1 ml potassium phosphate buffer (pH 7.5, 50 mM). 
Whole cells used during these experiments were washed twice with above buffer and 
resuspended in the buffer to an OD600 of approximately 10. 20-100 µl of this suspension 
were added to the oxygen saturated buffer and the endogenous respiration determined. 
The substrate dependent oxygen uptake was measured after the addition of substrate (1 
mM) as the difference of complete oxygen uptake rate and endogenous respiration.  
 
 
2.6.6 Spectrophotometric analyses of enzyme kinetics 
 
An enzymatic unit (1 Unit = 1U) represent the enzymatic activity responsible for the 
formation of 1 µM product/min or the transformation of µM substrate/ min at 25 °C. 
The specific activity, was expressed as Units/g protein. Enzymatic activities were 
assayed by monitoring the formation of reaction products on a UV-2100 
spectrophotometer (Shimadzu) over a substrate concentration range of 10 µM to 3 mM 
at wavelengths indicated in table 2.3 and using the respective reported extinction 
coefficients. Each enzymatic test was performed in a total final volume of 1 ml in 50 
mM potassium phosphate buffer (pH 7.5). The measurements were started by addition 
of substrate. For the kinetic measurements either crude extracts or partially purified 
proteins were used. The kinetics constants, Km and Vmax, were calculated by 
approximation to the Michaelis Menten equation v=Vmax · S/(Km+S) with the programm 
KaleidaGraph.  
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Table 2.3: Substrates used for the enzymatic kinetics. The extrinction coefficients of the 
reaction products and wavelengths used for enzyme activity determinations are 
indicated.  
 
Substrate ε product, pH 7.6 
[mM-1 cm-1] 
λ Product 
(nm) 
Reference 
2,3-Dihydroxybiphenyl 13.2 434 (Eltis et al., 1993) 
Catechol 36 375 (Heiss et al., 1995) 
3-Methylcatechol  16.8 382 (Heiss et al., 1995) 
2,2',3-
Trihydroxybiphenyl 
22.4 434 (Happe et al., 1993)
2,2',3-
Trihydroxybiphenyl ether 
7.8 290 This work 
 
 
2.6.7 SDS polyacrylamide gel-electrophoresis (SDS-PAGE) 
 
SDS polyacrylamide gels were used for determining the molecular weight of 
denaturated protein subunits and to check the efficiency of the protein purifications and 
were prepared as follows: 
 
5 ml sample gel (10% ) H2O       1.9 ml  
    acrylamide/N,N-methylbisacrylamide 30 %  1.7 ml  
    1.5 M Tris/HCl pH 8.8    1.3 ml
  
    10 % SDS      50 µl 
    10 % APS      50 µl 
    TEMED      2 µl 
2 ml staking gel (5%)  H2O               1.15 ml  
    acrylamide/N,N-methylbisacrylamide 30 %  330 µl 
    0,5 M Tris/HCl pH 6.8    500 µl
  
    10 % SDS      20 µl 
    10 % APS      20 µl 
    TEMED      2 µl 
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Gels used in this study were always 0.2 mm thick. The buffers used were prepared as 
follows: 
 
SDS running buffer:   Glycin     192 mM 
    SDS     0.1 % (w/v)  
    Tris/HCl    25 mM pH 8.3 
 
loading buffer 2x  ß-Mercaptoethanol   50 µl 
    Stock sample buffer   450 µl 
 
stock sample buffer   0.5 M Tris/HCl pH 6.8  2.4 ml 
    Glycerol    2.0 ml 
    10 % (w/v) SDS   4.0 ml 
    0.1 % (w/v) Bromophenol blue 1 ml 
 
The protein content of the samples to be analyzed was adjusted to 1 to 30 µg. All 
samples were diluted 1:1 with the double concentrated loading buffer and denaturated at 
95 °C for 8 minutes. Electrophoresis was performed at 15 mA for the first 10 min and at 
25 mA for the rest of the run. Gels were stained with Coomassie staining solution 
(Sambrook et al., 1989) or with Roti-Blue (Roth) over night. A broad range molecular 
weight standard (Bio-Rad) was loaded next to the protein samples for evaluating the 
molecular weight of the denaturated protein subunits. 
 
Broad range standard proteins  Phosphorylase  97.4 kDa 
      BSA    66.2 kDa 
      Albumine   45.0 kDa 
      Carboanhydrase  31.0 kDa 
      Trypsininhibitor  21.5 kDa 
      Lysozym   14.4 kDa 
 
2.6.8 Protein purification 
 
In this study two extradiol dioxygenases of Sphingomonas RW1, Edo2 (variants Edo 2-
2 and Edo 2-3) and Edo3 , were partially  purified. All purification steps were 
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performed aerobically in 1 day on a fast protein liquid chromatography (FPLC) system 
placed in the cold room (4 °C). All buffers were supplemented with 1 mM DTT as 
reducing agent.  
 
 
2.6.8.1 Ammonium sulfate precipitation 
 
A saturated (NH4)2SO4 solution  in K/Na-PO4- buffer (50 mM, pH 7.6) was prepared by 
dissolving the salt crystals under continuous stirring on a heating block at 90 °C. After 
cooling down to room temperature, an aliquot of the saturated supernatant was gently 
and dropwise added to an equal volume of crude extract in a glass beaker placed on ice. 
The mixture was then centrifuged at 45,000 rpm for 45 minutes at 4 °C. The protein 
pellet containing the precipitated meta-cleavage activity was then dissolved in 
potassium phosphate buffer 50 mM, pH 7.6 and loaded onto a Pharmacia phenyl 
sepharose column. 
 
 
2.6.8.2 FPLC (fast protein liquid chromatography) 
 
Edo2 and Edo3 were purified in this study by mean of hydrophobic interaction 
chromatography (HIC) and anion exchange chromatography. Protein elution was 
followed by an UV detector at 280 nm. Fractions of 0.5–4 ml were collected by mean of 
an automatic fraction collector. The fractions were checked for meta-cleavage activity 
using as a test substrate (2.6.1). Active fractions were either further purified or used for 
determination of kinetic properties. Purified proteins were stored in liquid nitrogen. 
Active fractions obtained after each purification step were analyzed by SDS-PAGE as 
described in 2.6.7. 
 
 
2.6.8.3 Hydrophobic interaction chromatography (HIC)  
 
Protein Edo3 was purified in a two step process involving an initial HIC 
chromatography. A HiLoad 16/10 phenyl sepharose high performance column was 
equilibrated with 1 M ammonium sulfate/10 % ethanol  in 50 mM phosphate buffer pH 
7.6. The protein was eluted with a linear 0.5 M to 0 M ammonium sulfate/10 % in 50 
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mM phosphate buffer pH 7.6 at a flow rate of 1 ml/min. Fractions of 1 ml were 
collected by an automatic sample collector connected to the FPLC.  
 
 
2.6.8.4 Anion exchange chromatography 
 
In the case of purification of Edo3, the active fractions eluted from the phenyl sepharose 
column were concentrated 4 times and loaded onto an anion exchange column (20 ml 
DEAE sepharose Fast flow, Pharmacia) previously equilibrated with Tris/HCl 10 mM 
pH 7.6 supplemented with 10 % ethanol. The proteins were eluted with a linear gradient 
0 to 0.6 M NaCl in Tris 10 mM pH 7.6 supplemented with 10% ethanol at a flow rate of 
1 ml/min. In the case of partial purification of Edo2-2 and Edo2-3 from E. coli 
BL21(DE3)[LysS] (pT7-22), and E. coli BL21(DE3)[LysS] (pT7-23) and of Edo2 from 
E. coli HB101 (pRW1), 1 ml of the protein crude extracts was directly loaded onto a 
prepacked MonoQ HR 5/5 (Pharmacia) column previously equilibrated with Tris/HCl 
pH 7.5 50 mM supplemented with 125 mM NaCl and 2 mM MnCl2. Proteins were 
eluted with a linear gradient of 125–500 mM NaCl in Tris/HCl pH 7.5 50 mM 
supplemented with 2  mM MnCl2 at a flow rate of 0.80 ml/min. 
 
 
2.7 Expression studies 
 
2.7.1 Resting cell assays 
 
2.7.1.1 Transformation of dioxin and dibenzofuran by E. coli DH10B (pMDK12) 
and E. coli DH10B (pMDK19)   
 
E. coli  DH10B cells, transformed with the expression systems pMDK12 or pMDK19, 
were precultured at 30 °C, together with the appropriate controls, i.e. E. coli  DH10B 
cells and E. coli  DH10B containing  pVLT35, in Luria-Bertani medium containing 30 
µg/ml spectinomycin, on a rotary shaker operated at 160 rpm. In 500 ml flasks, 100 ml 
of this medium supplemented with 1.0 mM isopropyl-thio-ß-D-galactopyranoside were 
inoculated with 0.5-2.0 % of preculture. Cells were grown under the same conditions as 
the preculture, harvested as soon as an OD600 of 2.0 was reached and washed twice with 
assay buffer consisting of 10 mM glucose in 0.1x M9 mineral medium. Cells were 
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resuspended to an OD600 of 2.0-10 in prewarmed assay buffer containing 0.1-0.5 mM 
dibenzofuran or dioxin dissolved in DMSO (Dimethylsulfoxid) (stock solution 100 
mM). For quantification of dibenzofuran or dioxin transformation, cells were incubated 
in aliquots of 1 ml in 10 ml reagent tubes closed with teflon coated screw caps and 
incubated at 30 oC on an overhead shaker. After appropriate time intervals, one whole 
tube was analyzed for the amount of substrate remaining. For doing this, 9 ml of 
methanol were added for extraction of residual dibenzofuran/dioxin from cell walls and 
to achieve complete dissolution. In control experiments it could be shown that by this 
method more than 95 % of residual substrate could be extracted. Samples were 
centrifuged in the test tubes at 9,000 g for 20 min and the supernatant either directly 
analyzed by reverse phase high-performance liquid chromatography (HPLC) (2.7.2) or 
stored at -20°C. For quantification of water soluble substrates or transformation 
products, 5 ml of cell suspension were incubated in 10 ml reagent tubes closed with 
teflon coated screw caps and incubated at 30 oC on an overhead shaker. At appropriate 
time intervals aliquots of 0.5 ml were removed, centrifuged, and the supernatant either 
directly analyzed by HPLC or stored at -20°C.     
 
 
2.7.1.2 Transformation of dioxin and dibenzofuran by mixed cultures 
 
E. coli  BL21(DE3)(LysS) (pT7-22), E. coli  BL21(DE3)(LysS) (pT7-23), E. coli  
BL21(DE3)(LysS) (pT7W4) and E. coli  BL21(DE3)(LysS) (pT7-5-RW) (Happe et al., 
1993) were cultured as previously described in 2.6.2. to achieve overexpression of 
Edo2-2, Edo2-3, Edo3, DbfB extradiol dioxygenases respectively. E. coli 
DH10B(pMDK12) was cultured as described in 2.6.2. Induced cells were harvested at 
room temperature and 6,000 rpm as OD600 reached 2.0 and washed twice with assay 
buffer consisting of 10 mM glucose in 0.1x M9 mineral medium. Resting cell assays 
were constituted containing a final concentration of 0.1 mM dioxin, E. coli DH10B 
(pMDK12) corresponding to an OD600 of 5 and E. coli cells overexpressing a given 
dioxygenase corresponding to an OD600 of 5. Thus the final optical density of the 
system was 10. Cells were incubated and samples taken as described above. 
Materials and Methods 
38 
2.7.2 HPLC (reverse phase high-performance liquid chromatography) analysis 
 
This method was adopted to identify metabolites of biotransformation reactions and to 
quantify substrate turnover and product formation rates. The reverse phase high-
performance liquid chromatography (HPLC) was operated with a Shimadzu LC-10AD 
liquid chromatograph system equipped with a DGU-3A degaser and a 3PD-M10A 
photodiode array detector. Dibenzofuran, dibenzo-p-dioxin and their metabolites were 
separated on an analytical SC 125 x 4.6 mm Lichrospher 100 RP8 5.0 µm column. An 
aqueous solvent system containing 0.1 % ortho-phosphoric acid and 36-45 % of 
methanol (for the identification and quantification of 2,3-dihydroxybiphenyl, 2,2´,3-
trihydroxybiphenyl, 2,2´,3-trihydroxybiphenyl ether, benzoate, salicylate, catechol and 
quantification of 3-chroman-4-on-2-yl-pyruvate 2-pyron-6-carboxylate and 2-
hydroxymuconate) 72 % of methanol (for the quantification of dioxin and dibenzofuran) 
or 18 % of methanol (for the identification of 3-chroman-4-on-2-yl-pyruvate, 2-pyron-
6-carboxylate and 2-hydroxymuconate) was used at a flow rate of 1 ml per min (tab. 
2.4). The eluent was monitored by measuring the absorption spectrum between 200 and 
400 nm. Transformation products were identified by comparison of the absorption 
spectra and retention volumes with authentic standards. Their concentration was 
analyzed based on the comparison of the peak area with that of authentic standards of 
known concentration. 
 
Table 2.4:  typical retention volumes of substrates and products used in this study  
 
Compound 72 % 45 % 36 % 18 % 
Dibenzo-p-dioxin 5.3    
Dibenzofuran 2.7    
2,3-Dihydroxybiphenyl     8.8   
2,2´,3-Trihydroxybiphenyl  4.3 9.0  
2,2´,3-Trihydroxybiphenyl ether  3.9 8.3  
Benzoate  3.6 7.6  
Salicylate   4.9 10.6  
Catechol  0.9 1.7 3.3 
 3-Chroman-4-on-2-yl-pyruvate   1.5 3.1  
2-Pyron-6-carboxylate   0.2 0.7 
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3 RESULTS 
 
 
 
3.1 Genetic characterization of edo2 and edo3 genes 
 
A Sphingomonas RW1 genomic library constructed in the cosmid pLAFR3 (Happe et 
al., 1993) was screened for the presence of meta-cleavage activity by plating it, 
incubating the plates overnight and spraying the E. coli S17-1 colonies with a solution 
of 0.1 % 2,3-dihydroxybiphenyl (2,3-DHB) in 10 % acetone-water (2.6.1). Several 
colonies exhibiting activity against 2,3-dihydroxybiphenyl were identified, the 
corresponding genomic inserts partial digested with BamHI and further subcloned into 
pUC18 vector precut with the same enzyme (B. Happe, data not published). The 
resulting plasmids were transformed into E. coli DH101. In particular two constructs, 
pRW1 and pRW4, carrying respectively a 3.3 Kb BamHI and a 10.5 Kb BamHI insert 
were further analyzed. In this study we present the genetic and biochemical 
characterization of two extradiol dioxygenase encoded by two genes encoded on the 3.3 
Kb BamHI and a 10.5 Kb BamHI inserts and subsequently named Edo2 and Edo3 
extradiol dioxygenases. 
 
 
3.1.1 Genetic characterization of the edo3 gene  
 
The 10.5 Kb BamHI genomic insert carried by the plasmid pRW4 was mapped through 
restriction analysis as follows. The plasmid pRW4 was initially subjected to single 
restriction by mean of SacI, PstI, EcoRI, SmaI, HindIII, SalI, SphI, XbaI restriction 
enzymes, respectively. The reaction samples were analyzed on a 0.8 % agarose gel. No 
HindIII, SphI and XbaI recognition sequences and multiple SalI sites were found in the 
insert. As SacI, PstI, EcoRI and SmaI were shown to cut the insert at reasonable 2-4 
times, those enzymes were used in all possible combinations to perform double 
restrictions of pRW4. By comparing the length of the resulting DNA fragments the 
restriction map presented in fig. 3.1 could be deduced. Several subclones of the 10.5 Kb 
BamHI fragment were prepared and screened for expressing an active 2,3-
dihydroxybiphenyl 2,3-dioxygenase. By restriction with SacI, five fragments have 
originated, three of which carrying only insert and no vector sequence and were 
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respectively 3.4 Kb, 3.1 Kb and 0.4 Kb in lenght. The 3.4 Kb and 3.1 Kb fragments 
were purified (2.5.7) and ligated to vector pBluescript II KS (AmpR) previously 
subjected to restriction with SacI. E. coli DH5α transformants were screened for meta-
cleavage activity by spraying the colonies with 2,3-DHB. Bacterial colonies turning to 
yellow after spraying with 2,3-DHB and therefore expressing meta-cleavage activity, 
were shown to carry the 3.1 Kb SacI DNA insert in pBluescript II KS, furtheron named 
pBl4A. Further subclones of  pRW4  were constructed by restriction with EcoRI, PstI 
and SacI and ligation of the respective purified 1270 bp EcoRI, 1945 SacI-EcoRI and 
800 bp EcoRI-PstI fragments to pBluescript II KS vector precut with the appropriate 
enzymes. However, none of the resulting plasmids, pBL5, pBl7, pBl6, in neither 
orientation of insertion into the cloning vector, expressed activity against 2,3-DHB. The 
10.5 Kb BamHI genomic insert was partially sequenced. In specific, 3215 base pairs 
delimited by SacI and EcoRI restriction sites, as evidenced in fig. 3.1B, have been 
sequenced. To obtain the sequence, pBl4A, pBl5A, pBl6 and pBl7 constructs were used 
as DNA template and the PCR primers listed in tab. 3.1 for the sequencing reaction. A 
800 bp ORF was found (fig. 3.2) in the resulting sequence which codes for a protein 
with homology with known extradiol dioxygenases and precisely sharing 38.6 % 
identity in the amino acid sequence with the biphenyl-2,3-diol 1,2-dioxygenase from P. 
pseudoalcaligenes KF 707 (BPHC_PSEPS)(Furukawa et al., 1987) and 38.3 % identity 
with the biphenyl-2,3-diol 1,2-dioxygenase of Pseudomonas strain LB400 
(BPHC_BURCE) (Eltis et al., 1993). The gene was therefore named edo3 extradiol 
dioxygenase. Immediately preceding the edo3 gene an 850 bp ORF was found encoding 
for a hydrolase, H3, sharing 34% identity in the amino acid sequence with the 2-
hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase of Pseudomonas LB400 
(BPHD_BURCE) (Hofer et al., 1993)(fig. 3.1B). The deduced H3 stop codon overlaps 
the edo3 gene ATG starting codon (fig. 3.2). A ribosome binding sequence can be 
identified 6 nt upstream of the H3 starting codon. In case of the edo3 gene no evident 
ribosome-binding site could be found, however an A-G rich region is present between 
position –10 and –15 in respect of the edo3 ATG starting codon. Possibly, in RW1 the 
two genes are cotranscribed. Flanking the edo3 and H3 genes, there are DNA regions 
sharing homology with known trascriptional regulators such as BM3R1 from Bacillus 
Megaterium (Shaw and Fulco, 1992) or E2 in Papilloma Virus (Fuchs et al., 1986).
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Table 3.1: List of primers used for the sequence analysis as indicated in fig. 3.1B.  
 
Name of the primers Primer sequence (5’-3’) 
M13-20 Primer GTAAAACGACGGCCAGT 
reverse Primer AACAGCTATGACCATG 
M1 CGGTTGGTGGAGTGGGTG 
M2 CACCCACTCCACCAACCG 
M3 GACCCCGGGTCCGATCGC 
M4 GCGATCGGACCCGGGGTC 
M5 CTCTACGGCCTCCCCTGG 
M6 CCAGGGGAGGCCGTAGAG 
M7 GCGGATGCGGAACGGATG 
M8 CATCCGTTCCGCATCCGC 
M9 CTCGGCCGCCACTGCAAC 
M10 GTTGCAGTGGCGGCCGAG 
M11 CCCGCCTTCTCCGCGATG 
M12 CATCGCGGAGAAGGCGGG 
M13 CCTGCTGTTCGACGTGGC 
M14 GCCACGTCGAACAGCAGG 
M15 CCATCAGCACCAGTCCCTCG 
M16 CAACGGCTCAGGCATTGCG 
M17 GTCGGCAACTCGCTCGGC 
M18 GTCGGCAACTCGCTCGGC 
M20 CATCTCCAGCATTTCCTCAC 
M21 CGGTCAGGGGCCGTCGGC 
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SacI
PstI EcoRI PstI
SmaI
SacI
EcoR I
SmaISacI
EcoRI
PstI SacI
EDO 3H3
pbl7
pbl4
pbl6
pbl5
1 Kb
pUC18
EcoRI-SacI-SmaI-BamH
SacI PstIBamHI
SmaI
EcoRI PstI SacI
BamHI-XbaI-SalI-PstI-HindIII
1 Kb
1 Kb
B
A
 
 
Fig. 3.1: A:restriction map of the 10,5 Kb BamHI DNA insert carried by pRW4 plasmid; B: detail of the sequenced region. By sequencing 
the two ORFs encoding for H3 and Edo3 proteins have been localized in the position shown on the map. The localization of subclones 
pBL4, pBL5, pBL6, pBL7 is also shown. 
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100
GACAGCTGGCGGGTGATGGG CCTGCAGGGCACCGGATCGA ACGACATCGTCATCGACCGG CCGGTCTTCGTTCCCGACTA TCGCATCCATTCGCAGATGG 200
ACGGCTATCGGCGGCTCCAC GACCAGCCCGACAAGCTCTA CGGCCTCCCCTGGGGACAGG TCTTCACCGCGACGGTCGCG GCCCCCGCGATCGGCGCGGC 300
GCGCCATGCGCTCGCGCTGT TCGCCGAGCGGATCGGATCG AGCAGCACCGACCCCAGCAA GGGTACCGGCGATCCCGACA TCCTGCGCCGCGTCGCAGAA 400
GCGAGGAGCCTGATCGACCG CGCCGAGGCGACGTTGTTGC GCAACTTCGACGGACTGATG GACGCGATCGCGGGGGACGA GGACATATCGCTGCTCGAAC 500
GGGCGCGGTGCCGCTACGAG ACCGGCTCGACCGTCGTGCG GATGATGGAGGCGGTCGACC TGCTGTTCGACGTGGCGGGC GGGCGCAGCGTGTTCCTCGA 600
TTCCGAGATCCAGGCCATCT GGCACGACATCCACATCGCC CGCGCGCACGTCGCCAACAA CCCGGTGCCGCTGGCGCGCA ACTATGGCGCGATGGTGCTG 700
GGCGGCGAGAACAAGGACTA TTTCATCTGATCGGGAAGGG AGGCCGCAATGCCTGAGCCG TTGCTGCCACGGGGCCAGGA GGTCGCCGTCGGCGAACACC 800
GCATCCATTATCTGAGCTAT GGCGAGGGCCCGGCGGTCGC GTTCCTGCACGGGAGCGGGC CGGGGGCGAGCGGCTACAGC AATTTCAAGCAGAACATCGA 900
CGCGATCGTGGCGGCGGGGC GCCGGGCGATCGTCCTCGAC ATGATCGGCTTCGGCCATTC GAGCAAGCCGGTCGGCTGCG ACTACACCACCGACCTGTTC 1000
GCGCGGACGATCCGGCAGGC GCTCGACGCGATCGGCGTCG GACGCTGCGTGCTGGTCGGC AACTCGCTCGGCGGCGCGGT CGCGATCCGCATCGCCCTCG 1100
ACGATCCCGAACGCGTCGAG GGACTGGTGCTGATGGCGCC CGGCGGCATCGAGGAGAACG AGGTCTATTATGCCATGCCC GGCATCCGCAGCATGGTGTC 1200
GGCCTTCGTCGGCGGGACGC TCGACCGGGAAGGGTTGCGG TCGCTGCTGCGCATGCTGGT CCACGATGCGTCGCTGGTCG ACGACGGGCTGGTCGACGAA 1300
CGGTTCGAGGTCCTTCGGAC CCAGCCGGTCGAGGTGCTGT CGCGGCTGAAGGTGCCGTCG ATGGCGCACGAACTGGGCAA TATCCGCTGCCCCATCCTCG 1400
GCTTCTGGGGGCGGGAGGAC CAGTTCACGCCGATGTCGGG CTTCTCGAAATTCCTCGATG CCAGCCCGGACTGCGCGTTC ACGCTCCTGTCGAACTGCGG 1500
CCATTGGGTGATGGTCGAGC AGGCCGGGCTGTTCAACGCC CATCTCCAGCATTTCCTCAC CGCGCGGATGGGTGCCGCCC GGCAAGCGGAGGCCGTCGGC 1600
CCATGAAAGTCTCGCGCCTC GGCTATCTCAGCTTCACCTC CGTCGACCTGCCCGGCTGGC GGCGTTTCGGAACCGGCGTC ATCGGGGCGATGGACGTCCC 1700
CGGAACGGAGGGGGACGTCC GCCTCAAGATCGACGAGCAT CCGTTCCGCATCCGCGTCGA GGCCGGCGACGCCGATCGGT TGAGCGGCATCGGCTGGGAG 1800
CTGGCGTCGCGGGCGGACCA TGACGCGCTGTACGAGCGGC TGAACGGCCTCGGCCTCAAG CTGCGCGACGGCGATGCGGC CGGCGCGGCGAAACGCTGCG 1900
M  P  E  P   L  L  P  R  G  Q  E   V  A  V  G  E  H  R
  I  H  Y  L  S  Y   G  E  G  P  A  V  A   F  L  H  G  S  G  P   G  A  S  G  Y  S   N  F  K  Q  N  I  D
 A  I  V  A  A  G  R   R  A  I  V  L  D   M  I  G  F  G  H  S   S  K  P  V  G  C  D   Y  T  T  D  L  F
A  R  T  I  R  Q  A   L  D  A  I  G  V  G   R  C  V  L  V  G   N  S  L  G  G  A  V   A  I  R  I  A  L  D
  D  P  E  R  V  E   G  L  V  L  M  A  P   G  G  I  E  E  N  E   V  Y  Y  A  M  P   G  I  R  S  M  V  S
 A  F  V  G  G  T  L   D  R  E  G  L  R   S  L  L  R  M  L  V   H  D  A  S  L  V  D   D  G  L  V  D  E
R  F  E  V  L  R  T   Q  P  V  E  V  L  S   R  L  K  V  P  S   M  A  H  E  L  G  N   I  R  C  P  I  L  G
  F  W  G  R  E  D   Q  F  T  P  M  S  G   F  S  K  F  L  D  A   S  P  D  C  A  F   T  L  L  S  N  C  G
 H  W  V  M  V  E  Q   A  G  L  F  N  A   H  L  Q  H  F  L  T   A  R  M  G  A  A  R   Q  A  E  A  V  G
P  .
M  K  V  S  R  L   G  Y  L  S  F  T  S   V  D  L  P  G  W  R   R  F  G  T  G  V   I  G  A  M  D  V  P
 G  T  E  G  D  V  R   L  K  I  D  E  H   P  F  R  I  R  V  E   A  G  D  A  D  R  L   S  G  I  G  W  E
L  A  S  R  A  D  H   D  A  L  Y  E  R  L   N  G  L  G  L  K   L  R  D  G  D  A  A   G  A  A  K  R  C  V
M5
M13
M14
M6
M17
M18
M15
M16
M20
M8
M7
*
SacI
KpnI
GGGCAGCGGGCATTGCGACT GGGTACTGCTCGGCGCGATC GTCGAGGGCCGCCCATTGCT GGAGACCCTGCTCGTCCCGC GCGCGGACTATGCGATCGAG
PstI
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TCGCCGATTATTTCGCGACC GAGGACCCGGCCGGGAATAT CATCGAATTCTACTGCGAGC GCACCGGGTGCGGCGATCCC TTCCGGTCGCCGGCCGGCGT 2000
CCGGGGGTTCGTCACCGGCG AGATGGGGCTCGGCCATGTC GTCGTCCCGGCCGCCGGGGC GCTGGAGGAGACCCACGACT TCTACCGCTCCGTGCTCGGC 2100
TTCGGCGCCAGCGACGACCT GACCATCGCGCTGCCGATCG AGGGCGTCCCGCCGATGCGC GTGCTGTTCATGCACGCCGA CAATCCCCGCCACCACAGCC 2200
TCGCGCTGTTCAGCAAGCCG TCGCCGACCGGGATCGTCCA TCTCATGCTCGAGCTGGAGG ACGTCGACGAGGTCGGGCGT TGCCTCGACCGGGTCGGGGC 2300
CCACGGGCTGGGGCTGATGG CGACGCTCGGCCGCCACTGC AACGACAATATGCTGTCCTT CTACGTCAACGGGCCGGCGG GGGTGGCGGTGGAGATCGGG 2400
TGCGAGGGGCTGCAGCTCGA CTGGACCCGGTTCGAACCCA CGGTGAGCAGCGTGGCGGAT CATTGGGGGCATGCCTATCG ACAGCTCGCCGACGGCCCCT 2500
GACCGGCGCGGGGACCCCGG GTCCGATCGCAGCGCGCCCG CCCTCCCGCCGGGGGCGGGC GTCGATCGTCGTCCGGCCGG CGGGAAGCCGGATTGCAATC 2600
GTCACCATGCCAAAATACAC AACGCGACAACTGGGAAGAC GTCTTAAAACAAGGGTTTGA GCATTGCGACGGAAGATGCC GATCCAAAGCCGGGCGAAGG 2700
TGACCTCGGACGCGATCCTG GAGGCCGCCGAGATCATCGT CCTGAACGAGGGCTATGAGA AGGCGACGACCAACTACATC GCGGAGAAGGCGGGGGCGAG 2800
CATCGGCTCGCTTTATCAAT ATTTCCCGAACAAGGACGCG ATCATCTCGGCGCTGATCGA GCAGACCGTCTCGCGGATCG CCAACGGGACGCGGGCGGTG 2900
CTGCGCGAATCGATCGAGCT GCCGCTGGAGCAGGCGAGCC GCGCCACCTACGAATATCTG CTGCACCAGTTCCGCGAGAA CAAGGTGCTGCTCTACAGCA 3000
TCTCGAAGCAGACGCCCGAG CTGGTCGAGCTCACCAAGAA CCTCTCGGTCGAGAAGTTCA CCCACTCCACCAACCGGGCG CTGCTCGAACAGCATCGCGA 3100
CGAGATCGTCGTCGAGGATA TCGAACAGGCGCTGATCATC CTAGAAATCGCCGTTCTCGC CAACATGCGGCGCTACATCC TCGAAAATCCGGCGGGGATG 3200
ACGGACCAGCTTAAG 3215
  A  D  Y  F  A  T   E  D  P  A  G  N  I   I  E  F  Y  C  E  R   T  G  C  G  D  P   F  R  S  P  A  G  V
 R  G  F  V  T  G  E   M  G  L  G  H  V   V  V  P  A  A  G  A   L  E  E  T  H  D  F   Y  R  S  V  L  G
F  G  A  S  D  D  L   T  I  A  L  P  I  E   G  V  P  P  M  R   V  L  F  M  H  A  D   N  P  R  H  H  S  L
  A  L  F  S  K  P   S  P  T  G  I  V  H   L  M  L  E  L  E  D   V  D  E  V  G  R   C  L  D  R  V  G  A
 H  G  L  G  L  M  A   T  L  G  R  H  C   N  D  N  M  L  S  F   Y  V  N  G  P  A  G   V  A  V  E  I  G
M3
M4
M21
M9
M10
M12
M11
M2
M1
C  E  G  L  Q  L  D   W  T  R  F  E  P  T   V  S  S  V  A  D   H  W  G  H  A  Y  R   Q  L  A  D  G  P  .
EcoRI
*
XhoI
PstI
SmaI
ClaI
SacI
EcoRI
 
 
Fig. 3.2: Complete sequence of the 3215 bp SacI-EcoR1 fragment indicated in fig. 3.1B. 
The primers used for the sequencing reactions and their specific orientation are 
indicated by arrows. The DNA regions encoding H3 and edo3 genes have been 
translated into amino acid sequences. The gene stop codons are indicated with a “*”. 
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3.1.2 Genetic characterization of the edo2 gene 
 
The 3.3 Kb BamHI genomic insert carried by the plasmid pRW1 (3.1) has been mapped 
by restriction analysis (B. Happe, data not published) by mean of the restriction 
enzymes EcoRI, PstI, BamHI and SalI (fig. 3.3). By sequence analysis a 892 nt ORF 
has been found encoding for a protein sharing homology with known extradiol 
dioxygenases and precisely sharing 42 % identity in the amino acid sequence with the 
biphenyl-2,3-diol 1,2-dioxygenase from Rhodococcus globerulus P6 (Asturias et al., 
1994) and the biphenyl-2,3-diol 1,2-dioxygenase from Pseudomonas pseudoalcaligenes 
(Furukawa et al., 1987) and thus named Edo2 extradiol dioxygenase (fig.3.4). 
Interestingly, the gene sequence presents three putative ATG starting codons indicated 
in fig. 3.4 as ATG1, ATG2 and ATG3. ATG2 directly follows ATG1, while ATG3 is 
located 18 bp downstream of ATG2. No clear ribosome-binding site could be identified 
at the appropriate position upstream of ATG3 and ATG1. However a region rich in 
adenosines and guanosines is present 10-5 bp upstream of ATG2, possibly indicating 
ATG2 to be the proper start codon in RW1. In this work we addressed the question 
which of the three putative starting codons is actually used during edo2 gene 
transcription in Sphingomonas RW1. Since it is unlikely for a protein to start with two 
methionines, we decided to focus on ATG2 and ATG3 as putative start codons. The 
possible protein variants with ATG2 and 3 as start codons and respective DNA ORFs of 
889 nt and 868 nt in length, were furtheron named Edo2-2 and Edo2-3.  
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EcoRI PstI BamHI SalIHindIII
2686 3400 3500 5100 5400 60000
EcoRI-SacI-KpnI-SmaI-BamHI/Sau3A BamHI-XbaI-SalI-PstI-SphI-HindIII
pUC18
EDO2
 
 
Fig 3.3: pRW1 restriction map. By sequencing analysis the edo2 gene could be positioned as indicated in the figure.
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ACGGGGCTAT TATGACGACG TCGTCACGGT CGATGGTGGG ACGGCCCTCT TCGCAAGCAA 60
GACGGTCTAC ATCGACGGAA CGCCCACCCG CTATCTCGCC TATCCGCTTT GAGAAGAATG 120
    M
ATGACAGACC AACAGTCGAA TATGCCGTCG CCGATCGTCG CCCTGGGCTA TCTGGGTTTC 180
M  T  D  Q   Q  S  N   M  P  S   P  I  V  A   L  G  Y   L  G  F
TATGCGCAGG ATCTCGCCGC GTGGGAGGAA TGGGCGACCC AGATTTTCGG GTTCGCGAAG 240
Y  A  Q  D   L  A  A   W  E  E   W  A  T  Q   I  F  G   F  A  K
GTTCGCGCGC CGGAAGGCAT TTCCAGCGAT CATCTCTACC TGCGGATCGA CGAGCGCCAA 300
V  R  A  P   E  G  I   S  S  D   H  L  Y  L   R  I  D   E  R  Q
TGGCGCTTCG CGGTCGAGCC CGGTACGGAA GGCCGCGTCG CTTTCATCGG CTGGGAGGCC 360
W  R  F  A   V  E  P   G  T  E   G  R  V  A   F  I  G   W  E  A
GCCGACGCCA ACGCGTTGGA GGAGGTCCAT CGGCGGCTCA CCGCCCAGGG GATCGAGGTC 420
A  D  A  N   A  L  E   E  V  H   R  R  L  T   A  Q  G   I  E  V
GTCAGGGATG CCGAACTGGC GCGAAAGCGC TGCGTGCAGG ACCTGATCCG CTGCGAGGAT 480
V  R  D  A   E  L  A   R  K  R   C  V  Q  D   L  I  R   C  E  D
CCCGACGGCT TCCGGCTGGA GTTCTTCCAC GGCCATCTCG TTTCCCGCGA GCCGTTCGTC 540
P  D  G  F   R  L  E   F  F  H   G  H  L  V   S  R  E   P  F  V
TCTCCGCGCG GCATCGGCTT CGTCACCGGC GACATGGGGC TCGGCCACAT CCTCATCACG 600
S  P  R  G   I  G  F   V  T  G   D  M  G  L   G  H  I   L  I  T
GTGAGCGACA TCGAAAAGTC GAAGGCCTTC TACCTGGACC TGCTCGGCTT CAGGATGAGC 660
V  S  D  I   E  K  S   K  A  F   Y  L  D  L   L  G  F   R  M  S
GATTACATCG TCTTCGGCGG GAACAAGGTG CATTTCACCC ACATCAACCC GCGTCACCAC 720
D  Y  I  V   F  G  G   N  K  V   H  F  T  H   I  N  P   R  H  H
AGCCTGGCCT TCGTCCAGAC CAGCGATCGC ATCGCGCGGC TGGGCCACTT CATGGTGGAG 780
S  L  A  F   V  Q  T   S  D  R   I  A  R  L   G  H  F   M  V  E
GCCGACGATG TCGACGCCGT CGGCTTCGCG CTCGACCGTC TTCATGCCAG CACATGGCAG 840
A  D  D  V   D  A  V   G  F  A   L  D  R  L   H  A  S   T  W  Q
CTGAAGGAGA CCCTCGGGCG CCACACCAAT GATCGCATGC TCTCCTTCTA CTGCGAAAAT 900
L  K  E  T   L  G  R   H  T  N   D  R  M  L   S  F  Y   C  E  N
CCTTCGGGGT CGCAGACGGA GTTCGGTTGG GGCGGGCGCA AGATCGCCCA CCCCGGCTGG 960
P  S  G  S   Q  T  E   F  G  W   G  G  R  K   I  A  H   P  G  W
CTGGTGGAAA CCTATGATGC GACCGCATTC TGGGGACACA AGGTTCCGGG CACCGAATAT 1020
L  V  E  T   Y  D  A   T  A  F   W  G  H  K   V  P  G   T  E  Y
TCGGACAGGG GTCCTCAGTC TCCACGCGAA GGAATTTGAA AATGGCGGAA AAGATTCGGG 1080
S  D  R  G   P  Q  S   P  R  E   G  I  *
TGTGCGCGGA GGGCGAGATC GAGGACGGCG GCTTCAAGGG TCATCGCCCT CAGGGAACCG 1140
ATG1
ATG2 ATG3
 
 
Fig. 3.4: Edo2 gene and protein sequence. The three putative ATG codons and the SD 
sequence are indicated.  
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3.1.3 Protein alignment of Edo2 and Edo3 with known extradiol dioxygenases 
 
The amino acid sequences of Edo3, Edo2-2 and Edo2-3 were deduced directly from the 
DNA sequence determined and compiled by mean of the GeneWork program. The 
Edo2-2 protein sequence differs from that one of Edo2-3 by 7 additional amino acids at 
the N-terminus. The protein sequences of Edo3, Edo2-2 and Edo2-3 were aligned with 
those of other known extradiol dioxygenases available in public databases by mean of 
the CLUSTAL_X program (Thompson et al., 1996) (fig 3.5).  The 7 additional amino 
acids present at the N-terminal domain of Edo2-2 extradiol dioxygenase are pushed out 
of the protein alignment as almost an exception in respect to all the other analyzed 
sequences. The protein alignment created by CLUSTALX was then used to generate the 
phylogenetic tree shown in fig. 3.6 by the program PRODIST of the PHYLIP 
(Felsenstein, 1985) package. Previously (Harayama et al., 1992) extradiol dioxygenases 
have been classified into two groups in respect of the substrate preference for either 
bicyclic or monocyclic substrates. It is now becoming clear that such division is only an 
approximation of the real more complex situation, as evidenced by the increasing 
number of three-dimensional studies conducted on a large number of extradiol 
dioxygenases, which revealed the presence of several subclasses of enzymes (Eltis and 
Bolin, 1996). However, only for a limited number of extradiol dioxygenases the 
substrate spectrum has been definitely characterized, and thus it is not clear whether the 
different subfamilies described by Eltis differ also in their respective catalytic 
properties. We can however observe, without any strong classification purpose, that 
Edo2-2, Edo 2-3 and Edo3 clearly cluster with several extradiol dioxygenase which are 
known to prefer bicyclic aromatics as substrates (Eltis and Bolin, 1996) such as: the 2,3-
dihydroxybiphenyl 1,2-dioxygenases from P. pseudoalcaligenes KF 707, the 2,3-
dihydroxybiphenyl 1,2-dioxygenases from P. cepacia LB400, 2,3-dihydroxybiphenyl 
1,2-dioxygenase from Pseudomonas sp. strain KKS102, the 2,3-dihydroxybiphenyl 1,2-
dioxygenases from R. globerulus P6. 
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DMPB_PSEPU ---------- MKKGVMRPGH VQLRV----- -------LN- LESALAHYRD  
XYE2_PSEPU ---------- MKKGVMRPGH VQLRV----- -------LN- LEAALTHYRD  
XYE1_PSEPU ---------- MNKGVMRPGH VQLRV----- -------LD- MSKALEHYVE  
XYLE_PSEAE ---------- MNKGIMRPGH VQLRV----- -------LD- MSKALEHYVE  
NAHH_PSEPU ---------- MNKGVMRPGH VQLRV----- -------LD- MGKALEHYVE  
BHC1_RHOGO ---------- --MSVQRLGY LGIEV----- -------SD- VDAWRTYATM  
TODE_PSEPU ---------- --MSIQRLGY LGFEV----- -------AD- VRSWRTFATT  
BPHC_BURCE ---------- --MSIRSLGY MGFAV----- -------SD- VAAWRSFLTQ  
BPHC_PSEPS ---------- ---SIRSLGY MGFAV----- -------SD- VAAWRSFLTQ  
BPHC_PSES1 ---------- ---SIERLGY LGFAV----- -------KD- VPAWDHFLTK  
EDO2-3     ---------- MPSPIVALGY LGFYA----- -------QD- LAAWEEWATQ  
EDO2-2     ---MTDQQSN MPSPIVALGY LGFYA----- -------QD- LAAWEEWATQ  
BPHC_PSEPA ---------- -MVAVTELGY LGLTV----- -------TN- LDAWRSYAAE  
BPH_RHA1   ---------- -MAKVTELGY LGLSV----- -------SN- LDAWRDYAAG  
NAHC_PSEPU --------MS KQAAVIELGY MGISV----- -------KD- PDAWKSFAMN  
BHC2_RHOGO ---------- -MTATPKFAH VVLQT----- -------SR- FEAMRDWYCT  
BHC3_RHOGO ---------- -MTVTPRLAH FVLQT----- -------NQ- LPAMTQWYID  
DBF_DPO360 ---------- -MSKVKELAY VGYEV----- -------SD- LAAWEHFGVD  
BPH_P20    ---------- -MQSVSTLGY MVIGV----- -------SD- LAAWESFAVN  
EDO3       ---------- --MKVSRLGY LSFTS----- -------VD- LPGWRRFGTG  
dbfB_new   ---------- --MSVKQLGY LIFECR---- -------ADV LEQMVVVYQD  
CDO_CTM    ---------- MSNITSDSNI VEVSVPRVHN LHHVELLTPK PNESLDFFTR  
PHEB_BACST ---MSKNFQE PIFDVAQLAH VELLS----- -------PK- LEESIVFFTK  
DPA_ARTGLO MTNFVPTPSV PAPDIVRCAY MEIVV----- -------TD- LAKSREFYVD  
BPH_BN6    ----MSQTET SPIRVEKIAH IVLFV----- -------KD- PELSAQWYSD  
 
Fig 3.5: Edo2-2, Edo2-3 and Edo3 protein sequences were aligned with those of known 
extradiol dioxygenases (see also fig. 3.6 and the respective legend). In the figure only 
the N-terminal segment of the alignment is shown.  
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Fig. 3.6: Phylogenetic tree obtained from the alignment of Edo2-2, Edo2-3 and Edo3 
with related extradiol dioxygenases. The protein sequences were first aligned using the 
CLUSTELX program. The phylogenetic analysis was performed using the neighbor-
joining algorithm of PHYLIP . Distance matrices were generated with the PRODIST 
program. The phylogenetic unrooted tree was drawn with DRAWTREE of the PHYLIP. 
The branch length correlate with the percentage divergence of the protein sequences, 
The numbers indicate the confidence (percent) estimated by bootstrap analysis with 
SEQBOOT program on 100 replications. Proteins are labeled by abbreviations. Their 
accession codes in the SwissProt or GeneBank databases and their origins are X60740 
for catechol 2,3-dioxygenase from Pseudomonas aeruginosa JI104 (XYLE_PSEAE), 
V01161 for catechol 2,3-dioxygenase from P. putida MT-2 (XYE1_PSEPU), M17159 
for catechol 2,3-dioxygenase from P. putida PpG7 (NAHH_PSEPU), U33263 for 
catechol 2,3-dioxygenase from Pseudomonas CF600 (DMPB_PSEPU), M65205 for 
catechol 2,3-dioxygenase from P. putida (XYE2_PSEPU), X75634 for 2,3-
dihydroxybiphenyl dioxygenase II from R. globerulus P6(BHC2_RHOGO), X75635 for 
2,3-dihydroxybiphenyl dioxygenase III from R. globerulus P6 (BHC3_RHOGO), 
X69504 for catechol 2,3-dioxygenase from Rhodococcus rhodochrous CTM 
(CDO_CTM),  X67860 for catechol 2,3-dioxygenase from Bacillus stearothermophilus 
FDTP-3 (PHEB_BACST), D76438 for 2,3-dihydroxybiphenyl dioxygenase from 
Rhodococcus sp. strain RHA1 (BPH_RHA1), M20640 for 2,3-dihydroxybiphenyl 
dioxygenase from Pseudomonas paucimobilis Q1 (BPHC_PSEPA), J04994 for 1,2- 
dihydroxynaphthalene dioxygenase from P. putida PpG7 (NAHC_PSEPU), X75633 for 
2,3-dihydroxybiphenyl 1,2-dioxygenases from R. globerulus P6 (BPHC1_RHOGO), 
J04996 for 3-methylcatechol 2,3-dioxygenase from P putida F1 (TODE_PSEPU), 
M15333 for 2,3-dihydroxybiphenyl 1,2-dioxygenases from P. pseudoalcaligenes KF 
707 (BPHC_PSEPS), X66122 for 2,3-dihydroxybiphenyl 1,2-dioxygenases from P. 
cepacia LB400 (BPHC_BURCE), M26433 for 2,3-dihydroxybiphenyl dioxygenase 
from Pseudomonas sp. strain KKS102 (BPHC_PSES1).U22355 for 2,3-
dihydroxybiphenyl dioxygenase from naphthalenesulfonate -degrading bacterium strain 
BN6 (BPH_BN6), JC4922 for 2,3-dihydroxybiphenyl dioxygenase from P. sp. strain 
P20 (BPH_P20), U57649 for dibenzofuran extradiol dioxygenase from Terrabacter sp. 
strain DPO360 (DBF_DPO360), U19817 for 3,4-dihydroxyphenylacetate 2,3-
dioxygenase from Arthrobacter globiformis (DPA_ARTGLO). 
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3.2 Biochemical characterization of Edo2-2, Edo2-3 and Edo3 extradiol 
dioxygenases 
 
3.2.1 Overexpression of Edo3 
 
Gene edo3 was amplified from pRW4 by mean of primers M13 
(CATATGAAAGTCTCGCGCCTCGG, forward) and M14 
(TTCGAACCCGGGGTCCCCGCGC, reverse) introducing respectively an NdeI site 
overlapping the edo3 ATG starting codon and a HindIII site 19 nt downstream of the 
stop codon. For the amplification conditions described in 2.5.3 have been used. The 
resulting 828 bp blunt end DNA fragment was ligated into vector pCR-Script Amp 
SK(+) precut with SrfI giving the construct pCRW4. The amplified gene was sequenced 
on both strands in order to check the integrity of the genetic information. The gene edo3 
was then excised from pCRW4 by mean of NdeI and HindIII restriction enzymes and 
inserted into the expression vector pT7-7, previously double restricted with NdeI and 
HindIII, originating plasmid pT7W4. E. coli DH5α was used for propagating both 
pT7W4 and pCRW4 constructs. Overexpression of Edo3 extradiol dioxygenase was 
carried out in E. coli BL21(DE3)LysS as previously described (2.6.2). 
 
 
3.2.2 Aerobic purification of Edo3 
 
E. coli cells overexpressing Edo3 (2.6.2) were harvested and washed twice in potassium 
phosphate buffer pH 7.6. A quantity of 10ml crude extract was prepared in the same 
buffer from 3 liters cell pellet. The dioxygenase activity was precipitated from crude 
extract by addition of saturated ammonium sulfate solution as described in 2.6.8.1. The 
resulting protein pellet was resuspended in phosphate buffer pH 7,6 and loaded on a 
phenyl sepharose Hiload 16/10 Pharmacia column (2.6.8.2). The protein was eluted 
with a gradient of 0.5 M to 0 M ammonium sulfate and precisely at a 100 mM 
concentration of ammonium sulfate. Samples showing activity against 2,3-
dihydroxybiphenyl were pooled, concentrated 4 times and loaded on a DEAE sepharose 
anion exchange column. The protein was eluted using a gradient from 0 mM to 600 mM 
NaCl and precisely at 200 mM concentration NaCl. Samples from each purification 
step, and showing significant activity against 2,3-dihydroxybiphenyl, were analyzed by 
SDS-PAGE (fig.3.7). 9% of the initial total activity could be recovered after 
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hydrophobic interaction chromatography, and a remaining 1.3 % activity was recovered 
after additional anion exchange chromatography (tab.3.2) showing protein Edo3 to be 
very unstable as previously reported for other extradiol dioxygenases such as DbfB 
(Happe et al., 1993).  
 
Tab. 3.2: Partial purification of Edo 3 from E. coli BL21(DE3)[LysS] (pT7-W4). 10 ml 
of cell extract with the indicated activity when measured with 100 µM of 2,3-
dihydroxybiphenyl was applied onto a phenyl sepharose Hiload 16/10 Pharmacia. 
Active recovered fractions were pooled and loaded onto an anion exchange column 
(DEAE sepharose Fast flow), and eluted as described in 2.6.8.4. 
 
 Total protein content 
(mg) 
Total activity 
(Ua) 
Specific activity 
(U/g) 
Recovery 
(%) 
Crude extract 355 1030 2900 100 
Phenyl sepharose 55 92 1670 9 
DEAE Sepharose 8.5 13.5 1590 1.3 
 a One unit is defined as the amount of protein that converts 1 µmol of 2,3-DHB per 
min. 
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Fig 3.7: SDS-PAGE monitoring the purification of Edo3 extradiol dioxygenase. Each 
sample loaded on the gel corresponds to a purification step: 1, molecular weight 
standard (765 multicolor by Amersham); 2, E. coli BL21(DE3)(pLysS)(pT7W4) crude 
extract; 3, phenyl sepharose eluate before and after being concentrated 4 times; 4, 
DEAE Sepharose eluate. In all lanes an amount corresponding to 30 µg total protein 
content has been applied. 
 
 
3.2.3 Hyperexpression of Edo 2-2 and Edo2-3 
 
Plasmid pRW1 was used as a template for the amplification of edo2-2 and edo2-3  
ORFs by mean of primers C230-2 (CATATG2ACAGACCAACAGTCGAATATG3) 
and C230-3 (GATG2ACAGACCAACAGTCGCATATG3), Primers C230-2 and C230-3 
introduced an NdeI site overlapping ATG2 on C230-2 and ATG3 on C230-3 
respectively making then possible to clone the resulting PCR products carrying edo2-2 
and edo2-3 respectively into the expression vector pT7-7, precut NdeI. By looking at 
the primer design (where the NdeI site has been underlined and ATG2 and 3 evidenced) 
it is possible to notice that, although both ATG2 and ATG3 are present on both primers 
C230-2 and C230-3, only ATG3 will eventually be present on edo2-3 cloned into pT7-7 
vector, since ATG2 will fall outside of the fragment amplified by mean of C230-3 and 
following NdeI restriction. On the other side both ATG2 and ATG3 will be present on 
edo2-2 once cloned into pT7-7 since ATG3 falls inside edo2 amplified by mean of 
C230-2 primer and resulting from NdeI restriction. Gene edo2-2 was therefore 
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eventually carrying both ATG2 and ATG3 while edo2-3 was carrying only ATG3 but 
not ATG2. The PCR reactions were carried out as described in 2.5.3. The resulting 1018 
bp and 1016 bp blunt-end DNA fragments were inserted into pCR-Script Amp SK(+) 
precut with SrfI, originating the recombinant plasmids pSK-22 and pSK-23, carrying 
respectively in the first case both ATG2 and ATG3 and in the second case only ATG3. 
The inserts were sequenced on both strands in order to check the integrity of the nucleic 
acid information. Plasmids pSK-22 and pSK-23 were digested with NdeI. The resulting 
1018 bp and 997 bp DNA fragments, carrying the ORFs of the two genes beginning 
exactly with ATG2 and ATG3 respectively, were ligated to plasmid pT7-7 previously 
subjected to restriction with NdeI, originating the two recombinant plasmids pT7-22 and 
pT7-23 respectively. E. coli  BL21(DE3)[LysS] cells were transformed with pT7-22 and 
pT7-23 constructs.  Overexpression of Edo2-2 and Edo2-3 extradiol dioxygenases was 
carried out as previously described (2.6.2). 
 
 
3.2.4 Investigation of the Edo2 protein native size  
 
In order to analyze which of the two Edo2 protein versions, i.e Edo2-2 or Edo2-3 would 
be actually synthesized in Sphingomonas RW1, both Edo2-2 and Edo2-3 extradiol 
dioxygenases were partially purified from E. coli BL21(DE3)[LysS] (pT7-22) and E. 
coli BL21(DE3)[LysS] (pT7-23) cells,  respectively and compared to Edo2 purified 
from E. coli DH101 (pRW1). In the case of  E. coli DH101 (pRW1), 2000 bp genomic 
information are present upstream of the edo2 gene, including therefore all putative edo2 
ATG starting codons and the wild type ribosome binding site which would be used 
during the gene expression in Sphingomonas RW1. Transcription start at ATG 2 would 
result in a molecular mass of the enzyme product of 1 kDa higher compared to a 
transcription start at ATG3. Such a difference should be visible after SDS-PAGE. A 
volume of 3 ml crude extract in potassium phosphate buffer (50 mM pH 7.5) was 
aerobically prepared from 200 ml induced cells of each E. coli strain (2.6.3). 1 ml of 
these protein preparations, containing 15-25 mg of protein, was loaded separately onto a 
MonoQ HR 5/5 (Pharmacia) anion exchange column (2.6.8.4). Proteins were eluted 
with a gradient from 125 mM to 500 mM NaCl. Fractions of 0.5 ml were collected and 
those containing the highest activity against 2,3-dihydroxybiphenyl, eluting at 
approximately 250 mM NaCl, were analyzed by SDS-PAGE. As shown in fig. 3.8, 
strong protein bands at molecular weights of about 34-35 kDa appeared in all lanes 
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where fractions containing activity against 2,3-dihydroxybiphenyl have been subjected 
to electrophoretic analysis. The molecular weight of the extradiol dioxygenase 
expressed from pRW1 (lane 6) appears to be identical in size to that expressed from 
pT7-22 (lane 5) but significantly larger than that expressed from pT7-23 (lane 4). 
Analysis of mixtures of fractions containing extradiol dioxygenase expressed from 
pRW1 and either extradiol dioxygenase expressed from pT7-23 (lane 2) or from pT7-22 
(lane 3) clearly evidenced that the enzyme expressed from pRW1 is different in size 
from that expressed from pT7-23 (two bands of proteins with molecular weights of 
about 34-35 kDa) but obviously identical in size to that expressed from pT7-22 (one 
band of proteins with molecular weights of about 35 KDa). This indicates Edo2-2 to be 
the most likely form of Edo2, produced in Sphingomonas RW1. 
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Fig. 3.8: SDS-PAGE analysis of partially purified Edo2 extradiol dioxygenases expressed from 
different vectors. Cell extracts  from E. coli HB101 (pRW1), E. coli (DE3)(LysS)(pT7-22) and 
E. coli BL21(DE3)(LysS)(pT7-23) were subjected to  ion exchange chromatography on a 
MonoQ HR 5/5 (Pharmacia) column and active fractions analyzed for the size of the expressed 
extradiol dioxygenase. The samples loaded onto the gel correspond to: 1, molecular weight 
marker low range (Bio-Rad); 2, Edo2 containing fraction from E. coli HB101 (pRW1) mixed 
with Edo2-3 containing fraction from E. coli BL21(DE3)LysS (pT7-23); 3,  Edo2 containing 
fraction from E. coli HB101 (pRW1) mixed with Edo2-2 containing fraction from E. coli 
BL21(DE3)LysS (pT7-22); 4, Edo2-3 containing fraction from E. coli BL21(DE3)LysS (pT7-
23), 5, Edo2-2 containing fraction from E. coli BL21(DE3)LysS (pT7-22); 6, Edo2 containing 
fraction from E. coli HB101 (pRW1); 7, E. coli BL21(DE3)(LysS) protein fraction eluted at the 
same NaCl concentration at which the extradiol dioxygenases were eluted. 
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3.2.5 Kinetic studies 
 
The activity of the different extradiol dioxygenases, in freshly prepared E. coli 
BL21(DE3)LysS cell free extracts (2.6.3), overexpressing the respective enzymes was 
always 9.000 +/- 2000 U/g protein for DbfB, 7500 +/- 1500 U/g protein for Edo 2-3, 
and significantly lower in the case of Edo 2-2 (2700 +/- 700 U/g protein) or Edo 3 
(2100 +/- 800 U/g protein) when measured with 100 µM 2,3-dihydroxybiphenyl as 
substrate. Activity in a cell free extract of Edo2 expressed by E. coli HB101 (pRW1) 
and measured under the same conditions showed only activities of approximately 100 
U/g protein. It can thus be concluded that the proteins were obviously overexpressed 
under the control of the T7 promoter, but that either overexpression was less effective 
for Edo2-2 and Edo3 or that the proteins were less effective compared to DbfB and 
Edo2-3. 
 
Table 3.3: Partial purification of Edo2-2 from E. coli BL21(DE3)[LysS] (pT7-22),  
Edo2-3 from E. coli BL21(DE3)[LysS] (pT7-23) and Edo2 from E. coli HB101 (pRW1) 
by anion exchange chromatography. 1 ml of cell extract showing the indicated 
activities, when measured with 100 µM of 2,3-dihydroxybiphenyl, was applied onto of 
MonoQ anion exchange column and eluted as described in 2.6.8.4. 
 
 Edo 2-2 Edo 2-3 Edo 2 
(pRW1) 
Applied protein (mg) 17.4 18.6 19.5 
Total activity applied (U) 56.8 130.7 2,4 
Specific activity (U/g protein) 3260 7025 120 
Total activity recovered (U) 4.8 26.6 0.35 
Recovery (%) 8.5 20.4 14.5 
Highest specific activity (U/g protein) 2360 8495 98 
 
 As described for DbfB and other extradiol dioxygenases, Edo2-2, 2-3 and 3 were 
highly unstable and lost between 25 and 50 % of activity per day when stored at 4 °C. 
Storage at -70 0C resulted only in a low loss of activity (less than 10 % per day). 
Partially purified enzymes, when purified under aerobic conditions, were highly 
unstable and complete loss of activity was usually observed in between 24 hours. In 
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order to, despite the instability of the proteins, get indications for their kinetic 
properties, Km values and relative maximal transformation rates with different 
dihydroxysubstituted substrates were recorded with freshly prepared cell free extracts 
and eluates after MonoQ chromatography containing highly active extradiol 
dioxygenases Edo2-2 and Edo2-3. 
 
Table 3.4. Kinetic constants were determined as described in 2.6.6. Maximal turnover 
rates of 3-methylcatechol by a given enzyme preparation are given relative to those 
measured with 2,3-dihydroxybiphenyl as substrate. 
 
Substrate  Edo2-2 Edo2-3 
  Km (µM) Vmax 
(%) 
Km(µM) Vmax 
 (%) 
2,3-dihydroxybiphenyl Cell extract 140A25 100 150A40 100 
 MonoQ eluate 95A20 100 80A25 100 
3-methylatechol Cell extract 410A80 35 520A130 45 
 MonoQ eluate 455A30 35 370A80 55 
 
Both Edo2-2 and Edo2-3 showed Km-values with 3-methylcatechol of around 400–500 
µM, independently if the kinetic data were measured using cell extract or partially 
purified enzyme, and maximal turnover rate was always one third to half of that 
measured with 2,3-dihydroxybiphenyl. Km values determined in cell extracts were 
slightly lower than those determined with partially purified enzyme. As thus no major 
differences were observed in kinetic data using cell free extract versus partially purified 
protein, further kinetic constants of Edo2-2 and Edo2-3 as well as of Edo3 were 
measured in cell extract and compared to those reported for DbfB of RW1. The results 
are summarized in table 3.5.  
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Tab. 3.5: Catalytic properties of different 2,3-dihydroxybiphenyl 1,2-dioxygenases originating from Sphingomonas sp. RW1. 
 The kinetic parameters were determined using cell extracts of E. coli BL21(DE3)[LysS] expressing Edo 2-2, 2-3 and 3, respectively and 
compared to those described for DbfB by Happe et al. (Happe et al., 1993). Km values are expressed in µM for all substrates. Maximal turnover 
rates are expressed relative to those determined with 2,3-dihydroxybiphenyl as substrate. The specific maximal activity expressed as U/mg of 
protein appears in parentheses. As turnover numbers were not calculated, the Vmax /Km values were compared relative to that for 2,3-
dihydroxybiphenyl set as 100, as indication for the specificity constant Kcat/Km.  
 
Substrate Edo 2-2 Edo 2-3 Edo 3 DbfB 
 Km 
(µM) 
Vmax 
(%) 
Vmax / 
Km (%) 
Km 
(µM) 
Vmax 
(%) 
Vmax / Km 
(%) 
Km 
(µM) 
Vmax 
(%) 
Vmax / 
Km (%) 
Km 
(µM) 
Vmax 
(%) 
Vmax / Km 
(%) 
2,3-dihydroxybiphenyl 140 
A25 
100 
 
100 
(6.5) 
150 
A40 
100 
(18.7) 
100 55 
A5 
100 
(2.3) 
100 8 
A2 
100 
(9.7) 
100 
catechol 830 
A270 
30 5 725 
A120 
33 7 4000 
A900 
3 0.04 83000 
A4000
42 0.004 
3-methylcatechol 410 
A80 
35 12 520 
A130 
45 13 10500 
A1500
26 0.14 5300 
A600 
29 0.04 
2,2‘,3-trihydroxybiphenyl 40 
A15 
28 98 65 
A15 
46 106 30 
A5 
90 165 11 
A1 
30 22 
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No major differences in terms of substrate preferences could be observed between 
Edo2-2 and Edo2-3. Both enzymes exhibit higher Km values with the monocyclic 
dihydroxylated compounds tested than with the tested bicyclic substrates. Taken the 
Vmax/ Km value as an indication for substrate specificity, 2,3-dihydroxybiphenyl and 
2,2‘,3-trihydroxybiphenyl were preferred over catechol and 3-methylcatechol as 
substrates. Similarly, 2,3-dihydroxybiphenyl and 2,2‘,3-trihydroxybiphenyl were the 
preferred substrates also for Edo 3 and DbfB. However those enzymes had significantly 
higher Km values with monocyclic substrates tested when compared to Edo2-2 or 2-3. 
The 2,3-dihydroxybiphenyl can be regarded as a 1000-fold better substrate than the 
monocyclic substrates in case of Edo 3 and DbfB, whereas in case of Edo 2-2 and 2-3 
the 2,3-dihydroxybiphenyl was only 10-20 better substrate. Comparison of 2,3-
dihydroxybiphenyl and 2,2’,3-trihydroxybiphenyl as substrates between the enzymes 
showed that Edo 3 obviously has a slight preference for the trihydroxybiphenyl, while 
DbfB extradiol dioxygenase had a slight preference for the dihydroxybiphenyl. 
 
 
3.3 Biochemistry of the 2,2',3-trihydroxybiphenyl ether metabolism  
 
3.3.1 Analysis of the transformation products on HPLC 
 
The extradiol cleavage of 2,2',3-trihydroxybiphenyl is supposed to result in the 
formation of the 6-(2-hydroxyphenyl)ester of  2-hydroxymuconic acid, which by 
spontaneous hydrolysis, gives rise to catechol and 2-hydroxymuconate (Wittich et al., 
1992) (Wittich personal communication). Thus appearance of a yellow color in 
transformation experiments with 2,2',3-trihydroxybiphenyl as substrate is not a measure 
for substrate transformation but only for transformation of the product catechol by the 
enzyme. In initial experiments the transformation of 2,2',3-trihydroxybiphenyl ether 
(THBE) was thus analyzed by monitoring the oxygen consumption during the 
dioxygenase reactions with an oxygen electrode as described by Happe (Happe et al., 
1993). Like for DbfB, 2,2',3-trihydroxybiphenyl ether dependent oxygen uptake was 
observed for all extradiol dioxygenases tested: Edo2-2, Edo2-3 and Edo3. However, this 
activity rapidly declined in between seconds indicating an inactivation of the enzyme 
during substrate turnover. Addition of 2,3-dihydroxybiphenyl to enzyme assays 
previously incubated with 2,2',3-trihydroxybiphenyl ether showed, that the enzyme was 
actually inactivated, as neither oxygen uptake nor the formation of a yellow color 
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appeared in the photometric assay. To verify that all extradiol dioxygenases of RW1 are 
capable to transform 2,2',3-trihydroxybiphenyl ether, a volume of 1 ml crude extract in 
phosphate buffer pH 7.5 was obtained from 50 ml culture, respectively, of E. coli 
BL21(DE3)[LysS](pT7-22), E. coli BL21(DE3)[LysS](pT7-23), E. coli 
BL21(DE3)[LysS](pT7W4) and E. coli BL21(DE3)[LysS](pT7-5-RW) cells cultured as 
previously described (2.6.2). A quantity of about 50 µg total proteins from each crude 
extract preparation was incubated with 2,2',3-trihydroxybiphenyl ether at a final 
concentration of 200 µM and in a total volume of 1 ml 50 mM potassium phosphate 
buffer pH 7.6 over 30 minutes. The 2,2',3-trihydroxybiphenyl-ether metabolites were 
analyzed by HPLC. An aqueous solvent system containing 40 % of methanol  and 0.1 % 
ortho-phosphoric acid at a flow rate of 1 ml per min was used, which allowed the 
elution of all above described metabolites in about 17 minutes detection time. Samples 
were taken from the reaction solution at times 0, 15 and 30 minutes and immediately 
injected in HPLC (fig. 3.9). Due to the rapid inactivation process, the transformation 
products appeared only in traces however in sufficient amount to be detected after by 
HPLC analysis. All enzymes tested were capable to transform 2,2',3-trihydroxybiphenyl 
ether as evidenced by the formation of two reaction products, which were identified as 
catechol and 2-pyrone-6-carboxylate by comparison of their retention behavior with 
those of authentic standards. Furthermore, the absorption spectra with maxima at 210 
nm and 270 nm on one hand and 200nm and 300 nm on the other were identical to those 
of authentic catechol and 2-pyrone-6-carboxylate, respectively. The formation of 
catechol and 2-pyrone-6-carboxylate with an absorption maximum at 300 nm at neutral 
conditions (ε = 8.700 M-1 cm-1) from 2,2',3-trihydroxybiphenyl ether contrasts previous 
assumptions of spontaneous rearrangement of the ring-cleavage product into catechol 
and 2-hydroxymuconate. No appearance of 2-hydroxymuconate could be observed.  
The formation of 2-pyrone-6-carboxylate opened up the possibility to develop a simple 
enzymatic test for 2,2',3-trihydroxybiphenyl ether transformation based on the 
formation of 2-pyrone-6-carboxylate. At a wavelength of 290 nm, the absorption of 
catechol, as well as its ring cleavage product 2-hydroxymuconic semialdehyde, or the 
2,2',3-trihydroxybiphenyl ether, are negligible (ε < 1000 M-1 cm-1)  compared to that of 
2-pyrone-6-carboxylate (ε = 7.800 M-1 cm-1). Thus, transformation of 2,2',3-
trihydroxybiphenyl ether was followed at 290 nm..  
A clear rise in absorption could be monitored using 10–100 µM 2,2',3-
trihydroxybiphenyl ether and Edo 2-2 containing cell extract corresponding to a final 
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concentration of  20–100  µg/ml. Activity usually declined significantly in between 20 
seconds. The activity, measured as the increase in absorbance at 290 nm during the first 
2-5 seconds of reaction, was clearly proportional to the amount of enzyme added. 
However, determinations of activities at different substrate concentration were not 
accurate enough to determine kinetic parameters for the turnover of this substrate. It 
could however be calculated that activity of Edo 2-2 with 20 µM of 2,2',3-
trihydroxybiphenyl ether was 65% of that with 20 µM  2,3-dihydroxybiphenyl. 
To get an indication on the affinity of Edo 2-2 for 2,2',3-trihydroxybiphenyl ether, the 
rate of DHB transformation (DHB was added to the reaction mixture in a concentration 
of 100 µM) was quantified photometrically (434 nm) in the presence of varying 
amounts of substrate (20-200 µM THBE). Clearly, the addition of 2,2',3-
trihydroxybiphenyl ether inhibited DHB transformation. This inhibition was evident 
even in the first seconds of the reaction and thus different from the enzyme inactivation 
observed during 2,2',3-trihydroxybiphenyl ether transformation. Assuming competitive 
inhibition to take place in the first seconds, the inhibition constant Ki of 2,2',3-
trihydroxybiphenyl ether can be assumed to be in the range 40-80 µM. It seems thus, 
that the enzyme has a reasonable high affinity for this compound. As Edo 2-2 like the 
other extradiol dioxygenases tested is rapidly and completely inactivated during THBE 
turnover, a turnover number, i.e. the amount of substrate molecules one enzyme 
molecule can transform before being completely inactivated, could be a measure for the 
effectivity of the enzyme. As none of the enzymes was purified to homogeneity, 
turnover numbers could not be calculated. However, the turnover capacity of the 
different enzymes could be compared by calculating the amount of THBE that can be 
transformed by the amount of respective extradiol dioxygenase, which cleaves 1 µmol 
of 2,3-dihydroxybiphenyl/min (1U). The total amount of 2-pyrone-6-carboxylate 
produced until complete inactivation of Edo 2-2 was proportional to the amount of 
enzyme added. It could be calculated that the amount of Edo 2-2 containing cell extract 
that is capable to transform 1 µmol/min of 2,3-dihydroxybiphenyl (1U) transforms a 
total of 0.05 µmole of THBE. Similar experiments were performed using Edo 3 or DbfB 
containing cell extracts. The activity of Edo3 with 20 µM THBE was only 25 % of that 
with 20 µM DHB. 1U of Edo 3 was calculated to be capable to transform 0.04 µmole of 
THBE. Thus, Edo 3 seems to be less effective than Edo 2. No significant 2-pyron-6-
carboxylate forming activity was observed with DbfB. This activity was less than 1% of 
that with DHB at substrate concentrations between 4 and 100 µM. 
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Fig. 3.9: Transformation of the 2,2',3-trihydroxybiphenyl ether by Edo2-3. The 
chromatogram was recorded at a wavelength of 210 nm and corresponds to a sample 
taken after 30 minutes incubation with the substrate. Absorption spectra indicated on 
the figure next to the corresponding peaks refer to the compounds: A: 2-pyrone-6-
carboxylate; B: catechol; C: 2,2',3-trihydroxybiphenyl ether. 
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Fig: 3.10: Dioxin degradation upper-pathway deduced from the HPLC analysis. 
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3.3.2 Further investigation on the inhibition of RW1 extradiol dioxygenase, 
caused by the reaction substrate 2,2',3-trihydroxybiphenyl ether 
 
The following experiment has been performed to better understand the mechanism 
through which 2,2',3-trihydroxybiphenyl ether inactivates the extradiol dioxygenases of 
Sphingomonas  sp. RW1 in vitro. Studies have been conducted on Edo 2, in the form of 
Edo 2-3, having this enzyme a high affinity for the 2,2',3-trihydroxybiphenyl ether in 
comparison with the other RW1 extradiol dioxygenases. In particular Edo2-3 was used 
instead of Edo2-2, as it was more stable in crude extract at room temperature but was 
undistinguishable from Edo2-2 concerning the kinetic parameters. A volume of 2 ml 
crude extract was prepared from 50 ml E. coli BL21(DE3)[LysS] (pT7-23) culture, 
under anaerobic conditions as previously described (2.6.3). Half volume of the crude 
extract was aerobically stored and half anaerobically, in a 2ml Duran glass closed with 
caucciu sealing and filled up with N2. Both preparations were kept cool on ice. A 1:10 
dilution in 50 mM potassium phosphate buffer (pH 7.5) of both anaerobic and aerobic 
crude extracts was prepared. The activity of the diluted extracts was measured with 1 
mM 2,3-dihydroxybiphenyl as substrate using 10 µl protein preparation in a final 
reaction volume of 1 ml 50 mM potassium phosphate buffer (pH 7.5) and following the 
appearance of the meta-cleavage product HOPDA (2-hydroxy-6-oxo-6-phenylhexa-2,4-
dienoic acid) during the first seconds of reaction (2.6.6). A specific activity of 3 U/g and 
0.8 U/g could be registered with the aerobic and anaerobic diluted protein extract 
preparation respectively. The diluted aerobic and anaerobic protein preparations were 
then incubated with a final concentration of 2 mM 2,2',3-trihydroxybiphenyl ether for 5 
minutes. An anaerobic 2,2',3-THB ether solution (2.2.1) was especially set up to be 
added to the diluted anaerobic Edo2-3 protein solution. After the incubation period, the 
residual activity in 10 µl solution Edo2-3 plus THBE was monitored with DHB as 
substrate (20 µM THBE in the reaction volume). No residual meta-cleavage activity 
with 2,3-DHB was detectable with the aerobic preparation. On the opposite, a specific 
activity of 0.6 U/g could be still recorded with the diluted cell extract anaerobically 
incubated in the presence of THBE, during the first seconds of reaction and before 
occurrence of inactivation, following exposure of the reaction mixture to O2 during the 
performance of the enzymatic assay. It can thus be concluded that 2,2',3-
trihydroxybiphenyl ether itself is not responsible  for the inactivation of the extradiol 
dioxygenase Edo2-3, but that inactivation needs the presence of oxygen and thus the 
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turnover of the substrate. As additional control Edo2-3 was incubated with 2 mM 2-
pyrone-6-carboxylate, being this one of the 2,2',3-trihydroxybiphenyl ether 
transformation products. No inhibition in this case has been observed, excluding the 
hypothesis that the compound 2-pyrone-6-carboxylate could be responsible of the 
inactivation of the meta-cleavage enzymes.  
 
 
3.4 Realization of two compact modular genetic cassettes encoding the 
dibenzofuran and dioxin degradation upper-pathways  
 
As all elements of the catabolic upper pathway for dibenzo-p-dioxin and dibenzofuran 
degradation have been described, the goal was to transfer those genes finally into 
organisms which are capable to handle chlorinated derivatives of catechol and 
salicylate, respectively and thereby to develop microorganisms capable to mineralize 
chlorinated derivatives of dibenzofuran and dibenzo-p-dioxin. For doing this, the 
genetic elements comprising the upper pathway have to be reassembled into compact 
modular gene cassettes. Those cassettes furthermore should be constructed in a fashion 
enabling the rational exchange of a certain gene by another one encoding for a protein 
of similar function, thus allowing the analysis of the function of various members of a 
family of genes in the degradation of a certain substrate. In the present work, two 
different genetic cassettes, addressed respectively to dioxin and dibenzofuran 
degradation, were constructed and analyzed. For the degradation of dibenzofuran into 
salicylate and of dibenzo-p-dioxin into catechol and 2-pyron-6-carboxylate, at least 
three enzyme systems are necessary, the initial angular dioxin dioxygenase system, a 
meta-cleavage dioxygenase and a 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate-type 
hydrolase (fig. 1.2). As previously described (Armengaud et al., 1998), the respective 
genes were dispersed over the chromosome of Sphingomonas RW1 strain. Moreover, 
genetic analysis of RW1 revealed the presence of a variety of genes obviously coding 
enzymes of a similar function, such as the three extradiol dioxygenases mentioned 
above. Both genetic cassettes (fig. 3.12, 3.13) contain as the first three genetic 
determinants the genes dxnA1A2, fdx1 and redA2 coding for the angular dioxin 
dioxygenase system, consisting of the DxnA1A2 dioxygenase, the ferredoxin Fdx1 and 
the reductase RedA2, respectively. The two expression modules differ in the gene 
encoding the meta-cleavage enzyme. The gene dbfB, encoding trihydroxybiphenyl 
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dioxygenase, was chosen for the realization of the genetic cassette addressed to the DF 
degradation, while the gene edo2-2, coding for the Sphingomonas RW1 Edo2-2 
extradiol dioxygenase, exhibiting the most favourable kinetic parameters for 2,2',3-
trihydroxybiphenyl ether transformation (3.3), was included in the cassette suitable for 
DD degradation. Several 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolases have 
been characterized in Sphingomonas sp. RW1 (Armengaud et al., 1998; Bunz et al., 
1993). Among them, DxnB was shown in our laboratory to convert hydroxy-6-oxo-6-
(2-hydroxyphenyl)hexa-2,4-dienoic acid with the respective highest activity. 
Furthermore dxnB gene clusters with the genes encoding the ring-hydroxylating dioxin 
dioxygenase (Armengaud et al., 1998). and is thus possibly the enzyme predominantly 
involved in both DF and DD degradation pathways. Therefore dxnB has been included 
in both cassettes. To reassemble all these ORFs, rare recognition restriction sequences, 
8 bp in length and corresponding to the restriction enzymes: SwaI, AscI, PacI, PmeI and 
Sse8387I, were introduced by PCR amplification, flanking the 5’ and 3’ ends of each 
gene of the expression modules. Two 6 bp restriction sites, SpeI and BsiWI, were 
additionally introduced upstream and downstream of the expression modules, 
respectively.  
The resulting two compact expression modules are dxnA1A2_redA2_fdx1_dbfB_dxnB 
and dxnA1A2_redA2_fdx1_edo2-2_dxnB respectively. Both cassettes were tested for 
conversion of dibenzofuran and dioxin in E. coli DH10B. 
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Table 3.6: Primers used for the amplification of the elements of the expression modules 
dxnA1A2_redA2_fdx1_dbfB_dxnB and dxnA1A2_redA2_fdx1_Edo2-2_dxnB.  
 
Primer Amplified 
genes 
Primer sequences 
M40 forward dxnA1A2 GGATTTAAATGGACTAGTGTTTGCTCAATTCAGTCGGGCG 
M27 reverse dxnA1A2 GCGCCAGATCTGTTGAGCTCACTGGGTG 
M41 reverse dxnA1A2 ATGGCGCGCCGTCAGTTCAATTATCCAATAATATTCC 
M28 forward dxnA1A2 AACAGATCTGGCGCATCTGCGCGCCAGTTGCCGAAAATCA
G 
M42 forward fdx1-redA2 GGGGCGCGCCGGAAGAGAAGGAAAGTAGG 
M43 reverse fdx1-redA2 CGGTTAATTAACGCTACGGTACAAGGCCGATTTC 
M44 forward dbfB GGGTTAATTAAGGAGCAAAAGGAGAGTTATCG 
M45 reverse dbfB CGGTTTAAACGACAATGTTAGGTGTATG 
M47 forward H1 GGGTTTAAACGTCGCCCGCGAAGTGAGGATAG 
M46 reverse H1 GCCCTGCAGGCGTACGGTCAAACGGATCGGAACTCG 
M32 forward Edo2-2 GCTTAATTAACTCGCCTATCCGCTTTG 
M34 reverse Edo2-2 CTGTTTAAACGCCCTCCGCGCACAC 
M33 forward Edo2-3 CTGTTTAAACGCCCTCCGCGCACAC 
 
 
3.4.1 Amplification of the different elements to be assembled in the expression 
modules  
 
The templates used for the amplification of the genes dxnA1A2 and dxnB,  dbfB,  redA2 
together with fdx1, and Edo2, were cosmid pAJ115, cosmid pAJ114, plasmid pAJ130 
(Armengaud et al., 1998) and plasmid pRW1, respectively. The genes were amplified 
comprising of at least 20 bp upstream of their ATG starting codons including therefore 
the putative Shine Dalgarno sequences. The primers used for this purpose were 
designed in a way to introduce unique restriction sites flanking each genetic element of 
the cassette (table 3.6). 
The unique restriction sites are mostly rare 8 bp cutters and are not present in the 
sequence of any of the genes included in the two cassettes. The only exception was as 
AscI restriction site which was found at position 459 downstream of the ATG in 
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dxnA1A2. It was therefore necessary to eliminate the internal AscI site, which was done 
through PCR as follows.  
The PCR amplification of dxnA1A2 was carried out in two steps. First, primers M40 and 
M27 were used to amplify a 542 bp fragment corresponding to the 5’ part of the gene: 
M40 primer introduced the restriction sites SwaI and SpeI at the 5’ end of the amplified 
fragment, while M27 primer eliminated, by mean of a point mutation, the AscI site and 
introduced a new BglII site at its 3’ end, to be used for the subsequent reconstitution of 
the gene. Primers M41 and M28 were used to amplify the 1466 bp fragment 
corresponding to the 3’ end of dxnA1A2 gene. Primer M41 introduced the restriction 
site AscI, necessary for the assembling of the genetic cassette, at the 5’ end of the 
amplified fragment and necessary for the assembling of the genetic cassette, while 
primer M27 was designed to complement the BglII site introduced by primer M27 (fig. 
3.11). None of the point mutation introduced by PCR to create the BglII site or abolish 
the AscI site, modified the protein aminoacid sequence. The 542 and 1466 bp amplified 
blunt end fragments were ligated to plasmid pCR-Script Amp SK(+) precut with SrfI 
originating the recombinant plasmids pMDKA and pMDKB respectively. Genes redA2 
and fdx1 could be coamplified in a single fragment by using as a template plasmid 
pAJ130 realized by J. Armengaud (Armengaud et al., 1998).  The 1691 bp fragment 
carrying both genes redA2 and fdx1 was amplified by mean of primers M42 and M43, 
introducing an AscI site and a PacI site at the 5´and 3´ ends of the amplified fragment 
respectively. The PCR product was inserted into pCR2.1 resulting in plasmid pMDK3. 
The amplification of the extradiol dioxygenase gene dbfB was carried out with primers 
M44 and M45, introducing a PacI and a PmeI restriction sites at the 5’ and 3’ ends of 
the fragments respectively. The amplified 957 bp fragment was purified and inserted 
into pCR-Script Amp SK(+) resulting in pMDK1. The amplification of the hydrolase 
dxnB gene was carried out with primers M45 and M46, introducing a PmeI restriction 
site and the two sites BsiWI and Sse8387I at the 5’ and 3’ ends of this gene, 
respectively. The amplified 923 bp fragment was purified and inserted into pCR2.1 
resulting in pMDK4. The amplification of Edo2-2, was carried out with primers M32 
and M34 introducing a PacI and a PmeI restriction sites at the 5’ and 3’ ends of the 
fragment, respectively. The resulting 1032 bp fragment was purified and inserted into 
pCR-Script Amp SK(+) resulting in pMDK7. All the inserts of the pMDKA, pMDKB, 
pMDK3, pMDK1 and pMDK7 plasmids were sequenced on both strands in order to 
check the integrity of the nucleic information.  
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AscI Ecl136II Acc65I
BanI
TCACTGGGTG AGGCGACATG GTACCTCGAC
AGTGACCCAC TCCGCTGTAC CATGGAGCTG
S  L  G  E   A  T  W   Y  L  D
 AAAGCCGTTG ACCGCGCGTC TACGCGGTCT AGACAACTCG
KpnI
   F  G  N   W  R  A  D   A  P  D   L  L  S
CTGAT
GACTA
 L  I
M27
M28
 TTTCGGCAAC TGGCGCGCCG ATGCGCCCGA CCTGTTGAGC
BssHII BglII Ecl136II Acc65I
BanI
KpnI
TCACTGGGTG AGGCGACATG GTACCTCGAC
S  L  G  E   A  T  W   Y  L  D
AGTGACCCAC TCCGCTGTAC CATGGAGCTG AAAGCCGTTG ACCGCGCGTC TACGCGGTCT AGACAACTCG
   F  G  N   W  R  A  D   A  P  D   L  L  S
 TTTCGGCAAC TGGCGCGCAG ATGCGCCAGA TCTGTTGAGC
elimination of AscI site
and introduction of Bgl II site
 
Fig 3.11: Site-directed mutagenesis of dxnA1A2 gene carried out by PCR eliminating an AscI site and introducing a BglII site.
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3.4.2 Assembling of the expression module dxnA1A2_redA2_fdx1_dbfB_dxnB and 
construction of the expression vector pMDK12 
 
As initial step in the realization of the modular cassettes, dxnA1A2 gene was initially 
reconstituted in pNEB193, as follows. Plasmid pMDKA was subjected to digestion by 
SacI and BglII originating a 563 bp fragment. The SacI restriction site originally 
belongs to the MCS of vector pCRScript in construct pMDKA. Since it does not cut the 
insert and is present in the MCS on pNEB193 as well, SacI was used to transfer the 542 
bp insert from pMDKA to pNEB193. SwaI and SpeI sites, supposed to flank the 5’ end 
of the genetic cassette, and introduced by PCR at the 5’ region of the 542 bp insert 
(3.4.1), are obviously also included in the 563 bp fragment resulting from the SacI-BglII 
digestion of pMDKA, and directly follow SacI site. Concomitantly, plasmid pMDKB 
was subjected to digestion by BglII and AscI. The resulting 1459 bp BglII -AscI and 563 
bp SacI-BglII fragments were purified and ligated into vector pNEB193 previously 
digested by SacI and AscI, originating the construct pMDK2. In a similar way, the two 
inserts from pMDK1 and pMDK4 were excised by digestion with PacI and PmeI, and, 
PmeI and Sse8387I, respectively. After purification, the resulting 952 bp and 933 bp 
fragments were inserted into vector pNEB193 previously subjected to restriction with 
PacI and Sse8387I. The resulting construct, pMDK8 was then digested with PacI and 
Sse8387I, while pMDK3 was digested with AscI and PacI. The two resulting fragments, 
respectively 1877 bp and 1686 bp in length, were purified and inserted into pMDK2 
already digested with AscI and Sse8387I. The resulting construct, designated pMDK10, 
was checked by several restriction analyses. Plasmid pMDK10 was digested with SwaI 
and Sse8387I. The resulting 5580 bp fragment, carrying the complete expression 
module dxnA1A2_redA2_fdx1_dbfB_dxnB, was purified and ligated for expression 
purposes under the control of the Ptac promoter to vector pVLT35 previously subjected 
to SmaI and PstI digestion, resulting in pMDK12 (fig. 3.12). 
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Fig. 3.12: Plasmid pMDK12. The expression module dxnA1A2_red A2_fdx1_ dbfB_dxnB. is ligated to vector pVLT35 under the control of the Ptac promoter. 
Unique restriction sites flanking each element of the cassette are indicated. The molecules corresponds to the main dibenzofuran metabolites originating from 
the activity of the enzymes codified by the cassette. 
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3.4.3 Realization of the expression module dxnA1A2_redA2_fdx1_edo2-2_dxnB 
and construction of the expression vector pMDK19.  
 
The gene dbfB in the construct pMDK10 was substituted by the extradiol dioxygenase 
gene edo2-2 (939 bp) as follows. Plasmid pMDK7 was digested with PacI and PmeI. 
The resulting 1027 bp was purified and ligated with the 7274 bp fragment, originated 
from pMDK10 double digested with PacI and PmeI, thus lacking the dbfB gene and 
carrying dxnA1A2-redA2-fdx1 and dxnB genes. The resulting construct pMDK18 was 
subjected to restriction with SwaI and Sse8387I giving a 5651 bp fragment which was 
purified and ligated under the control of the Ptac promoter to vector pVLT35, 
previously digested with SmaI and PstI, resulting in the construct pMDK19 (fig. 3.13). 
The recombinant clones were checked by several restriction enzymes for carrying the 
complete expression module dxnA1A2_redA2_fdx1_edo2-2_dxnB. 
 
hydrolase H1(dxnB)
BsiWI
Sse838 I
dioxin dioxygenase(dxnA1A2) reductase (redA2)/ferredoxin (fdx1)
meta-cleavage
 dioxygenase (edo2-2)
SwaI
SpeI AscI PacI
initial multicomponent dioxygenase
PmeI  
 
Fig. 3.13. Expression module dxnA1A2_red A2_fdx1_ edo2-2_dxnB. The extradiol 
dioxygenase gene dbfB has been substituted with edo2-2. The complete expression 
module has been cloned into vector pVLT35 under the control of the Ptac promoter. 
 
 
3.5 Expression studies 
 
3.5.1 Dibenzofuran conversion by E. coli (pMDK12) 
 
The expression vector pMDK12 was transformed into E. coli DH10B by electroporation 
(2.5.9). The enzymes specified by the dnxA1A2, redA2, fdx1, dbfB and dxnB genes on 
pMDK12 were tested for their ability to transform dibenzofuran by incubating resting 
E. coli DH10B (pMDK12) cells at 30 °C with 0.1 mM of the substrate as described in 
2.7.1 and following the reaction (i.e. disappearance of the substrate and formation of the 
products) over time by HPLC (2.7.2). Simultaneously, E coli DH10B (pMDK12) was 
tested for the capability to transform the expected reaction product salicylate. There was 
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no transformation of salicylate during a 24h incubation with resting cells of an OD600 of 
10. Trihydroxybiphenyl (100 µM) was rapidly transformed by E.coli DH10B 
(pMDK12) into 3-(chroman-4-on-2-yl)-pyruvate (approximately 90 µM) due to the 
relatively high meta-cleavage activity and spontaneous rearrangement of the ring-
cleavage product 2-hydroxy-6-oxo-6-(2-hydroxyphenyl)hexa-2,4-dienoate. Only minor 
amounts of salicylate (6-9 µM) were formed in this case. 3-(Chroman-4-on-2-yl)-
pyruvate can regarded to be relatively stable during an incubation period of 8 hours but 
minor disappearance of this compound was observed during extended incubation. 
Similar results were obtained when tryhydroxybiphenyl (100 µM) was subjected to 
transformation by a cell free extract of E. coli DH10B (pMDK12).  
The activity of DbfB in those extracts of E. coli DH10B (pMDK12) was quantified as a 
high 250-300 U/g protein with dihydroxybiphenyl as substrate. Activity of DxnB was 
quantified by the rate of formation of benzoate by E. coli DH10B (pMDK12). The 
formation of benzoate as quantified by HPLC occurred at rates of 3-5 µM/min when 
cells of an optical density of 5 were applied. This corresponds, assuming an OD600 of 1 
to be indicative for a protein content of approximately 100 mg of protein/l, to an activity 
of 6-10 U/g protein. Thus, the hydrolase activity was significantly lower compared to 
the meta-cleavage activity, explaining mainly 3-(chroman-4-on-2-yl)-pyruvate 
formation and negligible salicylate formation during trihydroxybiphenyl transformation. 
Dibenzofuran transformation, as quantified by reversed phase HPLC analysis (see fig. 
3.14 and 15) occurred at a rate of 0,2-0,3 µM/min by resting cells of an OD600 of 10, 
indicative for a transformation rate of 0,2-0,3 U/g protein. Salicylate was observed as 
the major transformation product formed in a yield higher then 90%. Only minor 
amounts of 3-(chroman-4-on-2-yl)-pyruvate, were formed. 2-Hydroxypenta-2,4-
dienoate, expected to be produced during the DxnB catalyzed hydrolysis of 2-hydroxy-
6-oxo-6-2-(hydroxyphenyl)hexa-2,4-dienoate into salicylate is not indicated in fig. 3.14 
as this compound was not detectable by the HPLC method employed. 
2,2´,3-trihydroxybiphenyl was observed not to accumulate during dibenzofuran 
transformation, indicating the ring-cleavage not to be rate-limiting in this recombinant 
degradation pathway. Formation of mainly salicylate and only minor amounts of 3-
(chroman-4-on-2-yl)pyruvate further indicates that, in contrasts to the situation with 
2,2’,3-trihydroxybiphenyl as substrate, hydrolysis by DxnB was not rate limiting during 
dibenzofuran transformation, showing that in E. coli DH10B (pMDK12) the initial 
angular dioxygenation is the limiting transformation reaction. From above evidence it 
Results 
75 
can be deduced that E. coli (pMDK12) follows the degradative route presented in fig. 
3.16. The initial step of the degradation of DBF is a stereospecific angular 
dioxygenation of one of the aromatic rings, carried out by the dioxin dioxygenase 
(DxnA1A2) acting with a specific reductase (RedA2) and a ferredoxin (Fdx1). The 
reaction product spontaneously rearrange to 2,2´,3-trihydroxybiphenyl, subsequently  
meta-cleaved in the dihydroxylated ring by an extradiol dioxygenase, DbfB, producing 
2,2´-dihydroxy-6-oxo-6-phenylhexa-2,4-dienoate.  
The 2,2´-dihydroxy-6-oxo-6-phenylhexa-2,4-dienoate is then converted by an hydrolase 
into salicylate. In case of a significant accumulation of the 2,2´-dihydroxy-6-oxo-6-
phenylhexa-2,4-dienoate, 3-(chroman-4-on-2-yl)-pyruvate will be formed by 
spontaneous rearrangement. 
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Fig. 3.14: Quantification over time of DBF transformation and salicylate accumulation 
by E. coli (pMDK12) cells of an OD600.of 10. Product and substrate concentrations are 
expressed in µM. 
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Fig. 3.15: End-products of the conversion of dibenzofuran by E. coli DH10B 
(pMDK12) as measured by HPLC. The chromatogram was recorded at a wavelength of 
210 nm and shows analysis of culture supernatant collected after 24 h incubation with 
the substrate. Products between 1 and 2 minutes were produced also when E. coli was 
incubated without substrate and therefore are not transformation products. Absorption 
spectra are indicated for: A: 3(chroman-4-on-2-yl)-pyruvate and B: salicylate. 
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Fig 3.16: Dibenzofuran degradative route as it has been deduced from the HPLC 
analysis of the transformation products following incubation of E. coli DH10B 
(pMDK12) resting cells at 30 °C with 0.1 mM of dibenzofuran. 
 
 
 
 
3.5.2 Dibenzofuran conversion by E. coli (pMDK19)  
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The expression vector pMDK19 was transformed into E. coli DH10B by 
electroporation. Like for E coli (pMDK12) also in the case of E. coli (pMDK19) 
experiments both in cell extract and with resting cells were performed. The activity of 
Edo2-2 expressed from pMDK19 was analyzed qualitatively by formation of a yellow 
colored ring-cleavage product during 2,3-dihydroxybiphenyl transformation by resting 
cells and quantified by use of a cell free extract. Induced cells of E. coli DH10B 
(pMDK19) exhibited relatively low, but significant activities of 20-25 U/g protein when 
measured with 100 µM of 2,3-dihydroxybiphenyl. In accordance with the relative 
activities observed with Edo2-2 overexpressed in E. coli (DE3)(LysS)(pT7-22), activity 
with trihydroxybiphenyl (50 µM) was 7-10 U/g protein, and that with catechol  (100 
µM) about 1.5 U/g protein. Thus the Edo2-2 gene product expressed from pMDK19 
resembles in its kinetic properties that overexpressed in E. coli (DE3)(LysS)(pT7-22).  
In accordance with results obtained with cell extracts, transformation of 2,3-
dihydroxybiphenyl (500 µM), by resting cells of pMDK19 of an optical density of 5 
occurred at rates higher than 15 µM/min, corresponding to activities >30 U/g protein 
and transformation of catechol at rates of 1-2 U/g protein, as quantified both by HPLC 
analysis of the catechol substrate as well as photometric analysis of the accumulation of 
the ring-cleavage product 2-hydroxymuconic semialdehyde. However, THB by resting 
cells was converted at rates significantly lower than those expected from experiments 
with cell free extracts.  Whereas cell extract experiments, as stated above showed 
activities of 7-10 U/g protein, resting cells of an OD 5 transformed less than 20 % of a 
100 µM solution of THB in 2 hours and thus exhibited activities lower than 0.5 U/g 
protein. The resting cells similarly to E. coli DH10B (pMDK12) were incubated at 30 
°C with 0.1 mM dibenzofuran (2.7.1). Samples were taken at time points 0,1,2,4,6,8,24 
hours and the transformation reaction followed by HPLC. Results are described in fig. 
3.17.
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Fig 3.17: Quantification over time of DBF transformation and salicylate as well as 
trihydroxybiphenyl accumulation by E. coli (pMDK19) cells of an OD600 of 10. Product 
and substrate concentrations are expressed in µM. 
 
Dibenzofuran transformation, as quantified by reversed-phase HPLC analysis (see fig. 
3.14 and 15) occurred, like with pMDK12, at a rate of 0.2–0.3 µM by resting cells of an 
OD600 of 10, indicative for a transformation  rate of 0.2–0.3 U/g protein. However, in 
contrast to pMDK12, both salicylate and trihydroxybiphenyl were observed as 
transformation products, together with minor amounts of 3(chroman-4-on-2-yl)-
pyruvate. Whereas THB was formed at rates of about 0.2 U/g protein, salicylate 
formation occurred at rates lower than 0.05 U/g protein. Obviously, in pMDK19, ring-
cleavage of THB rather than dioxygenation of dibenzofuran is the bottle-neck in the 
degradative pathway. 
0
20
40
60
80
100
120
0 5 10 15 20 25
Data 1
DBF
Salicylate
THB
D
B
F
time (h)
 
D
B
F/
TH
B
/S
al
. 
Results 
80 
3.5.3 Transformation of dibenzo-p-dioxin by E. coli DH10B (pMDK12) and E. 
coli DH10B (pMDK19) 
 
Cells of E. coli DH10B (pMDK12) and E. coli DH10B (pMDK19), carrying 
respectively dbfB and edo2-2 genes, were tested for their ability to transform dibenzo-p-
dioxin by incubation with 0.1 mM of this substrate and subsequent analysis of the 
transformation products by reversed-phase HPLC. In both cases, accumulation of the 
degradation intermediate 2,2',3-trihydroxydiphenyl-ether, resulting from the 
dihydroxylation of dibenzo-p-dioxin by the dioxin dioxygenase, and subsequent 
molecular rearrangement, was noticed. No other transformation products such as 
catechol or 2-pyrone-6-carboxylate (3.3.1) could be detected. Dioxin transformation, as 
quantified by reversed-phase HPLC analysis (fig.18) by both pMDK12 and 19 occurred 
at initial rates of 0.35–0.5 µM by resting cells of an OD600 of 10, indicative for a 
transformation rate of 0.35–0.5 U/g protein. Thus, dioxin transformation rates are 
significantly higher than dibenzofuran transformation rates. 
Fig. 18: Quantification over time of dioxin transformation and trihydroxybiphenyl ether 
accumulation by E. coli (pMDK19) or E. coli (pMDK12) cells of an OD600 of 10. 
Product and substrate concentrations are expressed in µM. 
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Fig 3.19. Conversion of dibenzo-p-dioxin by E. coli DH10B (pMDK19). The 
chromatogram was recorded at a wavelength of 210 nm and corresponds to a sample 
taken after 24 h incubation with the substrate. The only reaction product is the 2,2'.3-
trihydroxybiphenyl ether for which the absorption spectrum is also shown. 
 
 
3.5.4 Transformation of dibenzo-p-dioxin by mixed cell cultures 
 
It has been previously described that all extradiol dioxygenases of RW1, are rapidly 
inactivated during the turnover of 2,2´,3-trihydroxydiphenyl-ether. Studies on this 
phenomenon have been presented (3.3). 
The following experiment was set up to verify whether, by using whole cells 
overexpressing different extradiol dioxygenases, the 2,2´,3-trihydroxydiphenyl-ether 
produced by dioxygenation of dioxin could be, at least partially, subject to meta-
cleavage. Resting-cells assays were set-up with E. coli DH10B expressing the module 
pMDK12 (corresponding to an OD of 5) mixed with E. coli BL21(DE3)[LysS] (pT7-
22), E. coli BL21(DE3)[LysS] (pT7-23) or E. coli BL21(DE3)[LysS] (pTW7-5-RW),  
hyperexpressing the extradiol dioxgenases Edo2-2, Edo2-3, and DbfB respectively. 
Cells overexpressing the respective dioxygenases were added corresponding to an OD 
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of 5, such that the cell density in each system was approximately 10. Each mixed cell 
culture was tested for disappearance of the 2,2´,3-trihydroxydiphenyl-ether produced by 
E. coli DH10B (pMDK12) during incubation with 0.1 mM dioxin. Cells were 
precultured as described in 2.7.1.2. E. coli DH10B(pMDK12) cells of a final A600 of 5 
and incubated with 0.1 mM dioxin were used as a control. The resting cell assay was 
conducted as described in 2.7.1.2. The reversed-phase HPLC analysis revealed that all 
three meta-cleavage dioxygenases are active on 2,2´,3-trihydroxydiphenyl-ether in the 
conditions used but exhibit different conversion rates. After an incubation period of 24 
hours, all samples exhibited, as expected, quantitative depletion of dibenzo-p-dioxin 
(100 µM). However, quantitative accumulation of THB ether (> 90 µM) occurred only 
in the control. Slightly lower amounts of ether (approximately 80 µM) were observed in 
samples augmented with BL21(DE3)[LysS] (pTW7-5-RW), and significant lower 
amounts (approximately 25 and 15 µM, respectively) in samples augmented with E. coli 
BL21(DE3)(LysS)(pT7-23) or E. coli BL21(DE3)(LysS)(pT7-22).  
The catechol produced by the meta-cleavage of 2,2´,3-trihydroxydiphenyl-ether and 
successive hydrolysis should be further cleaved by each of the three enzymes DbfB, 
Edo2-2 and Edo2-3. This explains the failure to detect by HPLC any catechol during the 
transformation of dibenzo-p-dioxin in above experiments. However, the catechol meta-
cleavage product, 2-hydroxymuconic semialdehyde is yellow colored and thus can be 
detected in a spectrophotometric assay, when present in sufficient concentration.  
Actually, in resting cell assay containing E. coli DH10B (pMDK12) mixed with E. coli 
BL21(DE3)[LysS] (pT7-22), or BL21(DE3)[LysS] (pT7-23), the appearance of an 
intense yellow color during the first hours indicated that catechol had been produced 
and was further cleaved by the extradiol dioxygenases Edo2-2 or Edo2-3. These 
enzymes can therefore be definitely considered key enzymes for dioxin metabolism in 
Sphingomonas RW1. 
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4 Discussion 
 
 
 
In 1992, a Sphingomonas sp. strain named Sphingomonas sp. RW1, has been isolated 
from the river Elbe (Wittich et al., 1992) for its capability to grow on dioxin and 
dibenzofuran as sole carbon source. This strain was later on shown to be capable to also 
cometabolize several chlorinated congeners of dibenzofuran and dibenzo-p-dioxin. The 
pathways for the degradation of DD and DBF have been proposed (Wittich et al., 1992) 
and enzymes involved in the so-called upper pathway, i.e. the transformation of those 
compounds into salicylate and catechol, respectively have been purified and 
biochemically and genetically characterized. The first enzymatic activity involved in the 
catabolism of DD and DBF is driven by a dioxin dioxygenase. The enzyme has been 
purified and shown to be a multicomponent enzyme (Bunz and Cook, 1993). The 
enzymatic complex includes a reductase A2, a ferredoxin Fdx1 and a dioxygenase 
component, responsible for the initial angular dioxygenation of the two substrates. The 
second activity involved in the DD and DBF metabolism is driven by an extradiol or 
meta-cleavage dioxygenase. Sphingomonas sp. RW1 has been shown to contain at least 
three meta-cleavage enzymes (Happe et al., 1993) (Bunz et al., 1993) thus representing 
a class of isoenzymes, which all potentially could play a role in vivo in the metabolism 
of DDs and DBFs.  
Beside the meta-cleavage dioxygenases, various other enzymes and the respective genes 
of the dioxin and dibenzofuran degradative pathway were shown to be present on the 
RW1 not only as a single gene, but the presence of isoenzymes or isogenes for various 
steps of the degradative pathway became evident. In particular two reductases, three 
ferredoxins and two hydrolases have been characterized (Armengaud et al., 1998; 
Armengaud and Timmis, 1997b; Bunz and Cook, 1993; Bunz et al., 1993). All 
structural genes have been found to be dispersed on the genome of RW1 and not 
organized in operons (Armengaud et al., 1998). Once the structural genes involved in 
the DD and DBF degradation pathways had been identified, it became possible to 
project the realization of a gene cassette carrying all genes necessary for the metabolism 
of DD and DBF into catechol or salicylate or of chlorinated DDs and DBFs into 
chlorocatechols or chlorosalicylates. The final intention is to use such a gene cassette to 
extend the degradation capabilities of microorganisms capable of mineralizing 
chlorocatechols or chlorosalicylates and by this realizing a bacterium able to completely 
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mineralize chlorinated DDs and DBFs. In this study we present the realization of this 
gene cassette besides further studies on the DD and DBF metabolism in RW1 and the 
characterization of a new extradiol dioxygenase observed in this organism, namely 
Edo3.  
 
 
4.1 Genetic and biochemical characterization of Edo3 and Edo2 extradiol 
dioxygenases 
 
One RW1 meta-cleavage dioxygenase, DbfB has been described by Happe to be 
capable of transformation of trihydroxyiphenyl and assumed to be involved in the 
degradation of dibenzofuran and dibenzo-p-dioxin. A second gene encoding a distinct 
meta-cleavage dioxygenase, named Edo2 was briefly described by J. Armengaud 
(Armengaud et al., 1998). In the current investigation we could show, that RW1 
contains at least three meta-cleavage dioxygenases. The existence in some bacteria of 
multiple catabolic enzyme systems, such as ring-cleavage dioxygenases, is well 
established. As an example, Rhodococcus globerulus P6, capable of degrading biphenyl 
contains at least three (Asturias and Timmis, 1993), Rhodococcus erythropolis TA421 
seven (Kosono et al., 1997), and the dibenzofuran degrading organism Terrabacter sp 
strain DPO360 (Schmid et al., 1997) at least three meta-cleavage dioxygenases. Such a 
diversity of isoenzymes in the same organism is often interpreted to reflect a broader 
spectrum of substrates that the microorganism can handle under disparate 
environmental conditions.  
Actually, in Rhodococcus sp. I1 (Irvine et al., 2000), the inactivation of one of five 
extradiol dioxygenase genes abolished the capability of the strain to grow on 
isopropylbenzene and the inactivation of another one resulted in derivatives unable to 
grown on naphthalene. Obviously, the respective gene products have substrate 
specificities or their expression is regulated in a way that they are specifically involved 
in the degradation of only a subset of the growth substrates.  Separate inactivation of 
two other meta-cleavage dioxygenase genes had no influence on the degradative 
phenotype, indicating that they either have a yet unkown or no obvious function, or that 
they can be substituted by one of the other genes encoding meta-cleavage enzymes. The 
fact that different meta-cleavage dioxygenases were involved in the degradation of a 
single substrate has already been reported by A. Schmid (Schmid et al., 1997). Three 
different dioxygenases were observed in cell extracts of dibenzofuran grown 
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Terrabacter sp. strain DPO 360, two of them exhibiting high activity against 
dihydroxy- or trihydroxybiphenyl, and thus assumed to be of importance for 
dibenzofuran degradation. Whereas the third enzyme was shown to exhibit high activity 
against catechol and thus is obviously of major importance for further degradation of 
intermediate catechol. A similar situation as in Terrabacter sp. strain DPO360 was 
observed in Sphingomonas sp. RW1. Inactivation of the dbfB gene resulted in 
derivatives growing slower with dibenzofuran. As, however, significant growth was still 
observed, it can be assumed that, together with the dbfB gene product, a second ring-
cleavage dioxygenase is functioning during growth on dibenzofuran.    
In the present report, two distinct meta-cleavage dioxygenases, Edo2 and Edo3, were 
genetically and biochemically characterized. The respective genes had originally been 
identified on two 10.5 Kb and 3300 bp DNA fragments from RW1, respectively. 
Immediately preceeding edo3, a gene with high similarities to a 2-hydroxy-6-oxo-6-
phenylhexa-2,4-dienoate hydrolase, and designated H3, was found, whose termination 
codon overlaps the starting codon of the Edo3 structural gene. Interestingly crude 
extracts of E. coli clones carrying both genes (E.coli pBl4) did not exhibit detectable 
meta-cleavage activity with the test substrate 2,3-dihydroxybiphenyl. This suggests that 
either H3 hydrolase further processes the 2,3-dihydroxybiphenyl ring cleavage product 
with such high activities that no intermediate accumulation of the yellow colored ring-
cleavage product occurs, or that the transcription of H3 gene prevents that one of edo3. 
Experiments analyzing this phenomenon are currently under investigation. The edo3 
gene was then amplified and cloned separately from the H3 gene. This time meta-
cleavage activity was observed with both the E. coli colonies on plate as well as with 
cell crude extracts or cell suspension. The sequence analysis of the edo2 gene revealed 
the presence of three putative ATG starting codons. ATG2 directly follows ATG1 while 
ATG3 is localized 21 bp downstream of ATG2. A SD sequence was found in front of 
edo2, which seems to identify ATG2 as the most likely starting codon. Comparison of 
the subunit size of Edo2-2 (expressed with ATG2 as start codon) and Edo 2-3 
(expressed with ATG3 as start codon) with that expressed from the original 3.3 Kb 
RW1 genomic insert subcloned in E.coli DH101, showed that, actually, the ATG2 start 
codon is used in this strain and thus, most probably, also in the original host RW1.  
The protein sequences of Edo3, Edo2-2 and Edo2-3, directly deduced from the genetic 
one, have been aligned with those of several previously described extradiol-
dioxygenases. Edo 3, Edo2-2 and Edo2-3 were found to be clustered with typical meta-
cleavage enzymes specialized in bicyclic aromatic compounds. Interestingly the seven 
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amino acids at the N-terminus of Edo2-2 fall out of the protein alignment, as they do 
not fit the sequence of a typical extradiol dioxygenase. However, comparison of kinetic 
parameters between Edo2-2 and Edo2-3 revealed no significant differences, indicating 
those 7 amino acids to have no major influence on the substrate specificity.  
In 1996 Lindsay D. Eltis and Jeffrey T. Bolin have performed an alignment of a 
selection of 35 extradiol dioxygenases protein sequences (Eltis and Bolin, 1996) and 
used the results to discuss the phylogenetic relationship among them and to revise the 
classification system for these enzymes. In that study DbfB clearly clustered in the 
same clade with 2 domains enzymes, preferring bicyclic compounds. In the present 
study the amino acid sequence data obtained from the DNA sequence of Edo3, Edo2-2 
and Edo2-3 structural genes, has been newly aligned with those of related extradiol 
dioxygenases confirming the clustering of all RW1 extradiol dioxygenase with those of 
meta-cleavage dioxygenases preferring bicyclic compounds. All DbfB, Edo2-2, Edo2-3 
and Edo3 preferred 2,3-dihydroxybiphenyl as a substrate over catechol, and can be 
assigned to class I.3 (following classification as in (Eltis and Bolin, 1996)) of C23O in 
agreement with the sequence data.  
Despite the fact that all analyzed meta-cleavage enzymes preferred 2,3-
dihydroxybiphenyl over monocyclic biphenyls, significant differences in the extend of 
this preference were observed. Whereas Edo2 (in both assessed variants) showed a 
reasonable activity against the monocyclic substrates catechol and 3-methylcatechol 
(specificity constants differed by only one order of magnitude), both Edo3 and DbfB 
(Happe et al., 1993) showed only negligible activity against those substrates (specificity 
constants differing by 3 to more than 4 orders of magnitude). In this aspect, Edo1 and 3 
resembles the 2,3-dihydroxybiphenyldioxygenases purified from the dibenzofuran 
degrader Terrabacter sp. strain DPO360 (Schmid et al., 1997) whereas Edo 2 resembles 
those purified from the dibenzofuran degrader Terrabacter sp. strain DBF63 (Kasuga et 
al., 1997). All three dihydroxybiphenyl dioxygenases of RW1 showed a reasonable 
activity against trihydroxybiphenyl with specificity constants in the same order of 
magnitude as for dihydroxybiphenyl. Unfortunately, thus far only poor information is 
available on the kinetics of transformation of trihydroxybiphenyl by other 
dihydroxybiphenyl dioxygenases. However, the activity of such enzymes on 
trihydroxybiphenyl is not a unique feature restricted to a few specialized enzymes 
(Kasuga et al., 1997), (Asturias and Timmis, 1993) (Kohler et al., 1993). Kinetic 
properties have only been described for two extradiol dioxygenases of Terrabacter sp. 
strain DPO360 and for DbfB. All three enzymes showed a preference for dihydroxy- 
Discussion 
87 
over trihydroxybiphenyl with an extreme of bphC1 of Terrabacter, where the 
significant higher Km value with trihydroxybiphenyl is the major reason for the 20-fold 
higher Kcat/Km value for the dihydroxy- compared to the trihydroxybiphenyl. Edo 2 and 
Edo 3 of RW1 are thus the first enzymes with similar preferences for di- and 
trihydroxybiphenyl as substrates. 
 
 
4.2 The 2,2,3-trihydroxybiphenyl ether metabolism 
 
Despite of the fast inactivation of the extradiol dioxygenase in vitro, it was possible to 
characterize reaction products of this reaction by means of HPLC. In contrast to 
previous assumptions, the products of the reaction were characterized as catechol on the 
one hand and 2-pyrone-6-carboxylate on the other. 2-Hydroxymuconate was not 
observed as a product. Thus, the trihydroxybiphenylether ring cleavage product does 
not undergo a spontaneous hydrolysis as suggested by Wittich. In contrast, the ring-
cleavage product underwent an intramolecular arrangement as shown during the 
transformation of 2,3-dihydroxybiphenylether by a meta-cleavage enzyme from 
Pseudomonas cepacia Et4 where phenol and 2-pyron-6-carboxylate were observed as 
ring-cleavage products (Pfeifer et al., 1993). It can be proposed that a nucleophilic 
attack of the hydroxyl oxygen of the opened ring on the ester carbon occurs which 
results in the displacement of phenol (in case of dihydroxybiphenyl ether 
transformation) or of catechol (in case of trihydroxybiphenyl ether transformation) and 
ring closure of the aliphatic residue to give the pyron. As 2-pyrone-6-carboxylate is not 
used as a growth substrate by RW1 and was not observed as a metabolite during growth 
on dibenzo-p-dioxin, it can be assumed, that in RW1 the ring-cleavage product 
undergoes a fast enzymatic hydrolysis by a 2-hydroxy-6-oxo-6-phenylhexa-2,4-
dienoate hydrolase thus preventing the spontaneous formation of the pyron. Even 
though it cannot be excluded thus far that, during growth of RW1 on dibenzo-p-dioxin, 
a hydrolase capable of transforming the pyrone is induced, the most probable postulate 
in light of those observations is that a hydrolase highly active on 2-hydroxy-6-oxo-6-
phenylhexa-2,4-dienoate is necessary not only for dibenzofuran but also for dibenzo-p-
dioxin degradation. 
Both Edo 2 as well as Edo3 meta-cleavage dioxygenases as well as DbfB were rapidly 
inactivated during the transformation of trihydroxybiphenyl ether. The sensitivity of 
meta-cleavage dioxygenases towards inactivation has already been described and can be 
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due to completely different mechanisms. Catechol 2,3-dioxygenses are usually very 
labile enzymes and are rapidly inactivated upon exposure to oxidizing agents such as 
oxygen (Nozaki et al., 1968). Inactivation of e.g. catechol 2,3-dioxygenase of 
Pseudomonas putida MT-2 also occurs during catalytic turnover when substrate 
analogues such as chloro- or alkylanalogues (Cerdan et al., 1995) are provided. As the 
inactivated enzyme could be reactivated by the incubation with FeSO4, the authors 
assume that oxidation and/or removal of the ferrous ion in the catalytic center was 
responsible for the inactivation. Cerdan et al. (Cerdan et al., 1994) showed that the 
inhibition in case of the Pseudomonas putida mt-2 catechol 2,3-dioxygenase (class 
I.2.A) is not due to inactivation by the substrate itself nor due to the reaction products, 
but only occurs in the presence of oxygen plus substrate. This contrasts the observations 
of Klecka and Gibson (Klecka and Gibson, 1981) who showed that the catechol 2,3-
dioxygenase of Pseudomonas putida F1 (class I.3.B) is inactivated by 3- and 4-
chlorocatechol, even though those substrates are not transformed by the enzyme. Thus, 
in this case inactivation, which again was shown to be reversible upon addition of 
ferrous iron, does not need substrate turnover, but possibly binding of both oxygen and 
the substrate to the enzyme. Polissi and Harayama (Polissi and Harayama, 1993) first 
demonstrated that the inactivation of Pseudomonas putida mt-2 catechol dioxygenase 
can be overcome by the presence of the XylT gene product. Hugo et al. (Hugo et al., 
1998) proved that the function of XylT, identified as a (2Fe-2S) ferredoxin, is the 
reduction of oxidized iron in the catalytic site and thus reactivation of the enzyme after 
being inactivated during substrate turnover.  
Another mechanism has been described as suicide inactivation during the turnover of 3-
chlorocatechol by the mt-2 derived catechol 2,3-dioxygenase (Bartels et al., 1984). It is 
assumed that the intermediate ring-cleavage product is highly reactive and binds 
irreversibly to the enzyme. This is assumed to be due to nucleophilic groups near the 
active site of the enzyme, which can attack the activated acyl-group carbon. Very 
recently, an enzyme has been described, which quickly produces 2-hydroxymuconate as 
a reaction product (Mars et al., 1997). It is assumed that, in this enzyme, the produced 
acylchloride undergoes a fast hydrolysis to produce 2-hydroxymuconate, thereby 
avoiding the irreversible inactivation of the enzyme, which otherwise occurs by the 
formation of covalent enzyme-product-conjugates.  
In the present investigation, it was shown that the inactivation of Edo2 by 
trihydroxybiphenyl ether is not mediated by the substrate nor by any of the products, 
but occurs during the transformation reaction in the presence of oxygen. These results 
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exclude inactivation due to substrate mediated chelation of the iron from the active 
center of the enzyme. The experiments performed do not differentiate between 
inactivation due to oxidation of the ferrous iron in the catalytic center as described by 
Cerdan or inactivation due to the formation of a covalent enzyme-product-conjugate. 
The ring-cleavage product supposedly formed during the cleavage of 
trihydroxybiphenyl ether, is the 6-(2-hydroxyphenyl)ester of 2-hydroxymuconate which 
can be assumed to be very susceptible to nucleophilic attack and thus resembles the 
acylchloride formed during 3-chlorocatechol turnover by catechol 2,3-dioxygenases. Its 
susceptibility to nucleophilic attack is seen by the spontaneous rearrangement of the 
ester to form catechol and 2-pyron-6-carboxylate. However, F. Pfeifer  et al. (Pfeifer et 
al., 1993) did not report on any observable inactivation of 2,3-dihydroxybiphenyl 
dioxygenase purified from the diphenylether degrading strain Pseudomonas cepacia Et4 
during the turnover of 2,3-dihydroxybiphenylether. 
During our experiments we observed turnover capacities of Edo 2 and Edo 3 of 40 - 50 
nmol/U which are very similar to values reported for turnover capacities of those 
catechol 2,3-dioxygenases which are sensitive to inhibition during 3-chlorocatechol 
turnover (values of 60 - 220 nmol/unit of catechol 2,3-dioxygenase activity with 
catechol (Mars et al., 1999). Turnover numbers of 3-chlorocatechol by catechol 2,3-
dioxygenases were determined by the group of Reineke (personal communication) and 
are about 100 substrate molecules transformed per enzyme molecule before complete 
inactivation of the enzyme occurred. The GJ31 enzyme resistant to that kind of 
inactivation showed turnover numbers of 11,000. Cerdan et al (Cerdan et al., 1994) 
reported a very fast inactivation of catechol 2,3-dioxygenase of Pseudomonas putida 
mt-2 during turnover of 4-ethylcatechol such that kinetic values could not be 
determined for this substrate. However, the turnover capacity was determined as a 
reasonable 6500 (amount of substrate molecules transformed before complete 
inactivation of the enzyme per enzyme molecule), whereas those of 3-methylcatechol 
and catechol were 210,000 and 1,400,000 respectively. Those inactivations were due to 
oxydation of the central ferrous iron and could be overcome by the presence of the 
XylT ferredoxin. It thus seems that inactivation of extradiol dioxygenases by the 
oxidation of the central ferrous iron depend on the structure of the substrate but seems 
to be much less effective than inactivation by the formation of covalent enzyme-
product-conjugates. Even though Edo2 and 3 were not purified to homogeneity, their 
catalytic efficiencies could be estimated assuming their expression in E. coli to be in the 
same order of magnitude compared to DbfB. The thereby estimated Kcat values of 100 - 
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1000/sec are similar to those of various previously reported 2,3-dihydroxybiphenyl 
dioxygenases. This would correspond to turnover capacities in the order of magnitude 
of 100 -1000 molecules of trihydroxybiphenlether per enzyme molecule. Inactivation of 
Edo2 and 3 during trihydroxybiphenyl turnover is thus a very effective process. Cerdan 
et al. (Cerdan et al., 1994) calculated that a threshold of 18.000 in turnover number 
(before complete inactivation of an enzyme molecule) for a certain catechol derivative 
is necessary to support growth of Pseudomonas putida mt-2 on substituted aromatics. In 
case of growth of Pseudomonas putida GJ31 on chlorobenzene, a turnover number of 
11.000 is enough to support growth. However, from these data it is evident that the 
simple presence of Edo2 or 3 during growth on dioxin would not be enough to support 
the observed growth. Assuming an inactivation mechanism as reported for 3-
chlorocatechol turnover this means that the actual enzyme responsible for dibenzo-p-
dioxin turnover remains to be discovered. Wittich et al. (Wiitich et al., 1992) in the first 
report describing growth of RW1 on dibenzo-p-dioxin indicated a reasonable 
trihydroxybiphenyl ether dependent of dibenzo-p-dioxin grown cells of 25 % that 
observed with trihydroxybiphenyl. In contrast, only very poor activity (3 % of that with 
trihydroxybiphenyl) in cell extracts was observed. This could hint on the presence of a 
highly unstable extradiol dioxygenase present in RW1. However, it cannot be excluded, 
that the trihydroxybiphenyl ether mediated inactivation of extradiol dioxygenases is due 
to an oxydation of catalytically active ferrous iron in the active center and that XylT 
analogues are present in RW1 allowing reactivation of extradiol dioxygenases. 
 
 
4.3 Realisation of two modular compact genetic cassettes encoding respectively 
dibenzofuran and dioxin degradation upper pathways 
 
The structural genes encoding for the enzymes involved in the dibenzofuran and dioxin 
degradation upper pathway were assembled in two compact modular genetic cassettes. 
As previously described, RW1 possesses several class of isoenzymes, specifically two 
reductases, three ferredoxins, three extradiol dioxygenases and three hydrolases. It was 
initially necessary to make a choice of the genes to be included in the two genetic 
modules depending on the encoded enzymes. The genes dxnA1A2, redA2, fdx1, 
codifying for the multicomponent dioxin dioxygenase were included in both gene 
cassettes. In particular redA2 and fdx1 genes were coamplified from the genomic 
libraray of RW1 in a single PCR product where redA2 directly precedes fdx1.  
Discussion 
91 
The two compact modular genetic cassettes differ in the gene codifying for the extradiol 
dioxygenase. Previous studies conducted on DbfB (B. Happe, data not published) 
provided strong evidences that this enzyme could play the major role in the DBF 
degradation in RW1. In particular dbfB was knocked out in RW1. The metabolites 
produced after incubation of the knocked out strain in presence of DBF were analysed 
on HPLC. The HPLC analysis revealed accumulation in the culture medium of 2,2,3-
trihydroxybiphenyl. For this reason, the first gene cassette, dedicated to dibenzofuran 
degradation involved the dbfB gene. The gene edo 2-2 was choosen as the 
corresponding enzyme exhibits significant activity against trihydroxybiphenyl ether but 
also against catechol and 3-methylcatechol and thus a broader substrate specificity than 
Edo3. The gene edo2-2, complete of all putative ATG starting codons and the SD 
sequence was assembled in the DD dioxin cassette in place of dbfB. In both cassettes 
the last element is dxnB, the structural gene for the 2-hydroxy-6-oxo-6-phenylhexa-2,4-
dienoate hydrolase and capable of converting 2-hydroxy-6-oxo-6-(2-
hydroxyphenyl)hexa-2,4-dienoic acid (data not shown). The resulting two cassettes 
were therefore dxnA1A2_redA2-fdx1_dbfB_dxnB also defined as dibenzofuran gene 
cassette, and dxnA1A2_redA2-fdx1_edo2-2_dxnB, defined as dioxin gene cassette. All 
elements of the two cassettes have been amplified by PCR by mean of primers 
introducing unique 8 base cutter restriction sites at their 3’ and 5’ ends and including 
for all genes the natural SD sequence. Each element in the gene cassette can therefore 
be easily exchanged with other ones for instance newly discovered genes of metabolic 
importance, as studies on RW1 strains develop. New elements could be added as well. 
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4.4 DD and DBF conversion studies  
 
Experiments with both cassettes revealed that all enzymes relevant for the 
transformation of dibenzofuran into salicylate and of dibenzo-p-dioxin into catechol 
were expressed. This was evidenced for the initial dioxygenase by quantification of 
substrate transformation rates, for DbfB and Edo2-2 by quantification of 2,3-
dihydroxybiphenyl dioxygenase activities in cell extracts and for DxnB by the 
formation of benzoate from 2,3-dihydroxybiphenyl or of salicylate from dibenzofuran. 
However, activity of the initial dioxygenase was very low in E. coli cells (less than 1 
U/g protein). As expected, identical activity levels were observed for the initial 
dioxygenase in both modules. Activity of DbfB expressed from module I was 
significantly higher compared to that of Edo2-2 in module II (200U versus 20U/g 
protein when measured with dihydroxybiphenyl as substrate). This correlates with the 
higher activity of DbfB compared to Edo2-2 in the overexpression system (9.000 U 
versus 2700 U/g protein when measured with dihydroxybiphenyl as substrate) and 
could indicate that Edo2-2 actually has a lower catalytic activity compared to DbfB. 
Relatively low activity of DxnB was detected, but this activity was high enough to 
quantitatively convert 2-hydroxy-6-(2-hydroxyphenyl)-6-oxohexa-2,4-dienoate formed 
by the combined action of dioxin dioxygenase and DbfB into salicylate as expressed 
from module I. In this case, the substrate flow is limited by the activity of the initial 
dioxygenase and the ring-cleavage product is only produced at low rates. In contrast, 
DxnB activity was not high enough to prevent accumulation of 2-hydroxy-6-(2-
hydroxyphenyl)-6-oxohexa-2,4-dienoate and thus spontaneous rearrangement into 3-
(chroman-4-on-2-yl)-pyruvate when produced at a high rate by the direct action of 
DbfB on 2,2,3-trihydroxybiphenyl.  
Whereas the gene cassette comprising dbfB was performing properly for the 
transformation of dibenzofuran into salicylate, the gene cassette comprising edo2-2 was 
not. Despite the fact that the Edo2-2 activity with 2,3-dihydroxybiphenyl was only 
around 10 % of that of DbfB activity in E.coli cells used for transformation 
experiments, the respective activity with 2,3,3-trihydroxybiphenyl (ca. 10 U/g) on the 
first view should be sufficient for quantitative transformation of trihydroxybiphenyl 
produced from dibenzofuran (at a rate of 0.2–0.3 U/g). However, significant 
accumulation of trihydroxybiphenyl was observed during dibenzofuran transformation, 
indicating ring-cleavage to be rate limiting. The specific rates (U/g protein) of 
trihydroxybiphenyl transformation by whole cells of E. coli DH10B (pMDK19) and the 
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respective cell extracts differed by more than one order of magnitude and the low 
activities observed by whole cells were similar to those of dibenzofuran transformation 
and could indicate a bottleneck at this enzymatic step.  However, the reasons for this 
observed differences remains to be elucidated. It should be noted, that Wittich et al. 
(Wittich et al.,1992) did not observe any significant difference (less than a factor of 2) 
between specific oxygen uptake rates by Sphingomonas sp. RW1 upon incubation with 
di- or trihydroxybiphenyl and the respective activities determined in cell extracts, 
indicating substrate uptake not to be rate limiting and activities in-situ to be similar to 
those measuresd in cell extracts.  
Both gene cassettes enabled the respective E. coli derivatives to transform dibenzo-p-
dioxin. However, only trihydroxybiphenyl ether was observed as transformation 
product. Such an outcome can be expected from the kinetic data of the extradiol 
dioxygenases. Assuming that an amount of Edo2-2, which can transform 1µmol of 2,3-
dihydroxybiphenyl per minute, is capable of transforming 0.05 µmole of THBE, it can 
be calculated that E. coli (pMDK19) cells of an OD of 10 contain enough Edo2-2 to just 
transform a total of 1 µM trihydroxybiphenyl and thus 1% of the formed intermediate 
during the dibenzo-p-dioxin transformation experiments. Even though, higher activities 
of DbfB were observed in E. coli (pMDK12), the effectivity of this enzyme with THBE 
was shown to be lower than the effectivity of Edo2-2. The low effectivity of DbfB with 
THBE as substrate was confirmed by the experiments in which dibenzo-p-dioxin was 
transformed by E. coli cells expressing module I enzymes in the presence of E. coli 
cells overexpressing different extradiol dioxygenases. Less than 20 µM of THBE 
permanently released during dibenzo-p-dioxin turnover could be further transformed by 
E. coli BL21(DE3)(LysS)(pTW7-5RW) overexpressing DbfB present at an optical 
density of 5, a cell extract of which is capable of transforming 9000 µmole DHB/min g 
protein. Assuming further on OD of 5 to correspond to 0.5 g protein/l, the applied cell 
suspension should contain ca. 0.3 µM of DbfB. Thus the in-vivo turnover capacity of 
DbfB in E. coli  for THBE is lower than 60 substrate molecules/enzyme molecule. In 
contrast to cells overexpressing DbfB, cells overexpressing Edo2-2 or 2-3 were capable 
of a significant further transformation (75–85 µM) of intermediary released 
trihydroxybiphenyl ether. The extend of further transformation was in the same order of 
magnitude as that calculated taking account the kinetic data determined in cell extracts 
for THBE transformation (70–190 µM). Thus, in E. coli, there are no auxiliary 
functions present which can overcome the observed inactivation of extradiol 
dioxygenases in-vivo or which can prevent to some extend such inactivation. 
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Consequently, RW1 either contains not yet discovered reactivation systems or not yet 
discovered other extradiol dioxygenases not subject to such an inactivation.  
Recently, (Kasuga et al., 2001) characterized genes encoding an angular dioxygenase 
from the dibenzofuran degrader Terrabacter sp strain DBF63 and could show that the 
gene products of dbfA1 and A2, together encoding the terminal oxygenase components, 
were capable in E. coli of angular dioxygenation of both dibenzofuran and dibenzo-p-
dioxin. Similarly the carA genes of the carbazol degrader Pseudomonas sp. strain CA10 
were described to transform dibenzo-p-dioxin and dibenzofuran by an angular attack 
(Sato et al., 1997) and even the biphenyl dioxygenase of the biphenyl degrader 
Burkholderia sp. strain LB400 was shown to catalyze angular dioxygenation of 
dibenzo-p-dioxin and dibenzofuran (Seeger et al., 2001). However, the presence in a 
strain of a dioxygenase enabling angular dioxygenation and a complete pathway for 
mineralization of dihydroxybiphenyl or analogues is not enough to enable a strain to 
mineralize dibenzofuran or dibenzo-p-dioxin. Moreover, even though being capable of 
dibenzofuran degradation, both Terrabacter sp. strain DBF63 or Pseudomonas sp. 
HH69 did not mineralize dibenzo-p-dioxin. This can be due to different reasons such as 
low transformation rates or inadequate or missing induction of the pathway enzymes by 
the substrates. Failure to grow on dibenzofuran can be due to the absence of salicylate 
hydroxylating activities in the strain analyzed. Harms described that, in strain HH69, 
the trihydroxybiphenyl ether undergoes an unexpected ortho-cleavage (Harms et al., 
1990). They also reported that this strain does not grow on dibenzofuran in the presence 
of small amounts of dibenzo-p-dioxin and explained this by competitive inhibition of 
the meta-cleavage enzyme. In the light of the investigations in the current report, it can 
be proposed that the meta-cleavage enzyme in HH69 is fastly inactivated during 
trihydroxybiphenyl ether transformation, such that this compound is finally nearly 
quantitatively channeled into a simultaneously induced unproductive ortho-cleavage 
route. Kasuga et al. (Kasuga et al., 1997) reported that a dihydroxybiphenyl 
dioxygenase isolated from Terrabacter DBF63 is capable of transforming 
trihydroxybiphenyl ether into a yellow colored product. In contrast to their proposal, 
that the yellow coloration is due to the ring-cleavage product, it can be assumed that the 
coloration results from the cleavage of intermediary formed catechol as observed during 
the transformation of trihydroxybiphenyl ether by Edo2-2. However, the observed 
transformation does not give any indication of the efficiency of that reaction. Thus it 
can be proposed that in both HH69 and DBF63 the failure to grow on dibenzo-p-dioxin 
is due to a missing effective trihydroxybiphenyl ether transforming system.  
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Despite the fact that the developed gene cassettes function for dioxin only in the 
presence of a system overproducing extradiol dioxygenases, it can be concluded that the 
gene cassette comprising dbfB is functional for the degradation of dibenzofuran into 
salicylate. It can be thus a useful tool to rationally assemble, in future, complete 
degradative pathways for dibenzofuran, and, after elucidation of the transformation 
capacity for chlorinated dibenzofurans, to assemble organisms capable to mineralize 
chlorodibenzofurans. It was recently shown (Arfmann et al., 1997), that a coculture of 
Sphingomonas sp. RW1, transforming 4-chlorodibenzofuran into 3-chlorosalicylate and 
Burkholderia sp. RWS is capable to mineralize 4-chlorodibenzofuran. Taking into 
account the biochemistry of transformation as well as transformation rates of 
chlorodiobenzofurans (Wilkes et al., 1996) it can be reasoned that micorooragnisms 
capable to mineralize chloro- as well as some dichlorodibenzofurans can be constructed 
using the gene module constructed here under a suitable regulatory system. 
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5 Summary 
 
 
 
Extradiol dioxygenases have crucial roles in the degradation of various aromatic 
compounds, including the degradation of dibenzo-p-dioxin and dibenzofuran by 
Sphingomonas sp. RW, where such enzymes are responsible for the cleavage of the 
pathway intermediates 2,2´,3-trihydroxybiphenyl (THB) and 2,2´,3-trihydroxybiphenyl 
ether (THBE). In this study we showed that at least three different extradiol 
dioxygenases are encoded in the RW1 genome, namely DbfB (Edo1), Edo2 and Edo3 
which extends our knowledge on the genetic puzzle of catabolic genes in RW1.  
The Edo3 structural gene, 800 bp long, has been found to be preceded by a ORF, 
encoding a 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase, H3. The edo3 ATG 
start codon overlaps the H3 stop codon. Activity of Edo3 was observed when edo3 was 
cloned separately from H3. The sequence analysis of the edo2 (892 bp) gene revealed 
the presence of three putative ATG start codons and ATG2 was identified as the most 
likely one used in RW1 during the transcription of edo2. 
From the alignment of the amino acid sequences, Edo2 and Edo3 (like DbfB) were 
shown to cluster with extradiol dioxygenases specialized in transforming bicyclic 
aromatics. The respective substrate preferences were confirmed in kinetic experiments. 
However, Edo 2 and Edo 3 of RW1 are the first enzymes described with similar 
preferences for di- and trihydroxybiphenyl as substrates.  
All three dioxygenases underwent rapid inactivation during transformation of THBE. 
Despite rapid inactivation, catechol and 2-pyrone-6-carboxylate could be identified as 
reaction products of ring-cleavage and enzymatic tests to follow and kinetically 
characterize THBE transformation were developed. In this study it was shown that the 
inactivation is not mediated by the substrate nor by any of the reaction product but 
dependent on the presence of oxygen and substrate turnover. The inactivation was very 
effective, especially for DbfB where turnover numbers lower than 60 were determined 
but less pronounced for Edo3 and especially Edo2.  
The structural genes encoding for the enzymes involved in the dibenzofuran and dioxin 
degradation upper pathway were then assembled into two compact modular genetic 
cassettes with the intent to use them for the realization of genetically engineered 
microorganisms able to completely mineralize chlorinated dibenzofurans and dioxins. 
Those cassettes were constructed in a fashion enabling the rational exchange of a 
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certain gene by another one encoding for a protein of similar function, thus allowing the 
analysis of the function of various members of a family of genes in the degradation of a 
certain substrate. Based on the kinetic properties of their gene products, dbfB 
(dibenzofuran gene cassette) and edo2 (dibenzo-p-dioxin degradation) were included in 
those cassettes. It was evidenced that all enzymes relevant for the transformation of 
dibenzofuran into salicylate and of dibenzo-p-dioxin into catechol were expressed from 
both cassettes.  
The gene cassette comprising dbfB was performing properly as evidenced by 
quantitative transformation of dibenzofuran into salicylate without accumulation of 
intermediates or side-products. Both gene cassettes transformed dibenzo-p-dioxin as far 
as THBE only, due to in-vivo inactivation of extradiol dioxygenases. By the presence of 
cells overexpressing different extradiol dioxygenases, it could be verified that Edo2 is 
suited, however imperfectly, for the further transformation of THBE. 
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6 Abbreviations: 
 
 
 
A  Adenine 
Ap   Ampicillin 
APS  Ammonium persulphate 
ATP  Adenosine triphosphate 
BPH  Biphenyl 
BSA  Bovine serum albumin 
bp  Base pairs 
C  Cytosine 
CBP  Chlorinated biphenyl 
Cm  Chloramphenicol 
DBF  Dibenzofuran 
dbfB  THB-dioxygenase gene 
DMSO Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
dNTP  Deoxynucleotide triphosphate 
DTT  Dithiothreitol 
edo2  Gene for extradiol dioxygenase  
edo3  Gene for extradiol dioxygenase  
EDTA  Ethylenediaminetetraacetic acid 
FPLC  Fast Protein Liquid Chromatography 
G   Guanine 
g  Gram 
H3  Gene for 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase  
h  Hour 
HOPDA 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate 
HPLC  High Performance Liquid Chromatography 
IPTG  Isopropyl-thio-ß-D-galactopyranoside 
Kb  Kilobase 
Kcat  Maximal turnover number  
Kd  Dissociation constant 
kDa   Kilodalton 
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Km   Kanamycin 
Km  Michaelis constant 
l  Liter 
M  Molar 
m  milli- 
µ micro- 
min  minute 
n  nano- 
nt  nucleotide 
OD  Optical density 
ORF  Open reading frame 
PAGE  Polyacrylamide gel electrophoresis 
PAH  Polycyclic aromatic hydrocarbons  
PCR  Polymerase chain reaction 
RBS  Ribosome binding site 
rpm  Rounds per minute 
S  Substrate 
SD  Shine Dalgarno 
SDS  Sodium dodecyl sulphate  
sp.   Species 
T  Thymine 
Tab.  Table 
TAE  Tris-acetate/EDTA  
TEMED N,N,N,N-Tetramethylethylenediamine 
THB  2,2’,3-trihydroxybiphenyl 
THBE  2,2’,3-trihydroxybiphenyl ether 
Tris  Tris(hydroxymethyl)aminomethane 
U  Unit 
UV  Ultraviolet light 
V  Volt 
v  volume 
Vmax  Maximal enzymatic activity at substrate saturation  
w  Weight 
X-Gal  5-bromo-4-chloro-3-indolyl-β-D-galactoside 
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